TradingFloor Mobile
2026-04-14 / ALL-MARKETS
Full desktop terminal available Open Full Site ↗
Guest Preview Active
Create an account after 9s to keep the mobile market desk live.
Create Account Login
TFAI Command Terminal

Full Market Intelligence

AI-powered RNS digestion, live interactive charts, insider flow and broker targets — all in your pocket.

Create Free Account
Market AI 501 headlines · 27 AI picks today Tap a ticker to open AI chart · Ask AI above -- AI
Find by ticker, company name or close match. Tap + to add alerts.
Loading market intelligence…
Quant BTC Blending

Crypto Dream Desk

BTC structure, AI forecast, macro event odds and listed crypto-beta names blended into one mobile cockpit.

BTC logo
Loading BTC quant blending from the main site engine...
Open full quant desk

Live RNS Feed

49 types
All Market News Today All digested RNS titles 501
IGET logo
All News 15:59
IGET

Issue of Equity

Invesco Perpetual Select Trust plc - Global Equity Income Share Portfolio

SBO logo
All News 15:45
SBO

Holding(s) in Company

Schroder British Opportunities Trus

TR1 Buy
['Philip J Milton & Company Plc', '3.010000', 0]
FGP logo
All News 15:25
FGP

Director/PDMR Shareholding

FirstGroup PLC

<mark style="background-coloryellow">Purchase</mark> of Partnership Shares under the FirstGroup SIP
BGS logo
All News 15:06
BGS

Holding(s) in Company

Baillie Gifford Shin Nippon PLC

TR1 Buy
['City of London Investment Management Company Limited', '10.920000', '11.410000']
ONT logo
All News 15:01
ONT

Share Incentive Plan - Director/PDMR Shareholding

Oxford Nanopore Technologies Ltd

Under the SIP, the SIP Trustee will award each participating employee one Matching Share (as defined in the SIP) for each Ordinary Share <mark style="background-color:yellow">purchase</mark>d by the employee under the SIP. On 14 April 2026, the Company issued 136 Ordinary Shares to the SIP Trustee to hold on behalf of Francis Van Parys to satisfy the Matching Shares awarded under the SIP to him on that date, and 136 Ordinary Shares to the SIP Trustee to hold on behalf of Nick Keher to satisfy the Matching Shares awarded under the SIP to him on that date.
BGCG logo
All News 14:54
BGCG

Holding(s) in Company

Baillie Gifford China Growth Trust PLC

TR1 Buy
['City of London Investment Management Company Limited', '22.170000', '21.010000']
ALT logo
All News 14:26
ALT

Director/PDMR Dealing

Altitude Group Plc

Bob Wigley, Non-Executive Director, <mark style="background-color:yellow">purchase</mark>d 200,000 Ordinary Shares at an average price of 24.75 pence per share. Following the purchase of Ordinary Shares, Bob Wigleys beneficial holding is 400,000 Ordinary Shares, representing approximately 0.55% of the Companys issued share capital.
IPF logo
All News 14:26
IPF

Form 8.3

International Personal Finance PLC

IPF logo
All News 14:26
IPF

Form 8.3

International Personal Finance PLC

FTV logo
All News 14:16
FTV

Final Results

Foresight VCT PLC

**Summary**
Foresight VCT plc, managed by Foresight Group LLP, released its final results for the year ended 31 December 2025, approved by the Board of Directors on 13 April 2026. The company reported a Net Asset Value (NAV) Total Return per share of 0.1%, with dividends of 10.5p leading to a 10.4p fall in NAV from 82.0p to 71.6p. Key financial highlights include a special interim dividend of 6.4p and a final dividend of 4.1p, distributing £19.3 million and £12.4 million respectively. The company made six new investments totaling £7.8 million and twelve follow-on investments costing £7.7 million. The value of the investment portfolio decreased by £8.4 million, driven by the sale of an investment for £24.3 million and a loan repayment of £0.1 million, offset by new and follow-on investments. The company raised £38.6 million through a share offer in January 2026 and recommends a final dividend of 3.6p per share for 2025. The Chair’s statement highlights a 16.0% dividend yield, including a special dividend, and emphasizes the company’s diversified portfolio resilience in a challenging economic environment. The company maintains its strategic objectives, including paying annual dividends of at least 5% of NAV, achieving a NAV Total Return <mark style="background-color:yellow">above</mark> 5%, and implementing regular share buybacks. The Board and Manager remain committed to these goals, despite the flat performance in 2025, and are focused on long-term value creation for shareholders.
Year-on-Year Financial and Debt Comparison (2024 vs 2025)
Metric20242025Change
Net Asset Value (NAV) (£ million)222.9214.0-8.9 (-4.0%)
NAV per share (pence)82.071.6-10.4 (-12.7%)
Total Dividends Paid (£ million)31.731.70 (0.0%)
Dividend per share (pence)10.510.50 (0.0%)
Investment Portfolio Value (£ million)166.6158.2-8.4 (-5.0%)
New Investments (£ million)14.315.5+1.2 (+8.4%)
Follow-on Investments (£ million)7.77.70 (0.0%)
Proceeds from Disposals (£ million)36.524.4-12.1 (-33.1%)
Debt (Amounts falling due within one year) (£ million)3.32.2-1.1 (-33.3%)
Cash and Cash Equivalents (£ million)55.955.2-0.7 (-1.3%)
### Key Observations: 1. **Net Asset Value (NAV):** Decreased by 4.0% from £222.9 million in 2024 to £214.0 million in 2025, primarily due to dividend payments and investment losses. 2. **NAV per Share:** Fell by 12.7% from 82.0p to 71.6p, reflecting the decrease in NAV and the impact of dividends. 3. **Dividends:** Remained consistent at £31.7 million, with no change in dividend per share. 4. **Investment Portfolio:** Decreased by 5.0% from £166.6 million to £158.2 million, driven by a successful realisation and loan repayment, offset by new and follow-on investments. 5. **Debt:** Reduced by 33.3% from £3.3 million to £2.2 million, indicating improved liquidity. 6. **Cash and Cash Equivalents:** Slightly decreased by 1.3% from £55.9 million to £55.2 million, reflecting operational and investment activities.
SCT logo
All News 14:00
SCT

Holding(s) in Company

Softcat plc

TR1 Buy
['JPMorgan Asset Management Holdings Inc.', '4.612059', '4.559041']
NFG logo
All News 13:21
NFG

Holding(s) in Company

Next 15 Group PLC

TR1 Buy
['Liontrust Investment Partners LLP', '11.142000', '10.419000']
BGEU logo
All News 12:46
BGEU

Holding(s) in Company

Baillie Gifford European Growth Trust PLC

TR1 Buy
['1607 Capital Partners, LLC', '9.532047', '10.088416']
IPF logo
All News 11:10
IPF

Form 8.3

International Personal Finance PLC

LST logo
All News 11:05
LST

Holding(s) in Company

Light Science Technologies Holdings PLC

TR1 Buy
['Dr Graham Cooley', '4.18', '8.71']
IPF logo
All News 10:38
IPF

Form 8.3

International Personal Finance PLC

DGE logo
All News 08:53
DGE

Director/PDMR Shareholding

Diageo PLC

1. <mark style="background-coloryellow">purchase</mark> of partnership shares using deductions from salary
and
ASL logo
All News 08:43
ASL

Holding(s) in Company

Aberforth Smaller Companies Trust PLC

TR1 Buy
['Evelyn Partners Limited', '4.852125', '5.081000']
BRSC logo
All News 08:29
BRSC

Holding(s) in Company

Blackrock Smaller Companies Trust PLC

TR1 Buy
['Saba Capital Management, L.P.', '2.568941', '2.311881']
YNGA logo
All News 08:29
YNGA

Holding(s) in Company

Young & Co’S Brewery A

TR1 Buy
['FitzWalter Capital Limited', '15.349468', '14.408009']
PZC logo
All News 07:44
PZC

Director/PDMR Shareholding

PZ Cussons PLC

Dividend reinvestment and <mark style="background-color:yellow">purchase</mark> of Ordinary shares of 1p each in PZ Cussons plc
EOT logo
All News 07:41
EOT

Holding(s) in Company

European Opportunities Trust plc

TR1 Buy
['1607 Capital Partners, LLC', '10.641627', '11.875311']
AMOI logo
All News 06:30
AMOI

Anemoi enters into amended and updated binding Sale and Purchase Agreement to acquire Trasna, Share Consolidation and Warrantholder Surrender and Subscription Offer

Anemoi International Ltd

Anemoi International Ltd has entered into an amended and updated binding Sale and Purchase Agreement to acquire Trasna Solutions FZ LLC via a reverse takeover (RTO), valuing Trasna at $150 million. The transaction includes a share consolidation (1 for 100 reverse stock split), a voluntary warrant surrender and subscription offer for existing warrantholders at £0.02 per share, and a proposed name change to Trasna Ltd upon completion. The deal is subject to conditions, including due diligence and a fundraise, with readmission to the London Stock Exchanges Main Market planned post-RTO. Shareholders are cautioned that the transaction may not proceed or terms may change.
Offers
FIN logo
All News 06:06
FIN

Launch of Retail Offer

Finseta Plc

Finseta PLC, a foreign exchange and payments solutions company, announced a retail offer to raise up to £0.1 million by issuing new ordinary shares at 8.5 pence each. The offer is open to existing UK-based shareholders, with a minimum subscription of £100. The proceeds will be used alongside funds from a placing and subscription to support the companys operations. The retail offer is conditional on the completion of the placing and subscription, with shares expected to be admitted to trading on AIM around 20 April 2026.
Launch
ITRK logo
All News 06:02
ITRK

Strategic Review Initiation & Trading Statement

Intertek Group PLC

Intertek Group PLC initiates a strategic review to evaluate the potential separation of Intertek Energy & Infrastructure from Intertek Testing & Assurance, aiming to accelerate growth and create two specialist, global ATIC businesses. The review, concluding by mid-2027, assesses whether a sale or demerger would unlock full potential, enhance focus, and improve capital allocation. Intertek reports strong Q1 2026 performance with 5.4% LFL revenue growth, reiterates full-year guidance, and highlights robust demand across divisions, except for stable performance in World of Energy. The company emphasizes its AAA strategy, strong cash flow, and commitment to delivering value for shareholders through disciplined execution and strategic focus.
Metric2026 (Q1)2025 (FY)2024 (FY)Year-on-Year Change (2026 vs 2025)Year-on-Year Change (2025 vs 2024)
Group Revenue£838.5m£3,431.6m£3,393.2m3.7% (actual), 6.7% (constant currency)1.1% (actual), 4.3% (constant currency)
LFL Revenue£828.3m£3,416.3m£3,391.8m2.4% (actual), 5.4% (constant currency)0.7% (actual), 3.9% (constant currency)
Consumer Products Revenue£232.6m£902.5m (2025)£884.3m (2024)2.5% (actual), 6.5% (constant currency)2.1% (actual), 5.8% (constant currency)
Corporate Assurance Revenue£126.5m£485.6m (2025)£468.9m (2024)8.2% (actual), 10.8% (constant currency)3.6% (actual), 7.2% (constant currency)
Health and Safety Revenue£92.2m£350.9m (2025)£337.2m (2024)16.3% (actual), 15.8% (constant currency)4.1% (actual), 6.8% (constant currency)
Industry and Infrastructure Revenue£209.9m£788.0m (2025)£786.3m (2024)2.8% (actual), 6.7% (constant currency)0.2% (actual), 3.5% (constant currency)
World of Energy Revenue£177.3m£904.6m (2025)£916.5m (2024)(2.4%) (actual), 0.2% (constant currency)(1.3%) (actual), 1.8% (constant currency)
Net Financial Debt (FY)N/A£930-980m (FY26 Guidance)£880m (2025)~5.7% - 11.4% increase (estimated)N/A
HVO logo
All News 06:02
HVO

hVIVO launches unified brand identity

hVIVO plc

hVIVO plc announces a unified brand identity, marking its strategic transformation into a fully integrated clinical development partner. The rebrand follows the successful integration of Venn Life Sciences, CRS, and Cryostore, simplifying the groups structure under the hVIVO brand. The company now operates through four integrated service lines: Consulting, Clinical Trials, Human Challenge Trials, and Laboratories, offering a seamless pathway from pre-clinical strategy to clinical proof-of-concept. This transformation aims to accelerate drug development, reduce complexity, and provide high-quality human data for clients. CEO Yamin Mo Khan emphasizes the unified brands ability to help pharmaceutical and biotech companies bring medicines to patients faster.
Launch
ANIC logo
All News 06:01
ANIC

Tropic’s product receives regulatory approval

Agronomics Ltd

Tropic Biosciences, a portfolio company of Agronomics Limited, has received regulatory approval in Japan and Brazil for its non-browning banana variety. This approval allows the banana to be imported, sold, and consumed in both countries, with Brazil also permitting its cultivation. The development supports sustainability, reduces food waste, and expands market opportunities. Tropics innovation, launched in 2025, marks the first new commercial banana variety in over 75 years and was named one of TIME Magazines Best Inventions of 2025. The approvals in Japan and Brazil, two critical markets, enhance Tropics global regulatory footprint, reinforcing its leadership in agricultural biotechnology. Agronomics, with a 1.6% stake in Tropic, highlights the significance of these approvals in validating Tropics platform and unlocking commercial potential.
Approvals
MKA logo
All News 06:01
MKA

HYPROMAG AND MKANGO RARE EARTHS UK TO COLLABORATE

Mkango Resources Ltd

HyProMag and Mkango Rare Earths UK have been awarded a £6.5 million grant under the UKs DRIVE35 R&D competition to develop recycled neodymium-iron-boron (NdFeB) magnets for high-grade automotive applications. The project, named REACT UK, aims to establish a full circular supply chain for these magnets in the UK, combining advanced recycling methods and hydrogen-based processing to enhance sustainability and supply security. Led by HyProMag, the consortium includes Mkango UK, EMR Group, Jaguar Land Rover, Less Common Metals, and the University of Birmingham. The project will run for three years, with £3.2 million (49%) funded by the UK government. This initiative supports the UKs transition to zero-emission mobility and strengthens domestic manufacturing capabilities.
Collaborate
SEED logo
All News 06:01
SEED

Investment in Clean Food Group Funding Round

Seed Innovations Ltd

Seed Innovations Ltd (AIMSEED) has invested £260,000 in a £4.5 million funding round for its portfolio company, Clean Food Group (CFG), a UK biotech manufacturer of sustainable oils and fats. The funding, led by Clean Growth Fund and New Agrarian Company Limited, is structured as a convertible loan note (CLN) with a 12% annual coupon, maturing in August 2027. This investment supports CFGs scale-up of its Knowsley fermentation facility, positioning it as the worlds largest manufacturer of yeast-derived oils and fats. SEEDs total exposure to CFG, including equity and CLN, reaches £1.98 million, with CFG valued at £1.7 million in SEEDs 2025 Interim Report. CFG, pre-revenue with £13 million raised to date, aims to address supply chain fragility and sustainability in the global food system, targeting a sustainable food market projected to reach US$524 billion by 2032.
Premium Placing
PRU logo
All News 06:01
PRU

Director/PDMR Shareholding

Prudential plc

Acquisition of shares through the Prudential All Employee Share <mark style="background-color:yellow">Purchase</mark> Plan
FLTR logo
All News 06:01
FLTR

Holding(s) in Company

Flutter Entertainment PLC

TR1 Buy
['Bank of America Corporation', '2.873447', '0.309604']
HAS logo
All News 06:01
HAS

Director/PDMR Shareholding

Hays plc

<mark style="background-coloryellow">Purchase</mark> of shares at a price of 27p per share under the Hays plc US Employee Stock Purchase Plan on 13 April 2026. In accordance with the Plan rules, the shares will be held in a Holding Period of one year.
ESO logo
All News 06:01
ESO

Director/PDMR Shareholding

EPE Special Opportunities Limited

<mark style="background-coloryellow">Purchase</mark> of ordinary shares
GMS logo
All News 06:01
GMS

2025 Financial Results

Gulf Marine Services PLC

**Summary**
Gulf Marine Services PLC (GMS) reported its 2025 financial results, highlighting a 12% increase in revenue to US$188.1 million and adjusted EBITDA to US$112.9 million, driven by an additional leased vessel and higher day rates. Adjusted net profit rose 30% to US$41.8 million, while net profit decreased 49% to US$19.5 million due to impairment charges and tax expenses. Fleet utilization dropped to 87% due to maintenance and geopolitical disruptions. Net leverage improved to 1.39x, and net bank debt reduced to US$156.6 million. The company secured new contracts totaling 15.4 years, increasing its backlog to US$606 million. Despite geopolitical challenges, GMS maintained operational reliability and safety standards, achieving zero Lost Time Injury Rate (LTIR) and Total Recordable Injury Rate (TRIR). The company acquired a new mid-class vessel and aims to double its 2024 adjusted EBITDA by 2030. However, the ongoing geopolitical situation in the Gulf region poses risks, leading to a cautious outlook for 2026 and the suspension of dividend declarations. Management is closely monitoring the impact on operations and financial performance.
Financial Metric2023 (US$m)2024 (US$m)2025 (US$m)2025 vs 2024 Change
Revenue151.6167.5188.1+12%
Adjusted EBITDA87.5100.4112.9+12%
Adjusted Net Profit9.832.241.8+30%
Net Profit42.138.319.5-49%
Net Bank Debt267.3201.2156.6-22%
BLOE logo
All News 06:01
BLOE

Binding Framework Agreement - Project III Farm Out

Block Energy PLC

Block Energy plc has signed a binding Framework Agreement with Zhijiang Sanning Energy Co. Ltd for the farm-out of Project III in Georgia. Sanning will acquire 51% of Project III, carrying up to USD 75 million in costs for appraisal drilling and early facilities construction. Block retains 49% and operatorship, while keeping 100% ownership of other projects and existing production. The deal focuses on appraising the Patardzueli-Samgori field, with potential expansion to Rustavi and Teleti fields, targeting 2.77 TCF 2C Contingent Resources and a gross success case NPV10 of USD 2.2 billion. Final agreements are expected in H2 2026, with operations starting in 1H 2027, pending approvals. The partnership leverages Blocks upstream expertise and Sannings downstream capabilities, enhancing Georgias energy security and investment appeal.
Agreement
PRV logo
All News 06:01
PRV

AGM Trading Update

Porvair plc

Porvair plcs AGM trading update highlights that the groups performance in the first four months of 2026 is in line with expectations, with 5% constant currency revenue growth. Key points include
Strong aerospace order bookscontinued robust nuclear demandand subdued petrochemical sales.
Steady life sciences consumables orders and stable environmental instrument demand in the Laboratory division.
Firm aluminium and superalloys demand in Metal Melt Quality, with progress on the new US manufacturing line and successful Drache acquisition integration.
Unchanged full-year performance expectations, supported by a diversified portfolio, recurring revenue, and disciplined management.
Increased focus on M&A opportunities, with no change to long-term strategic outlook.
Upcoming Capital Markets Event in October 2026 and interim results announcement in June 2026.
Since the provided text does not contain specific financial or debt figures for comparison, I cannot generate an HTML table with year-on-year comparisons. However, I can provide a generic HTML table structure that you can use to input the relevant data if it becomes available:
Metric20252026Change
Revenue Growth5%
Debt
If you provide the actual financial and debt figures, I can populate this table accordingly.
AMCO logo
All News 06:01
AMCO

Final Results, Analyst Briefing & Investor Pres

Amcomri Group plc

Amcomri Group PLC reported strong financial results for the year ending December 31, 2025, with a 22% increase in revenue to £70.9 million, a 19.3% rise in adjusted EBITDA to £9.2 million, and a 145% surge in profit before tax to £4.1 million. The companys Buy, Improve, Build strategy drove organic and acquisitive growth, with acquisitions like EMC Elite Engineering and Radnor Technologies expanding its service offerings. Operational highlights included growth across both divisions, improved gross margins, and a strengthened team. Post-year-end, Amcomri acquired the National Compliance and Testing division of Enerveo Limited, further enhancing its market position. The company remains well-positioned for future growth with a strong acquisition pipeline and positive trading conditions in key markets.
Financial Metric2024 (£'000)2025 (£'000)Change (£'000)Change (%)
Revenue58,06670,93812,87222%
Adjusted EBITDA7,7009,2001,50019.3%
Profit Before Tax1,6754,1062,431145%
Net Debt6,10011,2005,10083.6%
Cash Balances12,1008,600(3,500)(28.9%)
### Explanation: 1. **Revenue**: Increased by £12,872,000 (22%) from £58,066,000 in 2024 to £70,938,000 in 2025. 2. **Adjusted EBITDA**: Increased by £1,500,000 (19.3%) from £7,700,000 in 2024 to £9,200,000 in 2025. 3. **Profit Before Tax**: Increased by £2,431,000 (145%) from £1,675,000 in 2024 to £4,106,000 in 2025. 4. **Net Debt**: Increased by £5,100,000 (83.6%) from £6,100,000 in 2024 to £11,200,000 in 2025. 5. **Cash Balances**: Decreased by £3,500,000 (28.9%) from £12,100,000 in 2024 to £8,600,000 in 2025.
HVO logo
All News 06:01
HVO

Influenza HCT contract signed with Traws Pharma

hVIVO plc

hVIVO plc, a leading clinical development partner, has signed a contract with Traws Pharma to conduct a Phase 2a human challenge trial for their influenza antiviral candidate, tivoxavir marboxil (TXM). The trial, utilizing hVIVOs Influenza Human Challenge Study Model, will assess TXMs safety, tolerability, and efficacy in reducing influenza-induced illness in 150 healthy participants. The study, expected to commence in H1 2026, highlights hVIVOs integrated clinical development services and Traws Pharmas strategy to accelerate TXMs development.
NewContract
IMB logo
All News 06:01
IMB

Trading Update

Imperial Brands PLC

Imperial Brands PLCs trading update for 14 April 2026 highlights a positive start to its 2030 transformation strategy, with the company reiterating its full-year guidance. Key points include
1. **Revenue Growth**Low-single-digit percent growth expected in tobacco & NGP (Next Generation Products) net revenue for H1 2026, driven by robust tobacco pricing and NGP innovation.
2. **Profitability**Group adjusted operating profit slightly higher in H1 compared to 2025, with growth accelerating in H2, in line with previous guidance.
3. **Earnings and Cash Flow**On track for at least high-single-digit earnings per share growth and at least £2.2 billion in free cash flow for the full year.
4. **Share Repurchase**Completed £0.7 billion of the £1.45 billion FY26 share buyback as part of an "evergreen" program.
5. **Strategic Initiatives**Progress in becoming more consumer-centric, data-led, and efficient through partnerships (e.g., Capgemini), supply chain optimization, and IT application rollouts.
6. **Geopolitical Risks**Monitoring potential impacts from the Middle East conflict, though no material business impact to date.
7. **Regional Performance**Strong NGP growth in Europe and AAACE regions, offset by challenges in the US, Australia, and Logista.
8. **Forex Impact**Translation foreign exchange expected to be a 2.0-2.5% headwind on H1 earnings per share and 0-1% on full-year earnings.
Interim results for H1 FY26 will be announced on 12 May 2026.
Financial MetricFY2025FY2026 (Expected)Change
Tobacco & NGP Net Revenue GrowthN/ALow-single-digit%N/A
Group Adjusted Operating Profit GrowthN/ASlightly higher than H1 2025N/A
Earnings Per Share GrowthN/AHigh-single-digit%N/A
Free Cash FlowN/A£2.2 billionN/A
Share Repurchase (Completed)£0.1 billion (Oct 2024)£0.7 billion (of £1.45 billion)+£0.6 billion
Net Debt to EBITDA LeverageN/A2.0-2.5 range (lower end)N/A
NGP Adjusted Operating LossesN/AModerately higherN/A
**Notes:** * The table compares expected financials for FY2026 with available data from FY2025. Since specific FY2025 figures are not provided in the text, the "FY2025" column mostly contains "N/A". * "Change" column indicates the difference between FY2026 and FY2025 where applicable. * This table focuses on key financial metrics mentioned in the text, including revenue growth, profit growth, cash flow, share repurchases, leverage, and operating losses.
CRTA logo
All News 06:01
CRTA

Trading Statement

Cirata plc

Cirata PLC reports a strong Q1 FY26 with its first-ever positive cash flow quarter, a 40% pipeline growth, and improved visibility through new KPIs (ACV, Billings, RCB). The company reaffirms its FY26 cash flow break-even target, highlighting momentum in enterprise sales, particularly with Cirata Symphony, and continued focus on new logo acquisition and existing customer expansion.
MetricQ1 FY26Q4 FY25 (31 Dec 2025)Year-on-Year Change
Cash Flow$0.7m (Positive)Not specified (Negative)First positive cash flow quarter in history
Closing ACV$4.9m$4.8m+2.08%
Billings$2.3mNot specifiedN/A
RCB$5.8mNot specifiedN/A
Cash Balance$4.7mNot specifiedN/A
Trade Receivables$0.7mNot specifiedN/A
Cash Overheads$3.1mNot specifiedN/A
Pipeline Growth+40% (since Jan 2026)Not specifiedN/A
CRPR logo
All News 06:01
CRPR

Full Year Trading Update

James Cropper PLC

James Cropper plc announces a strong FY26 performance, with adjusted EBITDA of £8.8m (up 30% YoY) and revenue of £103m (up 4% YoY). Advanced Materials saw high single-digit EBITDA growth, while Paper & Packaging significantly reduced losses. Net debt decreased to £8.3m, with a net debt/EBITDA ratio below 1x. Positive trading momentum continues into FY27, with confidence in medium-term growth for both divisions. The company expects to announce audited FY26 results in July 2026.
MetricFY25FY26Change
Adjusted EBITDA (£m)6.678.8+31.9%
Group Revenue (£m)99.0103.0+4.0%
Net Debt (£m)12.98.3-35.7%
Net Debt to EBITDA Ratio1.9x<1.0xImproved
DPP logo
All News 06:01
DPP

Q1 2026 Trading Update

DP Poland Plc

DP Poland PLC reports strong Q1 2026 performance with 18.9% system sales growth and 13.7% order increase, driven by operational efficiency, promotions, and timely deliveries. Franchise ownership rose to 35%, with four more Pizzeria 105 stores converted. Supply chain optimization and network expansion (141 Dominos stores, 71 Pizzeria 105) supported growth. Poland and Croatia saw robust sales and order increases. The company targets 50% franchise ownership by 2027, 200+ stores, and margin improvement through disposals, automation, and scaling. Outlook remains positive with double-digit growth expected in 2026.
DP Poland PLC - Financials and Debt Comparison (Q1 2026 vs Q1 2025)
MetricQ1 2026Q1 2025YoY Change
Group System Sales (£m)17.214.518.9%
Group System Orders (m)1.31.113.7%
Poland
Total System Sales (PLNm)78.466.318.2%
LFL System Sales (PLNm)67.962.48.9%
Total System Orders (m)1.31.113.3%
LFL System Orders (m)1.11.13.9%
Croatia
Total System Sales (EURm)1.20.928.8%
LFL System Sales (EURm)1.11.09.5%
Total System Orders (m)0.10.120.0%
LFL System Orders (m)0.10.12.0%
Network Expansion
Domino's Stores (YoY Change)141 (+17%)120—
Franchise-Owned Stores (% of Estate)35%12%—
Pizzeria 105 Stores Converted (Cumulative)1713—
ABDP logo
All News 06:01
ABDP

Half-year Report

Ab Dynamics

**Summary**
AB Dynamics PLC, a designer and manufacturer of advanced testing and simulation products for the global transport market, reported its unaudited interim results for the six months ended 28 February 2026. Key highlights include
**Financial Performance** Revenue decreased by 16% to £48.8 million due to delays in order intake and customer delivery requirements, as well as weaker volumes in the VadoTech Testing Services business in China. Adjusted EBITDA and operating profit also declined, but the operating margin was maintained at 18.6%. Net cash increased to £39.3 million.
**Strategic Review of VadoTech** Due to lower-than-anticipated customer activity in the VadoTech Testing Services business, the Group will undertake a strategic review of this business in the second half of the year. Exceptional items totaling £16.8 million, primarily a non-cash impairment charge, were recorded in relation to VadoTech.
**Innovation and Product Development** The Group continues to focus on innovation, with a technology roadmap aligned to regulatory and consumer ratings changes. The newly launched Delta S3 Spin simulator received its first order late in FY 2025 and further orders in FY 2026.
**Medium-Term Growth Ambitions** AB Dynamics remains committed to its medium-term growth targets, including average organic growth of 10% per year, margin expansion to greater than 20%, and strong cash generation.
**Current Trading and Outlook** The Group expects adjusted operating profit for FY 2026 to be in line with current market expectations, with a 55-60% revenue bias towards the second half of the year. The order book at the period end was £47 million, providing good visibility for the rest of FY 2026.
**Dividend** An interim dividend of 3.08p per share was declared, a 10% increase from the previous year, reflecting the Boards confidence in the Groups financial position and prospects.
Despite short-term challenges, AB Dynamics remains optimistic about its long-term growth prospects, supported by structural and regulatory drivers in the automotive sector.
Financial MetricH1 2026 (£m)H1 2025 (£m)Change (%)
Revenue48.858.0-16%
Gross Margin63.7%60.2%+350bps
Adjusted EBITDA11.312.9-12%
Adjusted Operating Profit9.110.8-16%
Adjusted Operating Margin18.6%18.6%0%
Net Cash39.327.2+44%
Debt (Lease Liabilities)(3.6)(3.4)-6%
### Key Observations: 1. **Revenue Decline**: Revenue decreased by 16% year-on-year, primarily due to delays in order intake and weaker volumes in the VadoTech Testing Services business in China. 2. **Margin Improvement**: Gross margin improved by 350 basis points to 63.7%, driven by operational improvements and positive revenue mix. 3. **Profitability**: Adjusted operating profit declined by 16%, but the adjusted operating margin was maintained at 18.6% due to cost mitigation actions. 4. **Cash Position**: Net cash increased significantly by 44% to £39.3m, reflecting strong working capital discipline. 5. **Debt**: Lease liabilities increased slightly by 6%, but overall debt remains minimal compared to cash reserves.
TCF logo
All News 06:01
TCF

Non-Binding Proposal to Acquire TheraCryf’s Assets

Theracryf Plc

TheraCryf plc received and rejected a non-binding, indicative proposal to acquire its lead neuropsychiatry assets, the Orexin-1 (Ox-1) and dopamine transporter (DAT) programs. The Board deemed the offer undervaluing the assets current and future potential, particularly the Ox-1 program, which targets addiction in a $42 billion market. Fully funded to reach Phase 1 clinical study by Q4 2026, the Ox-1 program is seen as a significant value driver. CEO Dr. Huw Jones emphasized the assets strategic importance and potential, citing recent industry transactions valuing similar assets at up to $7.8 billion. TheraCryf remains committed to advancing its programs to enhance shareholder value.
Proposals
PROC logo
All News 06:01
PROC

Fourth quarter trading update

Procook Group PLC

ProCook Group PLC reports strong Q4 and full-year FY26 results, significantly outperforming the UK kitchenware market. Revenue grew 19.2% in Q4 to £18.5m and 23.0% for the full year to £85.5m, driven by both retail and ecommerce channels. Like-for-like revenue increased 9.9% in Q4 and 11.8% for the year. The company opened 13 new stores, expanded its digital content library, and increased its Revolving Credit Facility to £15m. EBITDA is expected to be slightly ahead of market expectations, while operating profit and PBT are in line. ProCook ended the year with a net cash position of £4.4m and £20.4m in available liquidity. The company remains focused on growth, aiming for 100 stores, £100m revenue, and a 10% operating profit margin.
MetricFY25FY26YoY Change
Revenue (£m)69.585.5+23.0%
Ecommerce Revenue (£m)25.531.3+22.9%
Retail Revenue (£m)44.054.2+23.1%
LFL Revenue (£m)62.971.1+11.8%
Ecommerce LFL Revenue (£m)25.030.4+21.2%
Retail LFL Revenue (£m)37.940.7+5.7%
Net Cash Position (£m)1.04.4+340.0%
Available Liquidity (£m)10.020.4+104.0%
OXIG logo
All News 06:01
OXIG

Trading Update

Oxford Instruments PLC

Oxford Instruments PLC reports a resilient full-year performance for FY26, in line with market expectations. Key highlights include
**Order intake** up ~8% on an organic constant currency (OCC) basis, with a book-to-bill ratio of ~1.07.
**Advanced Technologies (AT) division** saw ~30% OCC order growth, driven by compound semiconductor market tailwinds and volume manufacturing customers.
**Imaging & Analysis (I&A) division** returned to growth in H2, with full-year orders marginally up on an OCC basis.
**Revenue** significantly improved in H2, slightly positive on an OCC basis.
**Operating profit margin** benefited from cost restructuring and H2 revenue growth.
**Share buyback program** progressed, with £11.7m of the second £50m tranche completed by March 2026.
Strong momentum and order book position the Group well for growth in FY27 and beyond. Preliminary results will be presented on June 9, 2026.
MetricFY25FY26Change
Order Intake (OCC)N/A+8%+8% (YoY)
Book-to-Bill RatioN/A1.07N/A
Imaging & Analysis Order Intake (OCC)N/AMarginally UpMarginally Up (YoY)
Advanced Technologies Order Intake (OCC)N/A+30%+30% (YoY)
H2 Revenue (OCC)N/ASlightly PositiveSlightly Positive (YoY)
Operating Profit MarginN/AImprovedImproved (YoY)
Share Buyback (Completed)N/A£61.7m (out of £100m)N/A
**Note:** Since the provided text does not contain specific financial figures for FY25, the table compares the changes and expectations for FY26 based on the available information. The "Change" column indicates the year-on-year comparison where possible.
SOS logo
All News 06:01
SOS

Full Year Trading Update

Sosandar Plc

Sosandar PLC reports strong FY26 performance with 14% revenue growth to £42.3m, driven by 24% increase in own site sales. Profit before tax (PBT) reached £0.4m, in line with market expectations, and gross margin improved to 63.9%. Net cash increased to £8.4m, supported by cash generation and share buybacks. The company maintained strong performance across all categories and third-party partnerships, with stores showing positive uplifts, though still impacting overall profitability. The Board remains confident in sustainable, profitable growth.
MetricFY26FY25Year-on-Year Change
Total Revenue (£m)42.337.1+14%
Own Site Revenue (£m)N/AN/A+24%
Profit Before Tax (£m)0.4-0.1+500%
Gross Margin (%)63.962.1+1.8%
Net Cash (£m)8.47.3+15%
PYC logo
All News 06:01
PYC

Physiomics Awarded New Contract by Numab

Physiomics Plc

Physiomics PLC has been awarded a new contract by Numab Therapeutics AG to develop a mechanistic pharmacokinetic-pharmacodynamic (PK/PD) modelling framework for a new oncology program. The project, starting in April 2026 and completing in Q3 2026, will support proof-of-concept activities and strategic decision-making. This collaboration strengthens Physiomics relationship with Numab Therapeutics, highlighting the integration of model-informed approaches in drug development.
NewContract
EDV logo
All News 06:01
EDV

Holding(s) in Company

Endeavour Mining Corp

<mark style="background-coloryellow">TR1</mark> Buy
['City and country of registered office (if applicable) New York, NY USA', 'applicable) 8.0133 8.0133 19,323,642', 0]
AI 0 news titles 0

No news for this category in the selected date range.

Acquisitions 3 news titles 3
Agreement 1 news title 1
BLOE logo
Agreement 06:01
BLOE

Binding Framework Agreement - Project III Farm Out

Block Energy PLC

Block Energy plc has signed a binding Framework Agreement with Zhijiang Sanning Energy Co. Ltd for the farm-out of Project III in Georgia. Sanning will acquire 51% of Project III, carrying up to USD 75 million in costs for appraisal drilling and early facilities construction. Block retains 49% and operatorship, while keeping 100% ownership of other projects and existing production. The deal focuses on appraising the Patardzueli-Samgori field, with potential expansion to Rustavi and Teleti fields, targeting 2.77 TCF 2C Contingent Resources and a gross success case NPV10 of USD 2.2 billion. Final agreements are expected in H2 2026, with operations starting in 1H 2027, pending approvals. The partnership leverages Blocks upstream expertise and Sannings downstream capabilities, enhancing Georgias energy security and investment appeal.
Agreement
Approvals 1 news title 1
ANIC logo
Approvals 06:01
ANIC

Tropic’s product receives regulatory approval

Agronomics Ltd

Tropic Biosciences, a portfolio company of Agronomics Limited, has received regulatory approval in Japan and Brazil for its non-browning banana variety. This approval allows the banana to be imported, sold, and consumed in both countries, with Brazil also permitting its cultivation. The development supports sustainability, reduces food waste, and expands market opportunities. Tropics innovation, launched in 2025, marks the first new commercial banana variety in over 75 years and was named one of TIME Magazines Best Inventions of 2025. The approvals in Japan and Brazil, two critical markets, enhance Tropics global regulatory footprint, reinforcing its leadership in agricultural biotechnology. Agronomics, with a 1.6% stake in Tropic, highlights the significance of these approvals in validating Tropics platform and unlocking commercial potential.
Approvals
Authorisation 0 news titles 0

No news for this category in the selected date range.

Awards 0 news titles 0

No news for this category in the selected date range.

BTC 0 news titles 0

No news for this category in the selected date range.

Blockchain 0 news titles 0

No news for this category in the selected date range.

Breakthrough 0 news titles 0

No news for this category in the selected date range.

BuyBack 1 news title 1
Cancellations 0 news titles 0

No news for this category in the selected date range.

CashOffer 0 news titles 0

No news for this category in the selected date range.

Collaborate 1 news title 1
MKA logo
Collaborate 06:01
MKA

HYPROMAG AND MKANGO RARE EARTHS UK TO COLLABORATE

Mkango Resources Ltd

HyProMag and Mkango Rare Earths UK have been awarded a £6.5 million grant under the UKs DRIVE35 R&D competition to develop recycled neodymium-iron-boron (NdFeB) magnets for high-grade automotive applications. The project, named REACT UK, aims to establish a full circular supply chain for these magnets in the UK, combining advanced recycling methods and hydrogen-based processing to enhance sustainability and supply security. Led by HyProMag, the consortium includes Mkango UK, EMR Group, Jaguar Land Rover, Less Common Metals, and the University of Birmingham. The project will run for three years, with £3.2 million (49%) funded by the UK government. This initiative supports the UKs transition to zero-emission mobility and strengthens domestic manufacturing capabilities.
Collaborate
ContractWin 0 news titles 0

No news for this category in the selected date range.

Covid-19 0 news titles 0

No news for this category in the selected date range.

Deals 0 news titles 0

No news for this category in the selected date range.

Diamond 0 news titles 0

No news for this category in the selected date range.

DirectorDealing 39 news titles 39
FGP logo
DirectorDealing 15:25
FGP

Director/PDMR Shareholding

FirstGroup PLC

<mark style="background-coloryellow">Purchase</mark> of Partnership Shares under the FirstGroup SIP
ONT logo
DirectorDealing 15:01
ONT

Share Incentive Plan - Director/PDMR Shareholding

Oxford Nanopore Technologies Ltd

Under the SIP, the SIP Trustee will award each participating employee one Matching Share (as defined in the SIP) for each Ordinary Share <mark style="background-color:yellow">purchase</mark>d by the employee under the SIP. On 14 April 2026, the Company issued 136 Ordinary Shares to the SIP Trustee to hold on behalf of Francis Van Parys to satisfy the Matching Shares awarded under the SIP to him on that date, and 136 Ordinary Shares to the SIP Trustee to hold on behalf of Nick Keher to satisfy the Matching Shares awarded under the SIP to him on that date.
ALT logo
DirectorDealing 14:26
ALT

Director/PDMR Dealing

Altitude Group Plc

Bob Wigley, Non-Executive Director, <mark style="background-color:yellow">purchase</mark>d 200,000 Ordinary Shares at an average price of 24.75 pence per share. Following the purchase of Ordinary Shares, Bob Wigleys beneficial holding is 400,000 Ordinary Shares, representing approximately 0.55% of the Companys issued share capital.
DGE logo
DirectorDealing 08:53
DGE

Director/PDMR Shareholding

Diageo PLC

1. <mark style="background-coloryellow">purchase</mark> of partnership shares using deductions from salary
and
PZC logo
DirectorDealing 07:44
PZC

Director/PDMR Shareholding

PZ Cussons PLC

Dividend reinvestment and <mark style="background-color:yellow">purchase</mark> of Ordinary shares of 1p each in PZ Cussons plc
PRU logo
DirectorDealing 06:01
PRU

Director/PDMR Shareholding

Prudential plc

Acquisition of shares through the Prudential All Employee Share <mark style="background-color:yellow">Purchase</mark> Plan
HAS logo
DirectorDealing 06:01
HAS

Director/PDMR Shareholding

Hays plc

<mark style="background-coloryellow">Purchase</mark> of shares at a price of 27p per share under the Hays plc US Employee Stock Purchase Plan on 13 April 2026. In accordance with the Plan rules, the shares will be held in a Holding Period of one year.
ESO logo
DirectorDealing 06:01
ESO

Director/PDMR Shareholding

EPE Special Opportunities Limited

<mark style="background-coloryellow">Purchase</mark> of ordinary shares
Discovery 0 news titles 0

No news for this category in the selected date range.

Exceeded 0 news titles 0

No news for this category in the selected date range.

FCA 0 news titles 0

No news for this category in the selected date range.

FDA 0 news titles 0

No news for this category in the selected date range.

Grants 0 news titles 0

No news for this category in the selected date range.

InvestmentPlan 0 news titles 0

No news for this category in the selected date range.

JV 0 news titles 0

No news for this category in the selected date range.

Launch 2 news titles 2
FIN logo
Launch 06:06
FIN

Launch of Retail Offer

Finseta Plc

Finseta PLC, a foreign exchange and payments solutions company, announced a retail offer to raise up to £0.1 million by issuing new ordinary shares at 8.5 pence each. The offer is open to existing UK-based shareholders, with a minimum subscription of £100. The proceeds will be used alongside funds from a placing and subscription to support the companys operations. The retail offer is conditional on the completion of the placing and subscription, with shares expected to be admitted to trading on AIM around 20 April 2026.
Launch
HVO logo
Launch 06:02
HVO

hVIVO launches unified brand identity

hVIVO plc

hVIVO plc announces a unified brand identity, marking its strategic transformation into a fully integrated clinical development partner. The rebrand follows the successful integration of Venn Life Sciences, CRS, and Cryostore, simplifying the groups structure under the hVIVO brand. The company now operates through four integrated service lines: Consulting, Clinical Trials, Human Challenge Trials, and Laboratories, offering a seamless pathway from pre-clinical strategy to clinical proof-of-concept. This transformation aims to accelerate drug development, reduce complexity, and provide high-quality human data for clients. CEO Yamin Mo Khan emphasizes the unified brands ability to help pharmaceutical and biotech companies bring medicines to patients faster.
Launch
Litigation 0 news titles 0

No news for this category in the selected date range.

NewContract 2 news titles 2
HVO logo
NewContract 06:01
HVO

Influenza HCT contract signed with Traws Pharma

hVIVO plc

hVIVO plc, a leading clinical development partner, has signed a contract with Traws Pharma to conduct a Phase 2a human challenge trial for their influenza antiviral candidate, tivoxavir marboxil (TXM). The trial, utilizing hVIVOs Influenza Human Challenge Study Model, will assess TXMs safety, tolerability, and efficacy in reducing influenza-induced illness in 150 healthy participants. The study, expected to commence in H1 2026, highlights hVIVOs integrated clinical development services and Traws Pharmas strategy to accelerate TXMs development.
NewContract
PYC logo
NewContract 06:01
PYC

Physiomics Awarded New Contract by Numab

Physiomics Plc

Physiomics PLC has been awarded a new contract by Numab Therapeutics AG to develop a mechanistic pharmacokinetic-pharmacodynamic (PK/PD) modelling framework for a new oncology program. The project, starting in April 2026 and completing in Q3 2026, will support proof-of-concept activities and strategic decision-making. This collaboration strengthens Physiomics relationship with Numab Therapeutics, highlighting the integration of model-informed approaches in drug development.
NewContract
Offers 4 news titles 4
AMOI logo
Offers 06:30
AMOI

Anemoi enters into amended and updated binding Sale and Purchase Agreement to acquire Trasna, Share Consolidation and Warrantholder Surrender and Subscription Offer

Anemoi International Ltd

Anemoi International Ltd has entered into an amended and updated binding Sale and Purchase Agreement to acquire Trasna Solutions FZ LLC via a reverse takeover (RTO), valuing Trasna at $150 million. The transaction includes a share consolidation (1 for 100 reverse stock split), a voluntary warrant surrender and subscription offer for existing warrantholders at £0.02 per share, and a proposed name change to Trasna Ltd upon completion. The deal is subject to conditions, including due diligence and a fundraise, with readmission to the London Stock Exchanges Main Market planned post-RTO. Shareholders are cautioned that the transaction may not proceed or terms may change.
Offers
Offtake 0 news titles 0

No news for this category in the selected date range.

Orders 0 news titles 0

No news for this category in the selected date range.

Partner 0 news titles 0

No news for this category in the selected date range.

Patents 0 news titles 0

No news for this category in the selected date range.

Placing 6 news titles 6
SEED logo
Placing 06:01
SEED

Investment in Clean Food Group Funding Round

Seed Innovations Ltd

Seed Innovations Ltd (AIMSEED) has invested £260,000 in a £4.5 million funding round for its portfolio company, Clean Food Group (CFG), a UK biotech manufacturer of sustainable oils and fats. The funding, led by Clean Growth Fund and New Agrarian Company Limited, is structured as a convertible loan note (CLN) with a 12% annual coupon, maturing in August 2027. This investment supports CFGs scale-up of its Knowsley fermentation facility, positioning it as the worlds largest manufacturer of yeast-derived oils and fats. SEEDs total exposure to CFG, including equity and CLN, reaches £1.98 million, with CFG valued at £1.7 million in SEEDs 2025 Interim Report. CFG, pre-revenue with £13 million raised to date, aims to address supply chain fragility and sustainability in the global food system, targeting a sustainable food market projected to reach US$524 billion by 2032.
Premium Placing
Positive 0 news titles 0

No news for this category in the selected date range.

Proposals 2 news titles 2
TCF logo
Proposals 06:01
TCF

Non-Binding Proposal to Acquire TheraCryf’s Assets

Theracryf Plc

TheraCryf plc received and rejected a non-binding, indicative proposal to acquire its lead neuropsychiatry assets, the Orexin-1 (Ox-1) and dopamine transporter (DAT) programs. The Board deemed the offer undervaluing the assets current and future potential, particularly the Ox-1 program, which targets addiction in a $42 billion market. Fully funded to reach Phase 1 clinical study by Q4 2026, the Ox-1 program is seen as a significant value driver. CEO Dr. Huw Jones emphasized the assets strategic importance and potential, citing recent industry transactions valuing similar assets at up to $7.8 billion. TheraCryf remains committed to advancing its programs to enhance shareholder value.
Proposals
Reports 18 news titles 18
ABDP logo
Reports 06:01
ABDP

Half-year Report

Ab Dynamics

**Summary**
AB Dynamics PLC, a designer and manufacturer of advanced testing and simulation products for the global transport market, reported its unaudited interim results for the six months ended 28 February 2026. Key highlights include
**Financial Performance** Revenue decreased by 16% to £48.8 million due to delays in order intake and customer delivery requirements, as well as weaker volumes in the VadoTech Testing Services business in China. Adjusted EBITDA and operating profit also declined, but the operating margin was maintained at 18.6%. Net cash increased to £39.3 million.
**Strategic Review of VadoTech** Due to lower-than-anticipated customer activity in the VadoTech Testing Services business, the Group will undertake a strategic review of this business in the second half of the year. Exceptional items totaling £16.8 million, primarily a non-cash impairment charge, were recorded in relation to VadoTech.
**Innovation and Product Development** The Group continues to focus on innovation, with a technology roadmap aligned to regulatory and consumer ratings changes. The newly launched Delta S3 Spin simulator received its first order late in FY 2025 and further orders in FY 2026.
**Medium-Term Growth Ambitions** AB Dynamics remains committed to its medium-term growth targets, including average organic growth of 10% per year, margin expansion to greater than 20%, and strong cash generation.
**Current Trading and Outlook** The Group expects adjusted operating profit for FY 2026 to be in line with current market expectations, with a 55-60% revenue bias towards the second half of the year. The order book at the period end was £47 million, providing good visibility for the rest of FY 2026.
**Dividend** An interim dividend of 3.08p per share was declared, a 10% increase from the previous year, reflecting the Boards confidence in the Groups financial position and prospects.
Despite short-term challenges, AB Dynamics remains optimistic about its long-term growth prospects, supported by structural and regulatory drivers in the automotive sector.
Financial MetricH1 2026 (£m)H1 2025 (£m)Change (%)
Revenue48.858.0-16%
Gross Margin63.7%60.2%+350bps
Adjusted EBITDA11.312.9-12%
Adjusted Operating Profit9.110.8-16%
Adjusted Operating Margin18.6%18.6%0%
Net Cash39.327.2+44%
Debt (Lease Liabilities)(3.6)(3.4)-6%
### Key Observations: 1. **Revenue Decline**: Revenue decreased by 16% year-on-year, primarily due to delays in order intake and weaker volumes in the VadoTech Testing Services business in China. 2. **Margin Improvement**: Gross margin improved by 350 basis points to 63.7%, driven by operational improvements and positive revenue mix. 3. **Profitability**: Adjusted operating profit declined by 16%, but the adjusted operating margin was maintained at 18.6% due to cost mitigation actions. 4. **Cash Position**: Net cash increased significantly by 44% to £39.3m, reflecting strong working capital discipline. 5. **Debt**: Lease liabilities increased slightly by 6%, but overall debt remains minimal compared to cash reserves.
Results 19 news titles 19
FTV logo
Results 14:16
FTV

Final Results

Foresight VCT PLC

**Summary**
Foresight VCT plc, managed by Foresight Group LLP, released its final results for the year ended 31 December 2025, approved by the Board of Directors on 13 April 2026. The company reported a Net Asset Value (NAV) Total Return per share of 0.1%, with dividends of 10.5p leading to a 10.4p fall in NAV from 82.0p to 71.6p. Key financial highlights include a special interim dividend of 6.4p and a final dividend of 4.1p, distributing £19.3 million and £12.4 million respectively. The company made six new investments totaling £7.8 million and twelve follow-on investments costing £7.7 million. The value of the investment portfolio decreased by £8.4 million, driven by the sale of an investment for £24.3 million and a loan repayment of £0.1 million, offset by new and follow-on investments. The company raised £38.6 million through a share offer in January 2026 and recommends a final dividend of 3.6p per share for 2025. The Chair’s statement highlights a 16.0% dividend yield, including a special dividend, and emphasizes the company’s diversified portfolio resilience in a challenging economic environment. The company maintains its strategic objectives, including paying annual dividends of at least 5% of NAV, achieving a NAV Total Return <mark style="background-color:yellow">above</mark> 5%, and implementing regular share buybacks. The Board and Manager remain committed to these goals, despite the flat performance in 2025, and are focused on long-term value creation for shareholders.
Year-on-Year Financial and Debt Comparison (2024 vs 2025)
Metric20242025Change
Net Asset Value (NAV) (£ million)222.9214.0-8.9 (-4.0%)
NAV per share (pence)82.071.6-10.4 (-12.7%)
Total Dividends Paid (£ million)31.731.70 (0.0%)
Dividend per share (pence)10.510.50 (0.0%)
Investment Portfolio Value (£ million)166.6158.2-8.4 (-5.0%)
New Investments (£ million)14.315.5+1.2 (+8.4%)
Follow-on Investments (£ million)7.77.70 (0.0%)
Proceeds from Disposals (£ million)36.524.4-12.1 (-33.1%)
Debt (Amounts falling due within one year) (£ million)3.32.2-1.1 (-33.3%)
Cash and Cash Equivalents (£ million)55.955.2-0.7 (-1.3%)
### Key Observations: 1. **Net Asset Value (NAV):** Decreased by 4.0% from £222.9 million in 2024 to £214.0 million in 2025, primarily due to dividend payments and investment losses. 2. **NAV per Share:** Fell by 12.7% from 82.0p to 71.6p, reflecting the decrease in NAV and the impact of dividends. 3. **Dividends:** Remained consistent at £31.7 million, with no change in dividend per share. 4. **Investment Portfolio:** Decreased by 5.0% from £166.6 million to £158.2 million, driven by a successful realisation and loan repayment, offset by new and follow-on investments. 5. **Debt:** Reduced by 33.3% from £3.3 million to £2.2 million, indicating improved liquidity. 6. **Cash and Cash Equivalents:** Slightly decreased by 1.3% from £55.9 million to £55.2 million, reflecting operational and investment activities.
GMS logo
Results 06:01
GMS

2025 Financial Results

Gulf Marine Services PLC

**Summary**
Gulf Marine Services PLC (GMS) reported its 2025 financial results, highlighting a 12% increase in revenue to US$188.1 million and adjusted EBITDA to US$112.9 million, driven by an additional leased vessel and higher day rates. Adjusted net profit rose 30% to US$41.8 million, while net profit decreased 49% to US$19.5 million due to impairment charges and tax expenses. Fleet utilization dropped to 87% due to maintenance and geopolitical disruptions. Net leverage improved to 1.39x, and net bank debt reduced to US$156.6 million. The company secured new contracts totaling 15.4 years, increasing its backlog to US$606 million. Despite geopolitical challenges, GMS maintained operational reliability and safety standards, achieving zero Lost Time Injury Rate (LTIR) and Total Recordable Injury Rate (TRIR). The company acquired a new mid-class vessel and aims to double its 2024 adjusted EBITDA by 2030. However, the ongoing geopolitical situation in the Gulf region poses risks, leading to a cautious outlook for 2026 and the suspension of dividend declarations. Management is closely monitoring the impact on operations and financial performance.
Financial Metric2023 (US$m)2024 (US$m)2025 (US$m)2025 vs 2024 Change
Revenue151.6167.5188.1+12%
Adjusted EBITDA87.5100.4112.9+12%
Adjusted Net Profit9.832.241.8+30%
Net Profit42.138.319.5-49%
Net Bank Debt267.3201.2156.6-22%
AMCO logo
Results 06:01
AMCO

Final Results, Analyst Briefing & Investor Pres

Amcomri Group plc

Amcomri Group PLC reported strong financial results for the year ending December 31, 2025, with a 22% increase in revenue to £70.9 million, a 19.3% rise in adjusted EBITDA to £9.2 million, and a 145% surge in profit before tax to £4.1 million. The companys Buy, Improve, Build strategy drove organic and acquisitive growth, with acquisitions like EMC Elite Engineering and Radnor Technologies expanding its service offerings. Operational highlights included growth across both divisions, improved gross margins, and a strengthened team. Post-year-end, Amcomri acquired the National Compliance and Testing division of Enerveo Limited, further enhancing its market position. The company remains well-positioned for future growth with a strong acquisition pipeline and positive trading conditions in key markets.
Financial Metric2024 (£'000)2025 (£'000)Change (£'000)Change (%)
Revenue58,06670,93812,87222%
Adjusted EBITDA7,7009,2001,50019.3%
Profit Before Tax1,6754,1062,431145%
Net Debt6,10011,2005,10083.6%
Cash Balances12,1008,600(3,500)(28.9%)
### Explanation: 1. **Revenue**: Increased by £12,872,000 (22%) from £58,066,000 in 2024 to £70,938,000 in 2025. 2. **Adjusted EBITDA**: Increased by £1,500,000 (19.3%) from £7,700,000 in 2024 to £9,200,000 in 2025. 3. **Profit Before Tax**: Increased by £2,431,000 (145%) from £1,675,000 in 2024 to £4,106,000 in 2025. 4. **Net Debt**: Increased by £5,100,000 (83.6%) from £6,100,000 in 2024 to £11,200,000 in 2025. 5. **Cash Balances**: Decreased by £3,500,000 (28.9%) from £12,100,000 in 2024 to £8,600,000 in 2025.
Significant 0 news titles 0

No news for this category in the selected date range.

Speculation 0 news titles 0

No news for this category in the selected date range.

Strategic 0 news titles 0

No news for this category in the selected date range.

Suspension 0 news titles 0

No news for this category in the selected date range.

TR1 48 news titles 48
SBO logo
TR1 15:45
SBO

Holding(s) in Company

Schroder British Opportunities Trus

TR1 Buy
['Philip J Milton & Company Plc', '3.010000', 0]
BGS logo
TR1 15:06
BGS

Holding(s) in Company

Baillie Gifford Shin Nippon PLC

TR1 Buy
['City of London Investment Management Company Limited', '10.920000', '11.410000']
BGCG logo
TR1 14:54
BGCG

Holding(s) in Company

Baillie Gifford China Growth Trust PLC

TR1 Buy
['City of London Investment Management Company Limited', '22.170000', '21.010000']
NFG logo
TR1 13:21
NFG

Holding(s) in Company

Next 15 Group PLC

TR1 Buy
['Liontrust Investment Partners LLP', '11.142000', '10.419000']
BGEU logo
TR1 12:46
BGEU

Holding(s) in Company

Baillie Gifford European Growth Trust PLC

TR1 Buy
['1607 Capital Partners, LLC', '9.532047', '10.088416']
ASL logo
TR1 08:43
ASL

Holding(s) in Company

Aberforth Smaller Companies Trust PLC

TR1 Buy
['Evelyn Partners Limited', '4.852125', '5.081000']
BRSC logo
TR1 08:29
BRSC

Holding(s) in Company

Blackrock Smaller Companies Trust PLC

TR1 Buy
['Saba Capital Management, L.P.', '2.568941', '2.311881']
EOT logo
TR1 07:41
EOT

Holding(s) in Company

European Opportunities Trust plc

TR1 Buy
['1607 Capital Partners, LLC', '10.641627', '11.875311']
EDV logo
TR1 06:01
EDV

Holding(s) in Company

Endeavour Mining Corp

<mark style="background-coloryellow">TR1</mark> Buy
['City and country of registered office (if applicable) New York, NY USA', 'applicable) 8.0133 8.0133 19,323,642', 0]
Takeover 0 news titles 0

No news for this category in the selected date range.

Understanding 0 news titles 0

No news for this category in the selected date range.

Updates 28 news titles 28
ITRK logo
Updates 06:02
ITRK

Strategic Review Initiation & Trading Statement

Intertek Group PLC

Intertek Group PLC initiates a strategic review to evaluate the potential separation of Intertek Energy & Infrastructure from Intertek Testing & Assurance, aiming to accelerate growth and create two specialist, global ATIC businesses. The review, concluding by mid-2027, assesses whether a sale or demerger would unlock full potential, enhance focus, and improve capital allocation. Intertek reports strong Q1 2026 performance with 5.4% LFL revenue growth, reiterates full-year guidance, and highlights robust demand across divisions, except for stable performance in World of Energy. The company emphasizes its AAA strategy, strong cash flow, and commitment to delivering value for shareholders through disciplined execution and strategic focus.
Metric2026 (Q1)2025 (FY)2024 (FY)Year-on-Year Change (2026 vs 2025)Year-on-Year Change (2025 vs 2024)
Group Revenue£838.5m£3,431.6m£3,393.2m3.7% (actual), 6.7% (constant currency)1.1% (actual), 4.3% (constant currency)
LFL Revenue£828.3m£3,416.3m£3,391.8m2.4% (actual), 5.4% (constant currency)0.7% (actual), 3.9% (constant currency)
Consumer Products Revenue£232.6m£902.5m (2025)£884.3m (2024)2.5% (actual), 6.5% (constant currency)2.1% (actual), 5.8% (constant currency)
Corporate Assurance Revenue£126.5m£485.6m (2025)£468.9m (2024)8.2% (actual), 10.8% (constant currency)3.6% (actual), 7.2% (constant currency)
Health and Safety Revenue£92.2m£350.9m (2025)£337.2m (2024)16.3% (actual), 15.8% (constant currency)4.1% (actual), 6.8% (constant currency)
Industry and Infrastructure Revenue£209.9m£788.0m (2025)£786.3m (2024)2.8% (actual), 6.7% (constant currency)0.2% (actual), 3.5% (constant currency)
World of Energy Revenue£177.3m£904.6m (2025)£916.5m (2024)(2.4%) (actual), 0.2% (constant currency)(1.3%) (actual), 1.8% (constant currency)
Net Financial Debt (FY)N/A£930-980m (FY26 Guidance)£880m (2025)~5.7% - 11.4% increase (estimated)N/A
PRV logo
Updates 06:01
PRV

AGM Trading Update

Porvair plc

Porvair plcs AGM trading update highlights that the groups performance in the first four months of 2026 is in line with expectations, with 5% constant currency revenue growth. Key points include
Strong aerospace order bookscontinued robust nuclear demandand subdued petrochemical sales.
Steady life sciences consumables orders and stable environmental instrument demand in the Laboratory division.
Firm aluminium and superalloys demand in Metal Melt Quality, with progress on the new US manufacturing line and successful Drache acquisition integration.
Unchanged full-year performance expectations, supported by a diversified portfolio, recurring revenue, and disciplined management.
Increased focus on M&A opportunities, with no change to long-term strategic outlook.
Upcoming Capital Markets Event in October 2026 and interim results announcement in June 2026.
Since the provided text does not contain specific financial or debt figures for comparison, I cannot generate an HTML table with year-on-year comparisons. However, I can provide a generic HTML table structure that you can use to input the relevant data if it becomes available:
Metric20252026Change
Revenue Growth5%
Debt
If you provide the actual financial and debt figures, I can populate this table accordingly.
IMB logo
Updates 06:01
IMB

Trading Update

Imperial Brands PLC

Imperial Brands PLCs trading update for 14 April 2026 highlights a positive start to its 2030 transformation strategy, with the company reiterating its full-year guidance. Key points include
1. **Revenue Growth**Low-single-digit percent growth expected in tobacco & NGP (Next Generation Products) net revenue for H1 2026, driven by robust tobacco pricing and NGP innovation.
2. **Profitability**Group adjusted operating profit slightly higher in H1 compared to 2025, with growth accelerating in H2, in line with previous guidance.
3. **Earnings and Cash Flow**On track for at least high-single-digit earnings per share growth and at least £2.2 billion in free cash flow for the full year.
4. **Share Repurchase**Completed £0.7 billion of the £1.45 billion FY26 share buyback as part of an "evergreen" program.
5. **Strategic Initiatives**Progress in becoming more consumer-centric, data-led, and efficient through partnerships (e.g., Capgemini), supply chain optimization, and IT application rollouts.
6. **Geopolitical Risks**Monitoring potential impacts from the Middle East conflict, though no material business impact to date.
7. **Regional Performance**Strong NGP growth in Europe and AAACE regions, offset by challenges in the US, Australia, and Logista.
8. **Forex Impact**Translation foreign exchange expected to be a 2.0-2.5% headwind on H1 earnings per share and 0-1% on full-year earnings.
Interim results for H1 FY26 will be announced on 12 May 2026.
Financial MetricFY2025FY2026 (Expected)Change
Tobacco & NGP Net Revenue GrowthN/ALow-single-digit%N/A
Group Adjusted Operating Profit GrowthN/ASlightly higher than H1 2025N/A
Earnings Per Share GrowthN/AHigh-single-digit%N/A
Free Cash FlowN/A£2.2 billionN/A
Share Repurchase (Completed)£0.1 billion (Oct 2024)£0.7 billion (of £1.45 billion)+£0.6 billion
Net Debt to EBITDA LeverageN/A2.0-2.5 range (lower end)N/A
NGP Adjusted Operating LossesN/AModerately higherN/A
**Notes:** * The table compares expected financials for FY2026 with available data from FY2025. Since specific FY2025 figures are not provided in the text, the "FY2025" column mostly contains "N/A". * "Change" column indicates the difference between FY2026 and FY2025 where applicable. * This table focuses on key financial metrics mentioned in the text, including revenue growth, profit growth, cash flow, share repurchases, leverage, and operating losses.
CRTA logo
Updates 06:01
CRTA

Trading Statement

Cirata plc

Cirata PLC reports a strong Q1 FY26 with its first-ever positive cash flow quarter, a 40% pipeline growth, and improved visibility through new KPIs (ACV, Billings, RCB). The company reaffirms its FY26 cash flow break-even target, highlighting momentum in enterprise sales, particularly with Cirata Symphony, and continued focus on new logo acquisition and existing customer expansion.
MetricQ1 FY26Q4 FY25 (31 Dec 2025)Year-on-Year Change
Cash Flow$0.7m (Positive)Not specified (Negative)First positive cash flow quarter in history
Closing ACV$4.9m$4.8m+2.08%
Billings$2.3mNot specifiedN/A
RCB$5.8mNot specifiedN/A
Cash Balance$4.7mNot specifiedN/A
Trade Receivables$0.7mNot specifiedN/A
Cash Overheads$3.1mNot specifiedN/A
Pipeline Growth+40% (since Jan 2026)Not specifiedN/A
CRPR logo
Updates 06:01
CRPR

Full Year Trading Update

James Cropper PLC

James Cropper plc announces a strong FY26 performance, with adjusted EBITDA of £8.8m (up 30% YoY) and revenue of £103m (up 4% YoY). Advanced Materials saw high single-digit EBITDA growth, while Paper & Packaging significantly reduced losses. Net debt decreased to £8.3m, with a net debt/EBITDA ratio below 1x. Positive trading momentum continues into FY27, with confidence in medium-term growth for both divisions. The company expects to announce audited FY26 results in July 2026.
MetricFY25FY26Change
Adjusted EBITDA (£m)6.678.8+31.9%
Group Revenue (£m)99.0103.0+4.0%
Net Debt (£m)12.98.3-35.7%
Net Debt to EBITDA Ratio1.9x<1.0xImproved
DPP logo
Updates 06:01
DPP

Q1 2026 Trading Update

DP Poland Plc

DP Poland PLC reports strong Q1 2026 performance with 18.9% system sales growth and 13.7% order increase, driven by operational efficiency, promotions, and timely deliveries. Franchise ownership rose to 35%, with four more Pizzeria 105 stores converted. Supply chain optimization and network expansion (141 Dominos stores, 71 Pizzeria 105) supported growth. Poland and Croatia saw robust sales and order increases. The company targets 50% franchise ownership by 2027, 200+ stores, and margin improvement through disposals, automation, and scaling. Outlook remains positive with double-digit growth expected in 2026.
DP Poland PLC - Financials and Debt Comparison (Q1 2026 vs Q1 2025)
MetricQ1 2026Q1 2025YoY Change
Group System Sales (£m)17.214.518.9%
Group System Orders (m)1.31.113.7%
Poland
Total System Sales (PLNm)78.466.318.2%
LFL System Sales (PLNm)67.962.48.9%
Total System Orders (m)1.31.113.3%
LFL System Orders (m)1.11.13.9%
Croatia
Total System Sales (EURm)1.20.928.8%
LFL System Sales (EURm)1.11.09.5%
Total System Orders (m)0.10.120.0%
LFL System Orders (m)0.10.12.0%
Network Expansion
Domino's Stores (YoY Change)141 (+17%)120—
Franchise-Owned Stores (% of Estate)35%12%—
Pizzeria 105 Stores Converted (Cumulative)1713—
PROC logo
Updates 06:01
PROC

Fourth quarter trading update

Procook Group PLC

ProCook Group PLC reports strong Q4 and full-year FY26 results, significantly outperforming the UK kitchenware market. Revenue grew 19.2% in Q4 to £18.5m and 23.0% for the full year to £85.5m, driven by both retail and ecommerce channels. Like-for-like revenue increased 9.9% in Q4 and 11.8% for the year. The company opened 13 new stores, expanded its digital content library, and increased its Revolving Credit Facility to £15m. EBITDA is expected to be slightly ahead of market expectations, while operating profit and PBT are in line. ProCook ended the year with a net cash position of £4.4m and £20.4m in available liquidity. The company remains focused on growth, aiming for 100 stores, £100m revenue, and a 10% operating profit margin.
MetricFY25FY26YoY Change
Revenue (£m)69.585.5+23.0%
Ecommerce Revenue (£m)25.531.3+22.9%
Retail Revenue (£m)44.054.2+23.1%
LFL Revenue (£m)62.971.1+11.8%
Ecommerce LFL Revenue (£m)25.030.4+21.2%
Retail LFL Revenue (£m)37.940.7+5.7%
Net Cash Position (£m)1.04.4+340.0%
Available Liquidity (£m)10.020.4+104.0%
OXIG logo
Updates 06:01
OXIG

Trading Update

Oxford Instruments PLC

Oxford Instruments PLC reports a resilient full-year performance for FY26, in line with market expectations. Key highlights include
**Order intake** up ~8% on an organic constant currency (OCC) basis, with a book-to-bill ratio of ~1.07.
**Advanced Technologies (AT) division** saw ~30% OCC order growth, driven by compound semiconductor market tailwinds and volume manufacturing customers.
**Imaging & Analysis (I&A) division** returned to growth in H2, with full-year orders marginally up on an OCC basis.
**Revenue** significantly improved in H2, slightly positive on an OCC basis.
**Operating profit margin** benefited from cost restructuring and H2 revenue growth.
**Share buyback program** progressed, with £11.7m of the second £50m tranche completed by March 2026.
Strong momentum and order book position the Group well for growth in FY27 and beyond. Preliminary results will be presented on June 9, 2026.
MetricFY25FY26Change
Order Intake (OCC)N/A+8%+8% (YoY)
Book-to-Bill RatioN/A1.07N/A
Imaging & Analysis Order Intake (OCC)N/AMarginally UpMarginally Up (YoY)
Advanced Technologies Order Intake (OCC)N/A+30%+30% (YoY)
H2 Revenue (OCC)N/ASlightly PositiveSlightly Positive (YoY)
Operating Profit MarginN/AImprovedImproved (YoY)
Share Buyback (Completed)N/A£61.7m (out of £100m)N/A
**Note:** Since the provided text does not contain specific financial figures for FY25, the table compares the changes and expectations for FY26 based on the available information. The "Change" column indicates the year-on-year comparison where possible.
SOS logo
Updates 06:01
SOS

Full Year Trading Update

Sosandar Plc

Sosandar PLC reports strong FY26 performance with 14% revenue growth to £42.3m, driven by 24% increase in own site sales. Profit before tax (PBT) reached £0.4m, in line with market expectations, and gross margin improved to 63.9%. Net cash increased to £8.4m, supported by cash generation and share buybacks. The company maintained strong performance across all categories and third-party partnerships, with stores showing positive uplifts, though still impacting overall profitability. The Board remains confident in sustainable, profitable growth.
MetricFY26FY25Year-on-Year Change
Total Revenue (£m)42.337.1+14%
Own Site Revenue (£m)N/AN/A+24%
Profit Before Tax (£m)0.4-0.1+500%
Gross Margin (%)63.962.1+1.8%
Net Cash (£m)8.47.3+15%
Vaccine 0 news titles 0

No news for this category in the selected date range.

Wins 0 news titles 0

No news for this category in the selected date range.

Worth 0 news titles 0

No news for this category in the selected date range.

Trading Floor
2026-04-14
501
Headlines
49
News Types
0IW3
Top Mover
Price Movers 2026-04-14
0IW3
+1.1%
GSEM
+0.0%
News Flow 501 items today
AI
0
Acquisitions
3
Agreement
1
Approvals
1
Authorisation
0
Awards
0
BTC
0
Blockchain
0
Breakthrough
0
BuyBack
1
Cancellations
0
CashOffer
0
Collaborate
1
ContractWin
0
Covid-19
0
Deals
0
Diamond
0
DirectorDealing
39
Discovery
0
Exceeded
0
FCA
0
FDA
0
Grants
0
InvestmentPlan
0
JV
0
Launch
2
Litigation
0
NewContract
2
Offers
4
Offtake
0
Orders
0
Partner
0
Patents
0
Placing
6
Positive
0
Proposals
2
Reports
18
Results
19
Significant
0
Speculation
0
Strategic
0
Suspension
0
TR1
48
Takeover
0
Understanding
0
Updates
28
Vaccine
0
Wins
0
Worth
0
Loading LSTM picks & Results Radar…

My Watchlist

RNS Alerts

Tap any ticker row to open its mobile stock terminal. Today’s move updates from the same stock-terminal feed.

No tickers on your watchlist yet.

RNS Alerts

Push Notifications
Alert me when a watchlist ticker gets new RNS
Email Alerts
2026-04-14 27 picks
93 Strong Beat
FTV
Foresight VCT PLC
Positive
Final Results
**Summary:** Foresight VCT plc, managed by Foresight Group LLP, released its final results for the year ended 31 December 2025, approved by the Board of Directors on 13 April 2026. The company reported a Net Asset Value (NAV) Total Return per share of 0.1%, with dividends of 10.5p leading to a 10.4p fall in NAV from 82.0p to 71.6p. Key financial highlights include a special interim dividend of 6.4p and a final dividend of 4.1p, distributing £19.3 million and £12.4 million respectively. The company made six new investments totaling £7.8 million and twelve follow-on investments costing £7.7 million. The value of the investment portfolio decreased by £8.4 million, driven by the sale of an investment for £24.3 million and a loan repayment of £0.1 million, offset by new and follow-on investments. The company raised £38.6 million through a share offer in January 2026 and recommends a final dividend of 3.6p per share for 2025. The Chair’s statement highlights a 16.0% dividend yield, including a special dividend, and emphasizes the company’s diversified portfolio resilience in a challenging economic environment. The company maintains its strategic objectives, including paying annual dividends of at least 5% of NAV, achieving a NAV Total Return <mark style="background-color:yellow">above</mark> 5%, and implementing regular share buybacks. The Board and Manager remain committed to these goals, despite the flat performance in 2025, and are focused on long-term value creation for shareholders.
**Summary**
Foresight VCT plc, managed by Foresight Group LLP, released its final results for the year ended 31 December 2025, approved by the Board of Directors on 13 April 2026. The company reported a Net Asset Value (NAV) Total Return per share of 0.1%, with dividends of 10.5p leading to a 10.4p fall in NAV from 82.0p to 71.6p. Key financial highlights include a special interim dividend of 6.4p and a final dividend of 4.1p, distributing £19.3 million and £12.4 million respectively. The company made six new investments totaling £7.8 million and twelve follow-on investments costing £7.7 million. The value of the investment portfolio decreased by £8.4 million, driven by the sale of an investment for £24.3 million and a loan repayment of £0.1 million, offset by new and follow-on investments. The company raised £38.6 million through a share offer in January 2026 and recommends a final dividend of 3.6p per share for 2025. The Chair’s statement highlights a 16.0% dividend yield, including a special dividend, and emphasizes the company’s diversified portfolio resilience in a challenging economic environment. The company maintains its strategic objectives, including paying annual dividends of at least 5% of NAV, achieving a NAV Total Return <mark style="background-color:yellow">above</mark> 5%, and implementing regular share buybacks. The Board and Manager remain committed to these goals, despite the flat performance in 2025, and are focused on long-term value creation for shareholders.
Year-on-Year Financial and Debt Comparison (2024 vs 2025)
Metric20242025Change
Net Asset Value (NAV) (£ million)222.9214.0-8.9 (-4.0%)
NAV per share (pence)82.071.6-10.4 (-12.7%)
Total Dividends Paid (£ million)31.731.70 (0.0%)
Dividend per share (pence)10.510.50 (0.0%)
Investment Portfolio Value (£ million)166.6158.2-8.4 (-5.0%)
New Investments (£ million)14.315.5+1.2 (+8.4%)
Follow-on Investments (£ million)7.77.70 (0.0%)
Proceeds from Disposals (£ million)36.524.4-12.1 (-33.1%)
Debt (Amounts falling due within one year) (£ million)3.32.2-1.1 (-33.3%)
Cash and Cash Equivalents (£ million)55.955.2-0.7 (-1.3%)
### Key Observations: 1. **Net Asset Value (NAV):** Decreased by 4.0% from £222.9 million in 2024 to £214.0 million in 2025, primarily due to dividend payments and investment losses. 2. **NAV per Share:** Fell by 12.7% from 82.0p to 71.6p, reflecting the decrease in NAV and the impact of dividends. 3. **Dividends:** Remained consistent at £31.7 million, with no change in dividend per share. 4. **Investment Portfolio:** Decreased by 5.0% from £166.6 million to £158.2 million, driven by a successful realisation and loan repayment, offset by new and follow-on investments. 5. **Debt:** Reduced by 33.3% from £3.3 million to £2.2 million, indicating improved liquidity. 6. **Cash and Cash Equivalents:** Slightly decreased by 1.3% from £55.9 million to £55.2 million, reflecting operational and investment activities.
14:16
Open Terminal ↗ RNS Source
80 Positive
AMOI
Anemoi International Ltd
Positive
Anemoi enters into amended and updated binding Sale and Purchase Agreement to acquire Trasna, Share Consolidation and Warrantholder Surrender and Subscription Offer
Anemoi International Ltd has entered into an amended and updated binding Sale and Purchase Agreement to acquire Trasna Solutions FZ LLC via a reverse takeover (RTO), valuing Trasna at $150 million. The transaction includes a share consolidation (1 for 100 reverse stock split), a voluntary warrant surrender and subscription offer for existing warrantholders at £0.02 per share, and a proposed name change to Trasna Ltd upon completion. The deal is subject to conditions, including due diligence and a fundraise, with readmission to the London Stock Exchanges Main Market planned post-RTO. Shareholders are cautioned that the transaction may not proceed or terms may change.
Anemoi International Ltd has entered into an amended and updated binding Sale and Purchase Agreement to acquire Trasna Solutions FZ LLC via a reverse takeover (RTO), valuing Trasna at $150 million. The transaction includes a share consolidation (1 for 100 reverse stock split), a voluntary warrant surrender and subscription offer for existing warrantholders at £0.02 per share, and a proposed name change to Trasna Ltd upon completion. The deal is subject to conditions, including due diligence and a fundraise, with readmission to the London Stock Exchanges Main Market planned post-RTO. Shareholders are cautioned that the transaction may not proceed or terms may change.
Offers
06:30
Open Terminal ↗ RNS Source
80 Positive
FIN
Finseta Plc
Positive
Launch of Retail Offer
Finseta PLC, a foreign exchange and payments solutions company, announced a retail offer to raise up to £0.1 million by issuing new ordinary shares at 8.5 pence each. The offer is open to existing UK-based shareholders, with a minimum subscription of £100. The proceeds will be used alongside funds from a placing and subscription to support the companys operations. The retail offer is conditional on the completion of the placing and subscription, with shares expected to be admitted to trading on AIM around 20 April 2026.
Finseta PLC, a foreign exchange and payments solutions company, announced a retail offer to raise up to £0.1 million by issuing new ordinary shares at 8.5 pence each. The offer is open to existing UK-based shareholders, with a minimum subscription of £100. The proceeds will be used alongside funds from a placing and subscription to support the companys operations. The retail offer is conditional on the completion of the placing and subscription, with shares expected to be admitted to trading on AIM around 20 April 2026.
Launch
06:06
Open Terminal ↗ RNS Source
88 Trading Edge
ITRK
Intertek Group PLC
Positive
Strategic Review Initiation & Trading Statement
Intertek Group PLC initiates a strategic review to evaluate the potential separation of Intertek Energy & Infrastructure from Intertek Testing & Assurance, aiming to accelerate growth and create two specialist, global ATIC businesses. The review, concluding by mid-2027, assesses whether a sale or demerger would unlock full potential, enhance focus, and improve capital allocation. Intertek reports strong Q1 2026 performance with 5.4% LFL revenue growth, reiterates full-year guidance, and highlights robust demand across divisions, except for stable performance in World of Energy. The company emphasizes its AAA strategy, strong cash flow, and commitment to delivering value for shareholders through disciplined execution and strategic focus.
Intertek Group PLC initiates a strategic review to evaluate the potential separation of Intertek Energy & Infrastructure from Intertek Testing & Assurance, aiming to accelerate growth and create two specialist, global ATIC businesses. The review, concluding by mid-2027, assesses whether a sale or demerger would unlock full potential, enhance focus, and improve capital allocation. Intertek reports strong Q1 2026 performance with 5.4% LFL revenue growth, reiterates full-year guidance, and highlights robust demand across divisions, except for stable performance in World of Energy. The company emphasizes its AAA strategy, strong cash flow, and commitment to delivering value for shareholders through disciplined execution and strategic focus.
Metric2026 (Q1)2025 (FY)2024 (FY)Year-on-Year Change (2026 vs 2025)Year-on-Year Change (2025 vs 2024)
Group Revenue£838.5m£3,431.6m£3,393.2m3.7% (actual), 6.7% (constant currency)1.1% (actual), 4.3% (constant currency)
LFL Revenue£828.3m£3,416.3m£3,391.8m2.4% (actual), 5.4% (constant currency)0.7% (actual), 3.9% (constant currency)
Consumer Products Revenue£232.6m£902.5m (2025)£884.3m (2024)2.5% (actual), 6.5% (constant currency)2.1% (actual), 5.8% (constant currency)
Corporate Assurance Revenue£126.5m£485.6m (2025)£468.9m (2024)8.2% (actual), 10.8% (constant currency)3.6% (actual), 7.2% (constant currency)
Health and Safety Revenue£92.2m£350.9m (2025)£337.2m (2024)16.3% (actual), 15.8% (constant currency)4.1% (actual), 6.8% (constant currency)
Industry and Infrastructure Revenue£209.9m£788.0m (2025)£786.3m (2024)2.8% (actual), 6.7% (constant currency)0.2% (actual), 3.5% (constant currency)
World of Energy Revenue£177.3m£904.6m (2025)£916.5m (2024)(2.4%) (actual), 0.2% (constant currency)(1.3%) (actual), 1.8% (constant currency)
Net Financial Debt (FY)N/A£930-980m (FY26 Guidance)£880m (2025)~5.7% - 11.4% increase (estimated)N/A
06:02
Open Terminal ↗ RNS Source
80 Positive
HVO
hVIVO plc
Positive
hVIVO launches unified brand identity
hVIVO plc announces a unified brand identity, marking its strategic transformation into a fully integrated clinical development partner. The rebrand follows the successful integration of Venn Life Sciences, CRS, and Cryostore, simplifying the groups structure under the hVIVO brand. The company now operates through four integrated service lines: Consulting, Clinical Trials, Human Challenge Trials, and Laboratories, offering a seamless pathway from pre-clinical strategy to clinical proof-of-concept. This transformation aims to accelerate drug development, reduce complexity, and provide high-quality human data for clients. CEO Yamin Mo Khan emphasizes the unified brands ability to help pharmaceutical and biotech companies bring medicines to patients faster.
hVIVO plc announces a unified brand identity, marking its strategic transformation into a fully integrated clinical development partner. The rebrand follows the successful integration of Venn Life Sciences, CRS, and Cryostore, simplifying the groups structure under the hVIVO brand. The company now operates through four integrated service lines: Consulting, Clinical Trials, Human Challenge Trials, and Laboratories, offering a seamless pathway from pre-clinical strategy to clinical proof-of-concept. This transformation aims to accelerate drug development, reduce complexity, and provide high-quality human data for clients. CEO Yamin Mo Khan emphasizes the unified brands ability to help pharmaceutical and biotech companies bring medicines to patients faster.
Launch
06:02
Open Terminal ↗ RNS Source
80 Positive
ANIC
Agronomics Ltd
Positive
Tropic’s product receives regulatory approval
Tropic Biosciences, a portfolio company of Agronomics Limited, has received regulatory approval in Japan and Brazil for its non-browning banana variety. This approval allows the banana to be imported, sold, and consumed in both countries, with Brazil also permitting its cultivation. The development supports sustainability, reduces food waste, and expands market opportunities. Tropics innovation, launched in 2025, marks the first new commercial banana variety in over 75 years and was named one of TIME Magazines Best Inventions of 2025. The approvals in Japan and Brazil, two critical markets, enhance Tropics global regulatory footprint, reinforcing its leadership in agricultural biotechnology. Agronomics, with a 1.6% stake in Tropic, highlights the significance of these approvals in validating Tropics platform and unlocking commercial potential.
Tropic Biosciences, a portfolio company of Agronomics Limited, has received regulatory approval in Japan and Brazil for its non-browning banana variety. This approval allows the banana to be imported, sold, and consumed in both countries, with Brazil also permitting its cultivation. The development supports sustainability, reduces food waste, and expands market opportunities. Tropics innovation, launched in 2025, marks the first new commercial banana variety in over 75 years and was named one of TIME Magazines Best Inventions of 2025. The approvals in Japan and Brazil, two critical markets, enhance Tropics global regulatory footprint, reinforcing its leadership in agricultural biotechnology. Agronomics, with a 1.6% stake in Tropic, highlights the significance of these approvals in validating Tropics platform and unlocking commercial potential.
Approvals
06:01
Open Terminal ↗ RNS Source
80 Positive
MKA
Mkango Resources Ltd
Positive
HYPROMAG AND MKANGO RARE EARTHS UK TO COLLABORATE
HyProMag and Mkango Rare Earths UK have been awarded a £6.5 million grant under the UKs DRIVE35 R&D competition to develop recycled neodymium-iron-boron (NdFeB) magnets for high-grade automotive applications. The project, named REACT UK, aims to establish a full circular supply chain for these magnets in the UK, combining advanced recycling methods and hydrogen-based processing to enhance sustainability and supply security. Led by HyProMag, the consortium includes Mkango UK, EMR Group, Jaguar Land Rover, Less Common Metals, and the University of Birmingham. The project will run for three years, with £3.2 million (49%) funded by the UK government. This initiative supports the UKs transition to zero-emission mobility and strengthens domestic manufacturing capabilities.
HyProMag and Mkango Rare Earths UK have been awarded a £6.5 million grant under the UKs DRIVE35 R&D competition to develop recycled neodymium-iron-boron (NdFeB) magnets for high-grade automotive applications. The project, named REACT UK, aims to establish a full circular supply chain for these magnets in the UK, combining advanced recycling methods and hydrogen-based processing to enhance sustainability and supply security. Led by HyProMag, the consortium includes Mkango UK, EMR Group, Jaguar Land Rover, Less Common Metals, and the University of Birmingham. The project will run for three years, with £3.2 million (49%) funded by the UK government. This initiative supports the UKs transition to zero-emission mobility and strengthens domestic manufacturing capabilities.
Collaborate
06:01
Open Terminal ↗ RNS Source
98 Exceptional
SEED
Seed Innovations Ltd
Positive
Investment in Clean Food Group Funding Round
Seed Innovations Ltd (AIM: SEED) has invested £260,000 in a £4.5 million funding round for its portfolio company, Clean Food Group (CFG), a UK biotech manufacturer of sustainable oils and fats. The funding, led by Clean Growth Fund and New Agrarian Company Limited, is structured as a convertible loan note (CLN) with a 12% annual coupon, maturing in August 2027. This investment supports CFGs scale-up of its Knowsley fermentation facility, positioning it as the worlds largest manufacturer of yeast-derived oils and fats. SEEDs total exposure to CFG, including equity and CLN, reaches £1.98 million, with CFG valued at £1.7 million in SEEDs 2025 Interim Report. CFG, pre-revenue with £13 million raised to date, aims to address supply chain fragility and sustainability in the global food system, targeting a sustainable food market projected to reach US$524 billion by 2032.
Seed Innovations Ltd (AIMSEED) has invested £260,000 in a £4.5 million funding round for its portfolio company, Clean Food Group (CFG), a UK biotech manufacturer of sustainable oils and fats. The funding, led by Clean Growth Fund and New Agrarian Company Limited, is structured as a convertible loan note (CLN) with a 12% annual coupon, maturing in August 2027. This investment supports CFGs scale-up of its Knowsley fermentation facility, positioning it as the worlds largest manufacturer of yeast-derived oils and fats. SEEDs total exposure to CFG, including equity and CLN, reaches £1.98 million, with CFG valued at £1.7 million in SEEDs 2025 Interim Report. CFG, pre-revenue with £13 million raised to date, aims to address supply chain fragility and sustainability in the global food system, targeting a sustainable food market projected to reach US$524 billion by 2032.
Premium Placing
06:01
Open Terminal ↗ RNS Source
93 Strong Beat
GMS
Gulf Marine Services PLC
Positive
2025 Financial Results
**Summary:** Gulf Marine Services PLC (GMS) reported its 2025 financial results, highlighting a 12% increase in revenue to US$188.1 million and adjusted EBITDA to US$112.9 million, driven by an additional leased vessel and higher day rates. Adjusted net profit rose 30% to US$41.8 million, while net profit decreased 49% to US$19.5 million due to impairment charges and tax expenses. Fleet utilization dropped to 87% due to maintenance and geopolitical disruptions. Net leverage improved to 1.39x, and net bank debt reduced to US$156.6 million. The company secured new contracts totaling 15.4 years, increasing its backlog to US$606 million. Despite geopolitical challenges, GMS maintained operational reliability and safety standards, achieving zero Lost Time Injury Rate (LTIR) and Total Recordable Injury Rate (TRIR). The company acquired a new mid-class vessel and aims to double its 2024 adjusted EBITDA by 2030. However, the ongoing geopolitical situation in the Gulf region poses risks, leading to a cautious outlook for 2026 and the suspension of dividend declarations. Management is closely monitoring the impact on operations and financial performance.
**Summary**
Gulf Marine Services PLC (GMS) reported its 2025 financial results, highlighting a 12% increase in revenue to US$188.1 million and adjusted EBITDA to US$112.9 million, driven by an additional leased vessel and higher day rates. Adjusted net profit rose 30% to US$41.8 million, while net profit decreased 49% to US$19.5 million due to impairment charges and tax expenses. Fleet utilization dropped to 87% due to maintenance and geopolitical disruptions. Net leverage improved to 1.39x, and net bank debt reduced to US$156.6 million. The company secured new contracts totaling 15.4 years, increasing its backlog to US$606 million. Despite geopolitical challenges, GMS maintained operational reliability and safety standards, achieving zero Lost Time Injury Rate (LTIR) and Total Recordable Injury Rate (TRIR). The company acquired a new mid-class vessel and aims to double its 2024 adjusted EBITDA by 2030. However, the ongoing geopolitical situation in the Gulf region poses risks, leading to a cautious outlook for 2026 and the suspension of dividend declarations. Management is closely monitoring the impact on operations and financial performance.
Financial Metric2023 (US$m)2024 (US$m)2025 (US$m)2025 vs 2024 Change
Revenue151.6167.5188.1+12%
Adjusted EBITDA87.5100.4112.9+12%
Adjusted Net Profit9.832.241.8+30%
Net Profit42.138.319.5-49%
Net Bank Debt267.3201.2156.6-22%
06:01
Open Terminal ↗ RNS Source
98 Exceptional
BLOE
Block Energy PLC
Positive
Binding Framework Agreement - Project III Farm Out
Block Energy plc has signed a binding Framework Agreement with Zhijiang Sanning Energy Co. Ltd for the farm-out of Project III in Georgia. Sanning will acquire 51% of Project III, carrying up to USD 75 million in costs for appraisal drilling and early facilities construction. Block retains 49% and operatorship, while keeping 100% ownership of other projects and existing production. The deal focuses on appraising the Patardzueli-Samgori field, with potential expansion to Rustavi and Teleti fields, targeting 2.77 TCF 2C Contingent Resources and a gross success case NPV10 of USD 2.2 billion. Final agreements are expected in H2 2026, with operations starting in 1H 2027, pending approvals. The partnership leverages Blocks upstream expertise and Sannings downstream capabilities, enhancing Georgias energy security and investment appeal.
Block Energy plc has signed a binding Framework Agreement with Zhijiang Sanning Energy Co. Ltd for the farm-out of Project III in Georgia. Sanning will acquire 51% of Project III, carrying up to USD 75 million in costs for appraisal drilling and early facilities construction. Block retains 49% and operatorship, while keeping 100% ownership of other projects and existing production. The deal focuses on appraising the Patardzueli-Samgori field, with potential expansion to Rustavi and Teleti fields, targeting 2.77 TCF 2C Contingent Resources and a gross success case NPV10 of USD 2.2 billion. Final agreements are expected in H2 2026, with operations starting in 1H 2027, pending approvals. The partnership leverages Blocks upstream expertise and Sannings downstream capabilities, enhancing Georgias energy security and investment appeal.
Agreement
06:01
Open Terminal ↗ RNS Source
88 Trading Edge
PRV
Porvair plc
Positive
AGM Trading Update
Porvair plcs AGM trading update highlights that the groups performance in the first four months of 2026 is in line with expectations, with 5% constant currency revenue growth. Key points include: - Strong aerospace order books, continued robust nuclear demand, and subdued petrochemical sales. - Steady life sciences consumables orders and stable environmental instrument demand in the Laboratory division. - Firm aluminium and superalloys demand in Metal Melt Quality, with progress on the new US manufacturing line and successful Drache acquisition integration. - Unchanged full-year performance expectations, supported by a diversified portfolio, recurring revenue, and disciplined management. - Increased focus on M&A opportunities, with no change to long-term strategic outlook. - Upcoming Capital Markets Event in October 2026 and interim results announcement in June 2026.
Porvair plcs AGM trading update highlights that the groups performance in the first four months of 2026 is in line with expectations, with 5% constant currency revenue growth. Key points include
Strong aerospace order bookscontinued robust nuclear demandand subdued petrochemical sales.
Steady life sciences consumables orders and stable environmental instrument demand in the Laboratory division.
Firm aluminium and superalloys demand in Metal Melt Quality, with progress on the new US manufacturing line and successful Drache acquisition integration.
Unchanged full-year performance expectations, supported by a diversified portfolio, recurring revenue, and disciplined management.
Increased focus on M&A opportunities, with no change to long-term strategic outlook.
Upcoming Capital Markets Event in October 2026 and interim results announcement in June 2026.
Since the provided text does not contain specific financial or debt figures for comparison, I cannot generate an HTML table with year-on-year comparisons. However, I can provide a generic HTML table structure that you can use to input the relevant data if it becomes available:
Metric20252026Change
Revenue Growth5%
Debt
If you provide the actual financial and debt figures, I can populate this table accordingly.
06:01
Open Terminal ↗ RNS Source
93 Strong Beat
AMCO
Amcomri Group plc
Positive
Final Results, Analyst Briefing & Investor Pres
Amcomri Group PLC reported strong financial results for the year ending December 31, 2025, with a 22% increase in revenue to £70.9 million, a 19.3% rise in adjusted EBITDA to £9.2 million, and a 145% surge in profit before tax to £4.1 million. The companys Buy, Improve, Build strategy drove organic and acquisitive growth, with acquisitions like EMC Elite Engineering and Radnor Technologies expanding its service offerings. Operational highlights included growth across both divisions, improved gross margins, and a strengthened team. Post-year-end, Amcomri acquired the National Compliance and Testing division of Enerveo Limited, further enhancing its market position. The company remains well-positioned for future growth with a strong acquisition pipeline and positive trading conditions in key markets.
Amcomri Group PLC reported strong financial results for the year ending December 31, 2025, with a 22% increase in revenue to £70.9 million, a 19.3% rise in adjusted EBITDA to £9.2 million, and a 145% surge in profit before tax to £4.1 million. The companys Buy, Improve, Build strategy drove organic and acquisitive growth, with acquisitions like EMC Elite Engineering and Radnor Technologies expanding its service offerings. Operational highlights included growth across both divisions, improved gross margins, and a strengthened team. Post-year-end, Amcomri acquired the National Compliance and Testing division of Enerveo Limited, further enhancing its market position. The company remains well-positioned for future growth with a strong acquisition pipeline and positive trading conditions in key markets.
Financial Metric2024 (£'000)2025 (£'000)Change (£'000)Change (%)
Revenue58,06670,93812,87222%
Adjusted EBITDA7,7009,2001,50019.3%
Profit Before Tax1,6754,1062,431145%
Net Debt6,10011,2005,10083.6%
Cash Balances12,1008,600(3,500)(28.9%)
### Explanation: 1. **Revenue**: Increased by £12,872,000 (22%) from £58,066,000 in 2024 to £70,938,000 in 2025. 2. **Adjusted EBITDA**: Increased by £1,500,000 (19.3%) from £7,700,000 in 2024 to £9,200,000 in 2025. 3. **Profit Before Tax**: Increased by £2,431,000 (145%) from £1,675,000 in 2024 to £4,106,000 in 2025. 4. **Net Debt**: Increased by £5,100,000 (83.6%) from £6,100,000 in 2024 to £11,200,000 in 2025. 5. **Cash Balances**: Decreased by £3,500,000 (28.9%) from £12,100,000 in 2024 to £8,600,000 in 2025.
06:01
Open Terminal ↗ RNS Source
80 Positive
HVO
hVIVO plc
Positive
Influenza HCT contract signed with Traws Pharma
hVIVO plc, a leading clinical development partner, has signed a contract with Traws Pharma to conduct a Phase 2a human challenge trial for their influenza antiviral candidate, tivoxavir marboxil (TXM). The trial, utilizing hVIVOs Influenza Human Challenge Study Model, will assess TXMs safety, tolerability, and efficacy in reducing influenza-induced illness in 150 healthy participants. The study, expected to commence in H1 2026, highlights hVIVOs integrated clinical development services and Traws Pharmas strategy to accelerate TXMs development.
hVIVO plc, a leading clinical development partner, has signed a contract with Traws Pharma to conduct a Phase 2a human challenge trial for their influenza antiviral candidate, tivoxavir marboxil (TXM). The trial, utilizing hVIVOs Influenza Human Challenge Study Model, will assess TXMs safety, tolerability, and efficacy in reducing influenza-induced illness in 150 healthy participants. The study, expected to commence in H1 2026, highlights hVIVOs integrated clinical development services and Traws Pharmas strategy to accelerate TXMs development.
NewContract
06:01
Open Terminal ↗ RNS Source
88 Trading Edge
IMB
Imperial Brands PLC
Positive
Trading Update
Imperial Brands PLCs trading update for 14 April 2026 highlights a positive start to its 2030 transformation strategy, with the company reiterating its full-year guidance. Key points include: 1. **Revenue Growth**: Low-single-digit percent growth expected in tobacco & NGP (Next Generation Products) net revenue for H1 2026, driven by robust tobacco pricing and NGP innovation. 2. **Profitability**: Group adjusted operating profit slightly higher in H1 compared to 2025, with growth accelerating in H2, in line with previous guidance. 3. **Earnings and Cash Flow**: On track for at least high-single-digit earnings per share growth and at least £2.2 billion in free cash flow for the full year. 4. **Share Repurchase**: Completed £0.7 billion of the £1.45 billion FY26 share buyback as part of an "evergreen" program. 5. **Strategic Initiatives**: Progress in becoming more consumer-centric, data-led, and efficient through partnerships (e.g., Capgemini), supply chain optimization, and IT application rollouts. 6. **Geopolitical Risks**: Monitoring potential impacts from the Middle East conflict, though no material business impact to date. 7. **Regional Performance**: Strong NGP growth in Europe and AAACE regions, offset by challenges in the US, Australia, and Logista. 8. **Forex Impact**: Translation foreign exchange expected to be a 2.0-2.5% headwind on H1 earnings per share and 0-1% on full-year earnings. Interim results for H1 FY26 will be announced on 12 May 2026.
Imperial Brands PLCs trading update for 14 April 2026 highlights a positive start to its 2030 transformation strategy, with the company reiterating its full-year guidance. Key points include
1. **Revenue Growth**Low-single-digit percent growth expected in tobacco & NGP (Next Generation Products) net revenue for H1 2026, driven by robust tobacco pricing and NGP innovation.
2. **Profitability**Group adjusted operating profit slightly higher in H1 compared to 2025, with growth accelerating in H2, in line with previous guidance.
3. **Earnings and Cash Flow**On track for at least high-single-digit earnings per share growth and at least £2.2 billion in free cash flow for the full year.
4. **Share Repurchase**Completed £0.7 billion of the £1.45 billion FY26 share buyback as part of an "evergreen" program.
5. **Strategic Initiatives**Progress in becoming more consumer-centric, data-led, and efficient through partnerships (e.g., Capgemini), supply chain optimization, and IT application rollouts.
6. **Geopolitical Risks**Monitoring potential impacts from the Middle East conflict, though no material business impact to date.
7. **Regional Performance**Strong NGP growth in Europe and AAACE regions, offset by challenges in the US, Australia, and Logista.
8. **Forex Impact**Translation foreign exchange expected to be a 2.0-2.5% headwind on H1 earnings per share and 0-1% on full-year earnings.
Interim results for H1 FY26 will be announced on 12 May 2026.
Financial MetricFY2025FY2026 (Expected)Change
Tobacco & NGP Net Revenue GrowthN/ALow-single-digit%N/A
Group Adjusted Operating Profit GrowthN/ASlightly higher than H1 2025N/A
Earnings Per Share GrowthN/AHigh-single-digit%N/A
Free Cash FlowN/A£2.2 billionN/A
Share Repurchase (Completed)£0.1 billion (Oct 2024)£0.7 billion (of £1.45 billion)+£0.6 billion
Net Debt to EBITDA LeverageN/A2.0-2.5 range (lower end)N/A
NGP Adjusted Operating LossesN/AModerately higherN/A
**Notes:** * The table compares expected financials for FY2026 with available data from FY2025. Since specific FY2025 figures are not provided in the text, the "FY2025" column mostly contains "N/A". * "Change" column indicates the difference between FY2026 and FY2025 where applicable. * This table focuses on key financial metrics mentioned in the text, including revenue growth, profit growth, cash flow, share repurchases, leverage, and operating losses.
06:01
Open Terminal ↗ RNS Source
88 Trading Edge
CRTA
Cirata plc
Positive
Trading Statement
Cirata PLC reports a strong Q1 FY26 with its first-ever positive cash flow quarter, a 40% pipeline growth, and improved visibility through new KPIs (ACV, Billings, RCB). The company reaffirms its FY26 cash flow break-even target, highlighting momentum in enterprise sales, particularly with Cirata Symphony, and continued focus on new logo acquisition and existing customer expansion.
Cirata PLC reports a strong Q1 FY26 with its first-ever positive cash flow quarter, a 40% pipeline growth, and improved visibility through new KPIs (ACV, Billings, RCB). The company reaffirms its FY26 cash flow break-even target, highlighting momentum in enterprise sales, particularly with Cirata Symphony, and continued focus on new logo acquisition and existing customer expansion.
MetricQ1 FY26Q4 FY25 (31 Dec 2025)Year-on-Year Change
Cash Flow$0.7m (Positive)Not specified (Negative)First positive cash flow quarter in history
Closing ACV$4.9m$4.8m+2.08%
Billings$2.3mNot specifiedN/A
RCB$5.8mNot specifiedN/A
Cash Balance$4.7mNot specifiedN/A
Trade Receivables$0.7mNot specifiedN/A
Cash Overheads$3.1mNot specifiedN/A
Pipeline Growth+40% (since Jan 2026)Not specifiedN/A
06:01
Open Terminal ↗ RNS Source
88 Trading Edge
CRPR
James Cropper PLC
Positive
Full Year Trading Update
James Cropper plc announces a strong FY26 performance, with adjusted EBITDA of £8.8m (up 30% YoY) and revenue of £103m (up 4% YoY). Advanced Materials saw high single-digit EBITDA growth, while Paper & Packaging significantly reduced losses. Net debt decreased to £8.3m, with a net debt/EBITDA ratio below 1x. Positive trading momentum continues into FY27, with confidence in medium-term growth for both divisions. The company expects to announce audited FY26 results in July 2026.
James Cropper plc announces a strong FY26 performance, with adjusted EBITDA of £8.8m (up 30% YoY) and revenue of £103m (up 4% YoY). Advanced Materials saw high single-digit EBITDA growth, while Paper & Packaging significantly reduced losses. Net debt decreased to £8.3m, with a net debt/EBITDA ratio below 1x. Positive trading momentum continues into FY27, with confidence in medium-term growth for both divisions. The company expects to announce audited FY26 results in July 2026.
MetricFY25FY26Change
Adjusted EBITDA (£m)6.678.8+31.9%
Group Revenue (£m)99.0103.0+4.0%
Net Debt (£m)12.98.3-35.7%
Net Debt to EBITDA Ratio1.9x<1.0xImproved
06:01
Open Terminal ↗ RNS Source
88 Trading Edge
DPP
DP Poland Plc
Positive
Q1 2026 Trading Update
DP Poland PLC reports strong Q1 2026 performance with 18.9% system sales growth and 13.7% order increase, driven by operational efficiency, promotions, and timely deliveries. Franchise ownership rose to 35%, with four more Pizzeria 105 stores converted. Supply chain optimization and network expansion (141 Dominos stores, 71 Pizzeria 105) supported growth. Poland and Croatia saw robust sales and order increases. The company targets 50% franchise ownership by 2027, 200+ stores, and margin improvement through disposals, automation, and scaling. Outlook remains positive with double-digit growth expected in 2026.
DP Poland PLC reports strong Q1 2026 performance with 18.9% system sales growth and 13.7% order increase, driven by operational efficiency, promotions, and timely deliveries. Franchise ownership rose to 35%, with four more Pizzeria 105 stores converted. Supply chain optimization and network expansion (141 Dominos stores, 71 Pizzeria 105) supported growth. Poland and Croatia saw robust sales and order increases. The company targets 50% franchise ownership by 2027, 200+ stores, and margin improvement through disposals, automation, and scaling. Outlook remains positive with double-digit growth expected in 2026.
DP Poland PLC - Financials and Debt Comparison (Q1 2026 vs Q1 2025)
MetricQ1 2026Q1 2025YoY Change
Group System Sales (£m)17.214.518.9%
Group System Orders (m)1.31.113.7%
Poland
Total System Sales (PLNm)78.466.318.2%
LFL System Sales (PLNm)67.962.48.9%
Total System Orders (m)1.31.113.3%
LFL System Orders (m)1.11.13.9%
Croatia
Total System Sales (EURm)1.20.928.8%
LFL System Sales (EURm)1.11.09.5%
Total System Orders (m)0.10.120.0%
LFL System Orders (m)0.10.12.0%
Network Expansion
Domino's Stores (YoY Change)141 (+17%)120—
Franchise-Owned Stores (% of Estate)35%12%—
Pizzeria 105 Stores Converted (Cumulative)1713—
06:01
Open Terminal ↗ RNS Source
84 Broker Upgrade
ABDP
Ab Dynamics
Positive
Half-year Report
**Summary:** AB Dynamics PLC, a designer and manufacturer of advanced testing and simulation products for the global transport market, reported its unaudited interim results for the six months ended 28 February 2026. Key highlights include: - **Financial Performance:** Revenue decreased by 16% to £48.8 million due to delays in order intake and customer delivery requirements, as well as weaker volumes in the VadoTech Testing Services business in China. Adjusted EBITDA and operating profit also declined, but the operating margin was maintained at 18.6%. Net cash increased to £39.3 million. - **Strategic Review of VadoTech:** Due to lower-than-anticipated customer activity in the VadoTech Testing Services business, the Group will undertake a strategic review of this business in the second half of the year. Exceptional items totaling £16.8 million, primarily a non-cash impairment charge, were recorded in relation to VadoTech. - **Innovation and Product Development:** The Group continues to focus on innovation, with a technology roadmap aligned to regulatory and consumer ratings changes. The newly launched Delta S3 Spin simulator received its first order late in FY 2025 and further orders in FY 2026. - **Medium-Term Growth Ambitions:** AB Dynamics remains committed to its medium-term growth targets, including average organic growth of 10% per year, margin expansion to greater than 20%, and strong cash generation. - **Current Trading and Outlook:** The Group expects adjusted operating profit for FY 2026 to be in line with current market expectations, with a 55-60% revenue bias towards the second half of the year. The order book at the period end was £47 million, providing good visibility for the rest of FY 2026. - **Dividend:** An interim dividend of 3.08p per share was declared, a 10% increase from the previous year, reflecting the Boards confidence in the Groups financial position and prospects. Despite short-term challenges, AB Dynamics remains optimistic about its long-term growth prospects, supported by structural and regulatory drivers in the automotive sector.
**Summary**
AB Dynamics PLC, a designer and manufacturer of advanced testing and simulation products for the global transport market, reported its unaudited interim results for the six months ended 28 February 2026. Key highlights include
**Financial Performance** Revenue decreased by 16% to £48.8 million due to delays in order intake and customer delivery requirements, as well as weaker volumes in the VadoTech Testing Services business in China. Adjusted EBITDA and operating profit also declined, but the operating margin was maintained at 18.6%. Net cash increased to £39.3 million.
**Strategic Review of VadoTech** Due to lower-than-anticipated customer activity in the VadoTech Testing Services business, the Group will undertake a strategic review of this business in the second half of the year. Exceptional items totaling £16.8 million, primarily a non-cash impairment charge, were recorded in relation to VadoTech.
**Innovation and Product Development** The Group continues to focus on innovation, with a technology roadmap aligned to regulatory and consumer ratings changes. The newly launched Delta S3 Spin simulator received its first order late in FY 2025 and further orders in FY 2026.
**Medium-Term Growth Ambitions** AB Dynamics remains committed to its medium-term growth targets, including average organic growth of 10% per year, margin expansion to greater than 20%, and strong cash generation.
**Current Trading and Outlook** The Group expects adjusted operating profit for FY 2026 to be in line with current market expectations, with a 55-60% revenue bias towards the second half of the year. The order book at the period end was £47 million, providing good visibility for the rest of FY 2026.
**Dividend** An interim dividend of 3.08p per share was declared, a 10% increase from the previous year, reflecting the Boards confidence in the Groups financial position and prospects.
Despite short-term challenges, AB Dynamics remains optimistic about its long-term growth prospects, supported by structural and regulatory drivers in the automotive sector.
Financial MetricH1 2026 (£m)H1 2025 (£m)Change (%)
Revenue48.858.0-16%
Gross Margin63.7%60.2%+350bps
Adjusted EBITDA11.312.9-12%
Adjusted Operating Profit9.110.8-16%
Adjusted Operating Margin18.6%18.6%0%
Net Cash39.327.2+44%
Debt (Lease Liabilities)(3.6)(3.4)-6%
### Key Observations: 1. **Revenue Decline**: Revenue decreased by 16% year-on-year, primarily due to delays in order intake and weaker volumes in the VadoTech Testing Services business in China. 2. **Margin Improvement**: Gross margin improved by 350 basis points to 63.7%, driven by operational improvements and positive revenue mix. 3. **Profitability**: Adjusted operating profit declined by 16%, but the adjusted operating margin was maintained at 18.6% due to cost mitigation actions. 4. **Cash Position**: Net cash increased significantly by 44% to £39.3m, reflecting strong working capital discipline. 5. **Debt**: Lease liabilities increased slightly by 6%, but overall debt remains minimal compared to cash reserves.
06:01
Open Terminal ↗ RNS Source
80 Positive
TCF
Theracryf Plc
Positive
Non-Binding Proposal to Acquire TheraCryf’s Assets
TheraCryf plc received and rejected a non-binding, indicative proposal to acquire its lead neuropsychiatry assets, the Orexin-1 (Ox-1) and dopamine transporter (DAT) programs. The Board deemed the offer undervaluing the assets current and future potential, particularly the Ox-1 program, which targets addiction in a $42 billion market. Fully funded to reach Phase 1 clinical study by Q4 2026, the Ox-1 program is seen as a significant value driver. CEO Dr. Huw Jones emphasized the assets strategic importance and potential, citing recent industry transactions valuing similar assets at up to $7.8 billion. TheraCryf remains committed to advancing its programs to enhance shareholder value.
TheraCryf plc received and rejected a non-binding, indicative proposal to acquire its lead neuropsychiatry assets, the Orexin-1 (Ox-1) and dopamine transporter (DAT) programs. The Board deemed the offer undervaluing the assets current and future potential, particularly the Ox-1 program, which targets addiction in a $42 billion market. Fully funded to reach Phase 1 clinical study by Q4 2026, the Ox-1 program is seen as a significant value driver. CEO Dr. Huw Jones emphasized the assets strategic importance and potential, citing recent industry transactions valuing similar assets at up to $7.8 billion. TheraCryf remains committed to advancing its programs to enhance shareholder value.
Proposals
06:01
Open Terminal ↗ RNS Source
88 Trading Edge
PROC
Procook Group PLC
Positive
Fourth quarter trading update
ProCook Group PLC reports strong Q4 and full-year FY26 results, significantly outperforming the UK kitchenware market. Revenue grew 19.2% in Q4 to £18.5m and 23.0% for the full year to £85.5m, driven by both retail and ecommerce channels. Like-for-like revenue increased 9.9% in Q4 and 11.8% for the year. The company opened 13 new stores, expanded its digital content library, and increased its Revolving Credit Facility to £15m. EBITDA is expected to be slightly ahead of market expectations, while operating profit and PBT are in line. ProCook ended the year with a net cash position of £4.4m and £20.4m in available liquidity. The company remains focused on growth, aiming for 100 stores, £100m revenue, and a 10% operating profit margin.
ProCook Group PLC reports strong Q4 and full-year FY26 results, significantly outperforming the UK kitchenware market. Revenue grew 19.2% in Q4 to £18.5m and 23.0% for the full year to £85.5m, driven by both retail and ecommerce channels. Like-for-like revenue increased 9.9% in Q4 and 11.8% for the year. The company opened 13 new stores, expanded its digital content library, and increased its Revolving Credit Facility to £15m. EBITDA is expected to be slightly ahead of market expectations, while operating profit and PBT are in line. ProCook ended the year with a net cash position of £4.4m and £20.4m in available liquidity. The company remains focused on growth, aiming for 100 stores, £100m revenue, and a 10% operating profit margin.
MetricFY25FY26YoY Change
Revenue (£m)69.585.5+23.0%
Ecommerce Revenue (£m)25.531.3+22.9%
Retail Revenue (£m)44.054.2+23.1%
LFL Revenue (£m)62.971.1+11.8%
Ecommerce LFL Revenue (£m)25.030.4+21.2%
Retail LFL Revenue (£m)37.940.7+5.7%
Net Cash Position (£m)1.04.4+340.0%
Available Liquidity (£m)10.020.4+104.0%
06:01
Open Terminal ↗ RNS Source
88 Trading Edge
OXIG
Oxford Instruments PLC
Positive
Trading Update
Oxford Instruments PLC reports a resilient full-year performance for FY26, in line with market expectations. Key highlights include: - **Order intake** up ~8% on an organic constant currency (OCC) basis, with a book-to-bill ratio of ~1.07. - **Advanced Technologies (AT) division** saw ~30% OCC order growth, driven by compound semiconductor market tailwinds and volume manufacturing customers. - **Imaging & Analysis (I&A) division** returned to growth in H2, with full-year orders marginally up on an OCC basis. - **Revenue** significantly improved in H2, slightly positive on an OCC basis. - **Operating profit margin** benefited from cost restructuring and H2 revenue growth. - **Share buyback program** progressed, with £11.7m of the second £50m tranche completed by March 2026. - Strong momentum and order book position the Group well for growth in FY27 and beyond. Preliminary results will be presented on June 9, 2026.
Oxford Instruments PLC reports a resilient full-year performance for FY26, in line with market expectations. Key highlights include
**Order intake** up ~8% on an organic constant currency (OCC) basis, with a book-to-bill ratio of ~1.07.
**Advanced Technologies (AT) division** saw ~30% OCC order growth, driven by compound semiconductor market tailwinds and volume manufacturing customers.
**Imaging & Analysis (I&A) division** returned to growth in H2, with full-year orders marginally up on an OCC basis.
**Revenue** significantly improved in H2, slightly positive on an OCC basis.
**Operating profit margin** benefited from cost restructuring and H2 revenue growth.
**Share buyback program** progressed, with £11.7m of the second £50m tranche completed by March 2026.
Strong momentum and order book position the Group well for growth in FY27 and beyond. Preliminary results will be presented on June 9, 2026.
MetricFY25FY26Change
Order Intake (OCC)N/A+8%+8% (YoY)
Book-to-Bill RatioN/A1.07N/A
Imaging & Analysis Order Intake (OCC)N/AMarginally UpMarginally Up (YoY)
Advanced Technologies Order Intake (OCC)N/A+30%+30% (YoY)
H2 Revenue (OCC)N/ASlightly PositiveSlightly Positive (YoY)
Operating Profit MarginN/AImprovedImproved (YoY)
Share Buyback (Completed)N/A£61.7m (out of £100m)N/A
**Note:** Since the provided text does not contain specific financial figures for FY25, the table compares the changes and expectations for FY26 based on the available information. The "Change" column indicates the year-on-year comparison where possible.
06:01
Open Terminal ↗ RNS Source
88 Trading Edge
SOS
Sosandar Plc
Positive
Full Year Trading Update
Sosandar PLC reports strong FY26 performance with 14% revenue growth to £42.3m, driven by 24% increase in own site sales. Profit before tax (PBT) reached £0.4m, in line with market expectations, and gross margin improved to 63.9%. Net cash increased to £8.4m, supported by cash generation and share buybacks. The company maintained strong performance across all categories and third-party partnerships, with stores showing positive uplifts, though still impacting overall profitability. The Board remains confident in sustainable, profitable growth.
Sosandar PLC reports strong FY26 performance with 14% revenue growth to £42.3m, driven by 24% increase in own site sales. Profit before tax (PBT) reached £0.4m, in line with market expectations, and gross margin improved to 63.9%. Net cash increased to £8.4m, supported by cash generation and share buybacks. The company maintained strong performance across all categories and third-party partnerships, with stores showing positive uplifts, though still impacting overall profitability. The Board remains confident in sustainable, profitable growth.
MetricFY26FY25Year-on-Year Change
Total Revenue (£m)42.337.1+14%
Own Site Revenue (£m)N/AN/A+24%
Profit Before Tax (£m)0.4-0.1+500%
Gross Margin (%)63.962.1+1.8%
Net Cash (£m)8.47.3+15%
06:01
Open Terminal ↗ RNS Source
80 Positive
PYC
Physiomics Plc
Positive
Physiomics Awarded New Contract by Numab
Physiomics PLC has been awarded a new contract by Numab Therapeutics AG to develop a mechanistic pharmacokinetic-pharmacodynamic (PK/PD) modelling framework for a new oncology program. The project, starting in April 2026 and completing in Q3 2026, will support proof-of-concept activities and strategic decision-making. This collaboration strengthens Physiomics relationship with Numab Therapeutics, highlighting the integration of model-informed approaches in drug development.
Physiomics PLC has been awarded a new contract by Numab Therapeutics AG to develop a mechanistic pharmacokinetic-pharmacodynamic (PK/PD) modelling framework for a new oncology program. The project, starting in April 2026 and completing in Q3 2026, will support proof-of-concept activities and strategic decision-making. This collaboration strengthens Physiomics relationship with Numab Therapeutics, highlighting the integration of model-informed approaches in drug development.
NewContract
06:01
Open Terminal ↗ RNS Source
Market Pulse --
Up
0
Down
0
Good0
Bad0
AI Net0
Most Active Tickers 0
No active AI ticker data for this session.
Strongest Bullish 0
No bullish tickers scored yet.
Strongest Bearish 0
No bearish tickers scored yet.
IRSH
IRSH
Price --
Move --
News 0
Mode AI
Site ↗
🤖 AI Chartist
Full AI chart intelligence
LSTM forecast path, EMA stack, RSI, MACD, support & resistance — all live in the Chart tab.
IRSH logo
Ticker Overview

IRSH

Pulse--
AI Net0
Market News501
Up
0
Down
0
🏢
Company Overview
Profile · broker target · market cap · sector · catalyst count
Select a ticker above
AI VIP Intelligence

Signal Storm

⚡ Live 2026-04-14 501 alerts
IRSH
IRSH IRSH
17:38
Market

Banco Comercial Português, S.A., informs about call notice of the Annual General Meeting and proposals

Open Terminal Source RNS
BP.
BP. BP.
17:31
Market

Director/PDMR Shareholding

Open Terminal Source RNS
SGE
SGE Sage Group PLC
17:26
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Fundsmith Investment Services Limited', '5.030000', 0]
Open Terminal Source RNS
SGE
SGE Sage Group PLC
17:26
Market

Transaction in Own Shares

Open Terminal Source RNS
VSVS
VSVS Vesuvius PLC
17:22
Market

Director/PDMR Shareholding

Open Terminal Source RNS
VSVS
VSVS Vesuvius PLC
17:20
Market

Director/PDMR Shareholding

Open Terminal Source RNS
SMWH
SMWH WH Smith PLC
17:04
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
JD.
JD. JD.
17:03
Market

Transaction in Own Shares

Open Terminal Source RNS
BRAI
BRAI BlackRock American Income T…
17:00
Market

Issue of Equity

Open Terminal Source RNS
LLOY
LLOY Lloyds Banking Group PLC
16:57
Market

Transaction in Own Shares

Open Terminal Source RNS
TFIF
TFIF TwentyFour Income Fund Ltd
16:53
Market

Issue of Equity

Open Terminal Source RNS
BPCR
BPCR BioPharma Credit PLC
16:45
Market

Transaction in Own Shares

Open Terminal Source RNS
BRGE
BRGE BlackRock Greater Europe In…
16:44
Market

Transaction in Own Shares

Open Terminal Source RNS
IMB
IMB Imperial Brands PLC
16:42
Market

Transaction in Own Shares

Open Terminal Source RNS
SHEL
SHEL Shell plc
16:41
Market

Transaction in Own Shares

Open Terminal Source RNS
ABF
ABF Associated British Foods PLC
16:40
Market

Transaction in Own Shares

Open Terminal Source RNS
GPE
GPE GREAT PORTLAND ESTATES PLC
16:37
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['BlackRock, Inc.', '13.130000', '12.780000']
Open Terminal Source RNS
RWA
RWA Robert Walters
16:36
Market

BLOCK LISTING SIX MONTHLY RETURN

Open Terminal Source RNS
AXL
AXL Arrow Exploration Corp.
16:33
Market

Standard form for notification of major holdings

TR1 Buy

TR1 Buy
['Clarendon Trust- Sub Fund B', '4.61', '5.02']
Open Terminal Source RNS
TFG
TFG Tetragon Financial Group Ltd
16:33
Market

Tetragon Financial Group Limited Announcement of Final Results of Tender Offer to Purchase Tetragon Non-Voting Shares

Open Terminal Source RNS
ANG
ANG Angling Direct PLC
16:32
Market

Transaction in Own Shares

Open Terminal Source RNS
BKG
BKG The Berkeley Group Holdings…
16:31
Market

Transaction in Own Shares

Open Terminal Source RNS
ESCT
ESCT The European Smaller Compan…
16:28
Market

Transaction in Own Shares

Open Terminal Source RNS
SCF
SCF Schroder Income Growth Fund
16:28
Market

Transaction in Own Shares

Open Terminal Source RNS
RDT
RDT Rosslyn Data Technologies p…
16:27
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
BGCG
BGCG Baillie Gifford China Growt…
16:26
Market

Transaction in Own Shares

Open Terminal Source RNS
FSTA
FSTA Fuller Smith & Turner
16:25
Market

Fuller, Smith & Turner PLC: Transaction in own shares

Open Terminal Source RNS
MONY
MONY MONY Group plc
16:25
Market

Transaction in Own Shares

Open Terminal Source RNS
COR
COR Coretx Holdings Plc
16:25
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Peel Hunt LLP', '12.501662', '13.537615']
Open Terminal Source RNS
GCP
GCP GCP Infrastructure Investme…
16:25
Market

Transaction in Own Shares

Open Terminal Source RNS
AGT
AGT AVI Global Trust PLC
16:24
Market

Transaction in Own Shares

Open Terminal Source RNS
BNKR
BNKR Bankers Investment Trust
16:23
Market

Transaction in Own Shares

Open Terminal Source RNS
ABDN
ABDN Abrdn PLC
16:22
Market

Director/PDMR Shareholding

Open Terminal Source RNS
BHMG
BHMG BH Macro Limited
16:22
Market

Transaction in Own Shares

Open Terminal Source RNS
SJG
SJG Schroder Japan Growth Fund
16:21
Market

Transaction in Own Shares

Open Terminal Source RNS
SCP
SCP Schroder UK Mid Cap Fund PLC
16:21
Market

Transaction in Own Shares

Open Terminal Source RNS
BVA
BVA Banco Bilbao Vizcaya Argent…
16:21
Market

MREL requirement

Open Terminal Source RNS
MTU
MTU Montanaro UK Smaller Compan…
16:18
Market

Transaction in Own Shares

Open Terminal Source RNS
HAN
HAN Hansa Trust
16:18
Market

Transaction in Own Shares

Open Terminal Source RNS
HUW
HUW Helios Underwriting PLC
16:18
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
CGT
CGT Capital Gearing Trust
16:17
Market

Transaction in Own Shares

Open Terminal Source RNS
RCH
RCH Reach PLC
16:15
Market

Director/PDMR Shareholding

Open Terminal Source RNS
BUT
BUT Brunner Investment Trust
16:14
Market

Transaction in Own Shares

Open Terminal Source RNS
FGT
FGT Finsbury Growth & Income Tr…
16:14
Market

Transaction in Own Shares

Open Terminal Source RNS
MYI
MYI Murray International Trust
16:13
Market

Issue of Equity

Open Terminal Source RNS
BREE
BREE Breedon Group PLC
16:11
Market

Director/PDMR Shareholding

Open Terminal Source RNS
MTE
MTE Montanaro European Smaller …
16:11
Market

Transaction in Own Shares

Open Terminal Source RNS
BARC
BARC Barclays PLC
16:11
Market

Form 8.5 EPT/Non RI BEAZLEY PLC

Open Terminal Source RNS
ARR
ARR Aurora Investment Trust plc
16:09
Market

Transaction in Own Shares

Open Terminal Source RNS
FSFL
FSFL Foresight Solar Fund Ltd
16:08
Market

Transaction in Own Shares

Open Terminal Source RNS
PCFT
PCFT Polar Capital Global Financ…
16:07
Market

Transaction in Own Shares

Open Terminal Source RNS
INCH
INCH Inchcape PLC
16:06
Market

Director/PDMR Shareholding

Open Terminal Source RNS
JEDT
JEDT JPMorgan Euro Small Compani…
16:06
Market

Transaction in Own Shares

Open Terminal Source RNS
PTEC
PTEC Playtech Plc
16:04
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
BGFD
BGFD Baillie Gifford Japan Trust
16:03
Market

Transaction in Own Shares

Open Terminal Source RNS
MRC
MRC The Mercantile Investment T…
16:02
Market

Transaction in Own Shares

Open Terminal Source RNS
TIR
TIR Tiger Royalties and investm…
16:02
Market

Change of Nominated Adviser

Open Terminal Source RNS
BGUK
BGUK Baillie Gifford UK Growth F…
16:01
Market

Transaction in Own Shares

Open Terminal Source RNS
FEML
FEML Fidelity Emerging Markets O…
16:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CBG
CBG Close Brothers Group plc
16:01
Market

Director/PDMR Shareholding

Open Terminal Source RNS
0RYA
0RYA Ryanair Holdings plc
16:00
Market

EU SHAREHOLDING UPDATE

Open Terminal Source RNS
DOTD
DOTD Dotdigital Group Plc
16:00
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
JMGI
JMGI JPMorgan Emerging Markets I…
15:59
Market

Transaction in Own Shares

Open Terminal Source RNS
IGET
IGET Invesco Perpetual Select Tr…
15:59
Market

Issue of Equity

Open Terminal Source RNS
BNC
BNC Banco Santander S.A.
15:59
Market

Santander informs of the MREL determined by SRB

Open Terminal Source RNS
RMV
RMV Rightmove PLC
15:57
Market

Transaction in Own Shares

Open Terminal Source RNS
BGEU
BGEU Baillie Gifford European Gr…
15:54
Market

Transaction in Own Shares

Open Terminal Source RNS
BGS
BGS Baillie Gifford Shin Nippon…
15:54
Market

Transaction in Own Shares

Open Terminal Source RNS
48DB
48DB 48DB
15:54
Market

Directorate change

Open Terminal Source RNS
HFEL
HFEL Henderson Far East Income L…
15:54
Market

Issue of Equity

Open Terminal Source RNS
KLR
KLR Keller Group PLC
15:52
Market

Director/PDMR Shareholding

Open Terminal Source RNS
UEM
UEM Utilico Emerging Markets Ltd
15:49
Market

Transaction in Own Shares & Total Voting Rights

Open Terminal Source RNS
PHI
PHI Pacific Horizon Investment …
15:49
Market

Transaction in Own Shares

Open Terminal Source RNS
GSCU
GSCU Great Southern Copper PLC
15:49
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Spreadex LTD', '1.357900', '2.292500']
Open Terminal Source RNS
JEMI
JEMI JPMorgan Global Emerging Ma…
15:49
Market

Transaction in Own Shares

Open Terminal Source RNS
SAIN
SAIN Scottish American Investmen…
15:48
Market

Transaction in Own Shares

Open Terminal Source RNS
CBA
CBA Ceiba Investments
15:47
Market

Result of EGM

Open Terminal Source RNS
MNG
MNG M&G Plc
15:46
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Morgan Stanley', '0.089291', '0.038623']
Open Terminal Source RNS
SBO
SBO Schroder British Opportunit…
15:45
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Philip J Milton & Company Plc', '3.010000', 0]
Open Terminal Source RNS
SOI
SOI Schroder Oriental Income Fu…
15:44
Market

Transaction in Own Shares

Open Terminal Source RNS
JUSC
JUSC JPmorgan US Smaller Compani…
15:42
Market

Transaction in Own Shares

Open Terminal Source RNS
BIPS
BIPS Invesco Bond Income Plus Li…
15:39
Market

Issue of Equity

Open Terminal Source RNS
CRWN
CRWN Crown Place VCT PLC
15:34
Market

Transaction in Own Shares and Total Voting Rights and Capital

Open Terminal Source RNS
AOF
AOF Africa Opportunity Fund Ltd
15:33
Market

Monthly Report

Open Terminal Source RNS
GEN
GEN Genuit Group plc
15:33
Market

Director/PDMR Shareholding

Open Terminal Source RNS
EDEN
EDEN Eden Research plc
15:31
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Octopus Investments Limited', '11.400000', '8.400000']
Open Terminal Source RNS
VTY
VTY Vistry Group PLC
15:31
Market

Director/PDMR Shareholding

Open Terminal Source RNS
HTG
HTG Hunting PLC
15:31
Market

Notification of major holdings

<mark style="background-color:yellow">TR1</mark> Buy

<mark style="background-coloryellow">TR1</mark> Buy
['Aberdeen Group plc', 'Below 5', '5.823068']
Open Terminal Source RNS
PRV
PRV Porvair plc
15:30
Market

Results of AGM

Open Terminal Source RNS
PNN
PNN Pennon Group Plc
15:25
Market

Rescheduled Full-Year Results Date

Open Terminal Source RNS
FGP
FGP FirstGroup PLC
15:25
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of Partnership Shares under the FirstGroup SIP

<mark style="background-coloryellow">Purchase</mark> of Partnership Shares under the FirstGroup SIP
Open Terminal Source RNS
LST
LST Light Science Technologies …
15:23
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
None
Open Terminal Source RNS
0A28
0A28 Prosus N.V.
15:22
Market

Transaction in Own Shares

Open Terminal Source RNS
GTE
GTE Gran Tierra Energy Inc
15:21
Market

Director/PDMR Shareholding - Replacement

Open Terminal Source RNS
CTY
CTY City Of London Investment T…
15:17
Market

Issue of Equity

Open Terminal Source RNS
RDT
RDT Rosslyn Data Technologies p…
15:08
Market

Director/PDMR Dealings

Open Terminal Source RNS
BGS
BGS Baillie Gifford Shin Nippon…
15:06
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['City of London Investment Management Company Limited', '10.920000', '11.410000']
Open Terminal Source RNS
BTRW
BTRW Barratt Redrow plc
15:02
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
LLOY
LLOY Lloyds Banking Group PLC
15:01
Market

Final Terms

Open Terminal Source RNS
ONT
ONT Oxford Nanopore Technologie…
15:01
Market

Share Incentive Plan - Director/PDMR Shareholding

Under the SIP, the SIP Trustee will award each participating employee one Matching Share (as defined in the SIP) for each Ordinary Share <mark style="background-color:yellow">purchase</mark>d by the employee under the SIP. On 14 April 2026…

Under the SIP, the SIP Trustee will award each participating employee one Matching Share (as defined in the SIP) for each Ordinary Share <mark style="background-color:yellow">purchase</mark>d by the employee under the SIP. On 14 April 2026, the Company issued 136 Ordinary Shares to the SIP Trustee to hold on behalf of Francis Van Parys to satisfy the Matching Shares awarded under the SIP to him on that date, and 136 Ordinary Shares to the SIP Trustee to hold on behalf of Nick Keher to satisfy the Matching Shares awarded under the SIP to him on that date.
Open Terminal Source RNS
BGCG
BGCG Baillie Gifford China Growt…
14:54
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['City of London Investment Management Company Limited', '22.170000', '21.010000']
Open Terminal Source RNS
SBRE
SBRE Sabre Insurance Group PLC
14:49
Market

Director/PDMR Shareholding

Open Terminal Source RNS
RWA
RWA Robert Walters
14:47
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
71XK
71XK 71XK
14:42
Market

8-K dated April 14, 2026 (1Q2026 presentation)

Open Terminal Source RNS
XPF
XPF XP Factory PLC
14:37
Market

Director/PDMR Shareholding

Open Terminal Source RNS
TAP
TAP Tap Global Group Plc
14:34
Market

Appointment of Joint Broker

Open Terminal Source RNS
EDEN
EDEN Eden Research plc
14:32
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
GSK
GSK GSK plc
14:31
Market

Director/PDMR Shareholding

Open Terminal Source RNS
COST
COST Costain Group PLC
14:30
Market

Director Declaration

Open Terminal Source RNS
ALT
ALT Altitude Group Plc
14:26
Market

Director/PDMR Dealing

Bob Wigley, Non-Executive Director, <mark style="background-color:yellow">purchase</mark>d 200,000 Ordinary Shares at an average price of 24.75 pence per share. Following the purchase of Ordinary Shares, Bob Wigleys beneficial holding is 4…

Bob Wigley, Non-Executive Director, <mark style="background-color:yellow">purchase</mark>d 200,000 Ordinary Shares at an average price of 24.75 pence per share. Following the purchase of Ordinary Shares, Bob Wigleys beneficial holding is 400,000 Ordinary Shares, representing approximately 0.55% of the Companys issued share capital.
Open Terminal Source RNS
GAMA
GAMA Gamma Communications PLC
14:26
Market

Form 8.3

Open Terminal Source RNS
SDR
SDR Schroders PLC
14:26
Market

Form 8.3

Open Terminal Source RNS
BEZ
BEZ Beazley plc
14:26
Market

Form 8.3

Open Terminal Source RNS
IPF
IPF International Personal Fina…
14:26
Market

Form 8.3

Open Terminal Source RNS
IPF
IPF International Personal Fina…
14:26
Market

Form 8.3

Open Terminal Source RNS
SNR
SNR Senior PLC
14:26
Market

Form 8.3

Open Terminal Source RNS
JTC
JTC JTC PLC
14:26
Market

Form 8.3

Open Terminal Source RNS
IIG
IIG Intuitive Investments Group…
14:26
Market

IIG plc - Form 8.3 - Philippe Jabre

Open Terminal Source RNS
RAT
RAT Rathbone Brothers PLC
14:24
Market

Form 8.3 Picton Property Income Limited

Open Terminal Source RNS
RAT
RAT Rathbone Brothers PLC
14:23
Market

Form 8.3 LondonMetric Property Plc & Schroder REIT Limited

Open Terminal Source RNS
SEI
SEI Sintana Energy Inc.
14:21
Market

Intention to list on the NSX

Open Terminal Source RNS
DO72
DO72 DO72
14:21
Market

ISM_MSESE_EARLY REDEMPTION_14-04-2026

Open Terminal Source RNS
JEMA
JEMA JPMORGAN EMERGING EUROPE MI…
14:18
Market

Ten Largest Investments

Open Terminal Source RNS
JCGI
JCGI JPMorgan China Growth & Inc…
14:18
Market

Ten Largest Investments

Open Terminal Source RNS
JMGI
JMGI JPMorgan Emerging Markets I…
14:18
Market

Ten Largest Investments

Open Terminal Source RNS
JFJ
JFJ JPMorgan Japanese Investmen…
14:18
Market

Ten Largest Investments

Open Terminal Source RNS
JEMI
JEMI JPMorgan Global Emerging Ma…
14:18
Market

Ten Largest Investments

Open Terminal Source RNS
JIGI
JIGI JPMorgan India Growth & Inc…
14:18
Market

Ten Largest Investments

Open Terminal Source RNS
JAGI
JAGI JPMorgan Asia Growth & Inco…
14:18
Market

Ten Largest Investments

Open Terminal Source RNS
JEDT
JEDT JPMorgan Euro Small Compani…
14:18
Market

Ten Largest Investments

Open Terminal Source RNS
JUGI
JUGI JPMorgan UK Small Cap Growt…
14:18
Market

Ten Largest Investments

Open Terminal Source RNS
JEGI
JEGI JPMorgan European Growth & …
14:18
Market

Ten Largest Investments

Open Terminal Source RNS
MRC
MRC The Mercantile Investment T…
14:18
Market

Ten Largest Investments

Open Terminal Source RNS
JGGI
JGGI JP Morgan Global Growth & I…
14:18
Market

Ten Largest Investments

Open Terminal Source RNS
JUSC
JUSC JPmorgan US Smaller Compani…
14:18
Market

Ten Largest Investments

Open Terminal Source RNS
JAM
JAM JPMorgan American Investmen…
14:18
Market

Ten Largest Investments

Open Terminal Source RNS
JCH
JCH JPMorgan Claverhouse Invest…
14:18
Market

Ten Largest Investments

Open Terminal Source RNS
FTV
FTV Foresight VCT PLC
14:16
Market

Final Results

**Summary:** Foresight VCT plc, managed by Foresight Group LLP, released its final results for the year ended 31 December 2025, approved by the Board of Directors on 13 April 2026. The company reported a Net Asset Value (NAV) Total Return…

**Summary**
Foresight VCT plc, managed by Foresight Group LLP, released its final results for the year ended 31 December 2025, approved by the Board of Directors on 13 April 2026. The company reported a Net Asset Value (NAV) Total Return per share of 0.1%, with dividends of 10.5p leading to a 10.4p fall in NAV from 82.0p to 71.6p. Key financial highlights include a special interim dividend of 6.4p and a final dividend of 4.1p, distributing £19.3 million and £12.4 million respectively. The company made six new investments totaling £7.8 million and twelve follow-on investments costing £7.7 million. The value of the investment portfolio decreased by £8.4 million, driven by the sale of an investment for £24.3 million and a loan repayment of £0.1 million, offset by new and follow-on investments. The company raised £38.6 million through a share offer in January 2026 and recommends a final dividend of 3.6p per share for 2025. The Chair’s statement highlights a 16.0% dividend yield, including a special dividend, and emphasizes the company’s diversified portfolio resilience in a challenging economic environment. The company maintains its strategic objectives, including paying annual dividends of at least 5% of NAV, achieving a NAV Total Return <mark style="background-color:yellow">above</mark> 5%, and implementing regular share buybacks. The Board and Manager remain committed to these goals, despite the flat performance in 2025, and are focused on long-term value creation for shareholders.
Year-on-Year Financial and Debt Comparison (2024 vs 2025)
Metric20242025Change
Net Asset Value (NAV) (£ million)222.9214.0-8.9 (-4.0%)
NAV per share (pence)82.071.6-10.4 (-12.7%)
Total Dividends Paid (£ million)31.731.70 (0.0%)
Dividend per share (pence)10.510.50 (0.0%)
Investment Portfolio Value (£ million)166.6158.2-8.4 (-5.0%)
New Investments (£ million)14.315.5+1.2 (+8.4%)
Follow-on Investments (£ million)7.77.70 (0.0%)
Proceeds from Disposals (£ million)36.524.4-12.1 (-33.1%)
Debt (Amounts falling due within one year) (£ million)3.32.2-1.1 (-33.3%)
Cash and Cash Equivalents (£ million)55.955.2-0.7 (-1.3%)
### Key Observations: 1. **Net Asset Value (NAV):** Decreased by 4.0% from £222.9 million in 2024 to £214.0 million in 2025, primarily due to dividend payments and investment losses. 2. **NAV per Share:** Fell by 12.7% from 82.0p to 71.6p, reflecting the decrease in NAV and the impact of dividends. 3. **Dividends:** Remained consistent at £31.7 million, with no change in dividend per share. 4. **Investment Portfolio:** Decreased by 5.0% from £166.6 million to £158.2 million, driven by a successful realisation and loan repayment, offset by new and follow-on investments. 5. **Debt:** Reduced by 33.3% from £3.3 million to £2.2 million, indicating improved liquidity. 6. **Cash and Cash Equivalents:** Slightly decreased by 1.3% from £55.9 million to £55.2 million, reflecting operational and investment activities.
Open Terminal Source RNS
GJ03
GJ03 GJ03
14:09
Market

Form 8.5 (EPT/RI) - Replacement of Schroders plc

Open Terminal Source RNS
FGT
FGT Finsbury Growth & Income Tr…
14:06
Market

Purchase of shares by the portfolio manager

Open Terminal Source RNS
AJB
AJB AJ Bell plc
14:04
Market

Director/PDMR Shareholding

Open Terminal Source RNS
AA4
AA4 Amedeo Air Four Plus Limited
14:01
Market

Form 8.3

Open Terminal Source RNS
IDOX
IDOX IDOX plc
14:01
Market

Form 8.3

Open Terminal Source RNS
QLT
QLT Quilter PLC
14:01
Market

Form 8.3 - LondonMetric PLC & Schroder REIT

Open Terminal Source RNS
QLT
QLT Quilter PLC
14:01
Market

Form 8.3 - BRCK Group plc

Open Terminal Source RNS
SCT
SCT Softcat plc
14:00
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['JPMorgan Asset Management Holdings Inc.', '4.612059', '4.559041']
Open Terminal Source RNS
SN.
SN. SN.
14:00
Market

Replacement: Annual Financial Report & AGM Notice

Open Terminal Source RNS
KLR
KLR Keller Group PLC
13:54
Market

Notice of 2026 Annual General Meeting

Open Terminal Source RNS
WEIR
WEIR Weir Group PLC
13:50
Market

Director/PDMR Shareholding

Open Terminal Source RNS
WEIR
WEIR Weir Group PLC
13:49
Market

Director/PDMR Shareholding

Open Terminal Source RNS
ONWD
ONWD Onward Opportunities Ltd
13:47
Market

Purchase of Shares by Portfolio Manager

Open Terminal Source RNS
SD34
SD34 SD34
13:45
Market

Notice to Noteholders

Open Terminal Source RNS
FH03
FH03 FH03
13:37
Market

Doc re. Form 8-K

Open Terminal Source RNS
OSEC
OSEC Octopus Aim VCT 2 PLC
13:31
Market

Admission of Further Securities to Trading

Open Terminal Source RNS
OSEC
OSEC Octopus Aim VCT 2 PLC
13:26
Market

Admission of Further Securities to Trading

Open Terminal Source RNS
ACG
ACG ACG Acquisition Co. Ltd.
13:23
Market

Exercise of Warrants and Total Voting Rights

Open Terminal Source RNS
NFG
NFG Next 15 Group PLC
13:21
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Liontrust Investment Partners LLP', '11.142000', '10.419000']
Open Terminal Source RNS
OSEC
OSEC Octopus Aim VCT 2 PLC
13:21
Market

Admission of Further Securities to Trading

Open Terminal Source RNS
MGNS
MGNS Morgan Sindall Group PLC
13:19
Market

Admission to Trading

Open Terminal Source RNS
SPI
SPI Spire Healthcare Group Plc
13:19
Market

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc

Open Terminal Source RNS
SNR
SNR Senior PLC
13:18
Market

Form 8.3 - The Vanguard Group, Inc.: Senior plc

Open Terminal Source RNS
SDR
SDR Schroders PLC
13:17
Market

Form 8.3 - The Vanguard Group, Inc.: Schroders plc

Open Terminal Source RNS
PCTN
PCTN Picton Property Income Ltd
13:17
Market

Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited

Open Terminal Source RNS
NCC
NCC NCC Group plc
13:16
Market

Form 8.3 - The Vanguard Group, Inc.: NCC Group plc

Open Terminal Source RNS
RLE
RLE Real Estate Investors PLC
13:16
Market

Director/PDMR Shareholding

Open Terminal Source RNS
JTC
JTC JTC PLC
13:15
Market

Form 8.3 - The Vanguard Group, Inc.: JTC plc

Open Terminal Source RNS
BLND
BLND British Land Company PLC
13:15
Market

Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The

Open Terminal Source RNS
BEZ
BEZ Beazley plc
13:14
Market

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

Open Terminal Source RNS
LMP
LMP LondonMetric Property Plc
13:14
Market

Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc

Open Terminal Source RNS
IQE
IQE IQE PLC
13:13
Market

Form 8.3 - IQE PLC

Open Terminal Source RNS
MNG
MNG M&G Plc
13:11
Market

Form 8.3 - BRITISH LAND COMPANY PLC

Open Terminal Source RNS
GENI
GENI Genincode PLC
13:10
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['First Equity Limited', '3.452667', '4.780615']
Open Terminal Source RNS
MNG
MNG M&G Plc
13:09
Market

Form 8.3 - IQE PLC

Open Terminal Source RNS
MNG
MNG M&G Plc
13:09
Market

Form 8.3 - PERMANENT TSB GROUP HOLDINGS PLC

Open Terminal Source RNS
YK33
YK33 YK33
13:07
Market

Change of Name

Open Terminal Source RNS
IRSH
IRSH IRSH
13:01
Market

Publication of a Supplementary Prospectus

Open Terminal Source RNS
JUP
JUP Jupiter Fund Management Plc
13:01
Market

Director/PDMR Shareholding

Open Terminal Source RNS
CKT
CKT Checkit PLC
13:00
Market

Form 8.3 - Checkit plc

Open Terminal Source RNS
ABDN
ABDN Abrdn PLC
12:59
Market

Form 8.3 - Picton Property Income Limited

Open Terminal Source RNS
ABDN
ABDN Abrdn PLC
12:55
Market

Form 8.3 - LondonMetric & Schroder REIT

Open Terminal Source RNS
EME
EME Empyrean Energy Plc
12:52
Market

Convertible Note Amendment

Open Terminal Source RNS
MSI
MSI MS INTERNATIONAL plc
12:51
Market

Grant of Options & Director/PDMR Shareholdings

Open Terminal Source RNS
ABDN
ABDN Abrdn PLC
12:50
Market

Form 8.3 - British Land Company plc, The

Open Terminal Source RNS
BGEU
BGEU Baillie Gifford European Gr…
12:46
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['1607 Capital Partners, LLC', '9.532047', '10.088416']
Open Terminal Source RNS
ABDN
ABDN Abrdn PLC
12:46
Market

Form 8.3 - Gamma Communications plc

Open Terminal Source RNS
ABDP
ABDP Ab Dynamics
12:46
Market

Director/PDMR Shareholding

Open Terminal Source RNS
IQE
IQE IQE PLC
12:41
Market

IQE plc: Rule 2.9 Announcement

Open Terminal Source RNS
QQ.
QQ. QQ.
12:39
Market

Director Declaration

Open Terminal Source RNS
OOA
OOA Octopus Aim Vct Plc
12:31
Market

Admission of Further Securities to Trading

Open Terminal Source RNS
TKO
TKO Taseko Mines Limited
12:31
Market

Taseko Updates Florence Copper and Gibraltar First Quarter Production

Open Terminal Source RNS
LST
LST Light Science Technologies …
12:27
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Simon Deacon', '9.69', '28.89']
Open Terminal Source RNS
OOA
OOA Octopus Aim Vct Plc
12:26
Market

Admission of Further Securities to Trading

Open Terminal Source RNS
OOA
OOA Octopus Aim Vct Plc
12:21
Market

Admission of Further Securities to Trading

Open Terminal Source RNS
BARC
BARC Barclays PLC
12:19
Market

Form 8.3 BRITISH LAND COMPANY PLC, THE

Open Terminal Source RNS
BARC
BARC Barclays PLC
12:19
Market

Form 8.3 SPIRE HEALTHCARE GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
12:19
Market

Form 8.3 LIFE SCIENCE REIT PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
12:19
Market

Form 8.3 NCC GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
12:19
Market

Form 8.3 IQE PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
12:19
Market

Form 8.3 JTC PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
12:18
Market

Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC

Open Terminal Source RNS
FARN
FARN Faron Pharmaceuticals Oy
12:16
Market

Faron Pharmaceuticals Ltd: Remaining offer shares registered with Finnish Trade Register

Open Terminal Source RNS
MONY
MONY MONY Group plc
12:14
Market

Admission to Trading

Open Terminal Source RNS
EGL
EGL Ecofin Global Utilities and…
12:08
Market

Portfolio Update as at 31 March 2026

Open Terminal Source RNS
LIO
LIO Liontrust Asset Management
12:08
Market

Form 8.3 - GAMMA COMMUNICATIONS PLC

Open Terminal Source RNS
BFSP
BFSP Blackfinch Spring VCT PLC
12:00
Market

Admission of Further Securities to Trading

Open Terminal Source RNS
GVCT
GVCT Guinness VCT PLC
11:59
Market

Admission of Further Securities to Trading

Open Terminal Source RNS
0UKI
0UKI Bank of Nova Scotia
11:50
Market

Form 8.3 - British Land Company plc, The

Open Terminal Source RNS
0UKI
0UKI Bank of Nova Scotia
11:45
Market

Form 8.3 - NCC Group plc

Open Terminal Source RNS
XGDU
XGDU Xtrackers IE Physical Gold …
11:41
Market

Final Terms

Open Terminal Source RNS
IRSH
IRSH IRSH
11:38
Market

Form 8.3 - Idox plc

Open Terminal Source RNS
SNR
SNR Senior PLC
11:37
Market

Form 8.3

Open Terminal Source RNS
IRSH
IRSH IRSH
11:36
Market

Form 8.3 - Beazley plc

Open Terminal Source RNS
IRSH
IRSH IRSH
11:36
Market

Form 8.3 - Schroders plc

Open Terminal Source RNS
IRSH
IRSH IRSH
11:32
Market

Form 8.3 - JTC plc

Open Terminal Source RNS
IRSH
IRSH IRSH
11:31
Market

Form 8.3 - British Land Company plc

Open Terminal Source RNS
IMB
IMB Imperial Brands PLC
11:29
Market

Director Declaration

Open Terminal Source RNS
IRSH
IRSH IRSH
11:28
Market

Form 8.3 - Senior plc

Open Terminal Source RNS
IRSH
IRSH IRSH
11:20
Market

Form 8.3 - International Personal Finance plc

Open Terminal Source RNS
BLND
BLND British Land Company PLC
11:18
Market

Rule 2.9 Announcement

Open Terminal Source RNS
PPET
PPET Patria Private Equity Trust
11:16
Market

Quarterly Disclosure

Open Terminal Source RNS
71XK
71XK 71XK
11:16
Market

8-K 1Q2026 earnings release;2026 Proxy

Open Terminal Source RNS
CCH
CCH Coca Cola HBC AG
11:16
Market

Notice of Results

Open Terminal Source RNS
IPF
IPF International Personal Fina…
11:15
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
SNR
SNR Senior PLC
11:13
Market

Form 8.3

Open Terminal Source RNS
JTC
JTC JTC PLC
11:12
Market

Form 8.3

Open Terminal Source RNS
IPF
IPF International Personal Fina…
11:10
Market

Form 8.3

Open Terminal Source RNS
SPI
SPI Spire Healthcare Group Plc
11:07
Market

Dividend Declaration

Open Terminal Source RNS
BEZ
BEZ Beazley plc
11:07
Market

Form 8.3

Open Terminal Source RNS
0RUH
0RUH Aroundtown S.A.
11:05
Market

Aroundtown announces successful result of the voluntary Exchange Offer for GCP shares, increasing its holding in GCP to 81.5%

Open Terminal Source RNS
LST
LST Light Science Technologies …
11:05
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Dr Graham Cooley', '4.18', '8.71']
Open Terminal Source RNS
AGT
AGT AVI Global Trust PLC
11:04
Market

Monthly Factsheet

Open Terminal Source RNS
DVNO
DVNO Develop North PLC
11:03
Market

Change of Venue for Annual General Meeting

Open Terminal Source RNS
VID
VID Videndum Plc
11:01
Market

Annual Report and Accounts 2025 & 2026 AGM Notice

Open Terminal Source RNS
ENT
ENT Entain PLC
11:01
Market

BetMGM Q1 2026 Update

Open Terminal Source RNS
PAC
PAC Pacific Assets Trust plc
10:56
Market

Monthly Fact Sheet as at 31 March 2026

Open Terminal Source RNS
BEZ
BEZ Beazley plc
10:51
Market

8.3 FILED ON BEHALF OF ZEDRA TRUST CO (GRNSY) LTD

Open Terminal Source RNS
BEZ
BEZ Beazley plc
10:47
Market

8.3 FILED ON BEHALF OF ZEDRA TRUST CO (GRNSY) LTD

Open Terminal Source RNS
KEN
KEN Kendrick Resources PLC
10:41
Market

Namibia REE Project, Teufelskuppe Drilling Update

Open Terminal Source RNS
AA4
AA4 Amedeo Air Four Plus Limited
10:41
Market

Form 8.3

Open Terminal Source RNS
AVCT
AVCT Avacta Group PLC
10:38
Market

Christina Coughlin - In Vivo 2026 Rising Leader

Open Terminal Source RNS
IPF
IPF International Personal Fina…
10:38
Market

Form 8.3

Open Terminal Source RNS
SDR
SDR Schroders PLC
10:36
Market

Form 8.3 - British Land Company Plc

Open Terminal Source RNS
AUGM
AUGM Augmentum Fintech PLC
10:36
Market

Form 8.3

Open Terminal Source RNS
JAR
JAR Jardine Matheson Holdings L…
10:32
Market

Transaction in Own Shares

Open Terminal Source RNS
ITRK
ITRK Intertek Group PLC
10:30
Market

Appointment of new Chairman and directorate change

Open Terminal Source RNS
OCDO
OCDO Ocado Group PLC
10:26
Market

Admission to Trading

Open Terminal Source RNS
SMJ
SMJ J Smart Co Contractors PLC
10:21
Market

Half-year Financial Report

Open Terminal Source RNS
BRK
BRK Brooks Macdonald Group
10:20
Market

Form 8.3 - LondonMetric Property plc and Schroder

Open Terminal Source RNS
DFI
DFI Dairy Farm International Ho…
10:18
Market

Director/PDMR Shareholding

Open Terminal Source RNS
DLN
DLN Derwent London PLC
10:15
Market

Annual Financial Report

Open Terminal Source RNS
MIG5
MIG5 Maven Income And Growth Vct…
10:12
Market

Issue of Equity

Open Terminal Source RNS
MAV4
MAV4 Maven Income and Growth VCT…
10:10
Market

Issue of Equity

Open Terminal Source RNS
MIG3
MIG3 Maven Income And Growth Vct…
10:08
Market

Issue of Equity

Open Terminal Source RNS
OXIG
OXIG Oxford Instruments PLC
10:08
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
MIG1
MIG1 Maven Income And Growth Vct…
10:07
Market

Issue of Equity

Open Terminal Source RNS
GLV
GLV Glenveagh Properties PLC
10:04
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
AGT
AGT AVI Global Trust PLC
10:04
Market

Update research from QuotedData

Open Terminal Source RNS
IDOX
IDOX IDOX plc
10:02
Market

Form 8.3

Open Terminal Source RNS
CWR
CWR Ceres Power Holdings PLC
10:01
Market

Notice of AGM & Publication of Annual Report

Open Terminal Source RNS
FLTR
FLTR Flutter Entertainment PLC
10:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BLND
BLND British Land Company PLC
09:58
Market

Form 8.3

Open Terminal Source RNS
CURY
CURY Currys PLC
09:57
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['JPMorgan Asset Management Holdings Inc.', '4.999805', '5.007933']
Open Terminal Source RNS
RVRG
RVRG River Global Plc
09:56
Market

Result of Meeting

Open Terminal Source RNS
GJ03
GJ03 GJ03
09:55
Market

Form 8.5 (EPT/RI) - Schroders plc

Open Terminal Source RNS
DO72
DO72 DO72
09:52
Market

Form 8.5 (EPT/NON-RI) - Schroders plc

Open Terminal Source RNS
ATT
ATT Allianz Technology Trust PLC
09:49
Market

Total Voting Rights

Open Terminal Source RNS
BUT
BUT Brunner Investment Trust
09:48
Market

Total Voting Rights

Open Terminal Source RNS
CYN
CYN CQS Natural Resources Growt…
09:46
Market

Dividend Declaration

Open Terminal Source RNS
MTLN
MTLN Metlen Energy & Metals PLC
09:46
Market

PDMR transaction notification

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:44
Market

Form8.5EPT/NonRIACONSORTIUMCOMPRISINGLONDONMETRICP

Open Terminal Source RNS
BEZ
BEZ Beazley plc
09:44
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Societe Generale', '4.869911', '6.132547']
Open Terminal Source RNS
STEM
STEM SThree plc
09:36
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
BARC
BARC Barclays PLC
09:35
Market

Form 8.5 EPT/Non RI GAMMA COMMUNICATIONS PLC

Open Terminal Source RNS
PEBB
PEBB The Pebble Group PLC
09:31
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
HSBA
HSBA HSBC Holdings PLC
09:31
Market

Overseas Regulatory Announcement - Grant of Awards

Open Terminal Source RNS
DOM
DOM Domino’s Pizza Group PLC
09:31
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Bank of Montreal', '3.065110', '2.943641']
Open Terminal Source RNS
GJ03
GJ03 GJ03
09:30
Market

Form 8.5 (EPT/RI) - British Land Company plc, The

Open Terminal Source RNS
GJ03
GJ03 GJ03
09:30
Market

Form 8.5 (EPT/RI) - Life Science REIT plc

Open Terminal Source RNS
STEM
STEM SThree plc
09:30
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['FIL Limited', '9.978100', '10.007300']
Open Terminal Source RNS
DO72
DO72 DO72
09:25
Market

Form 8.5 (EPT/NON-RI) - British Land Company plc

Open Terminal Source RNS
0H7D
0H7D Deutsche Bank AG NA O.N.
09:18
Market

Form 8.5 (EPT/RI)-International Personal Fin plc

Open Terminal Source RNS
0H7D
0H7D Deutsche Bank AG NA O.N.
09:17
Market

Form 8.5 (EPT/RI) - Senior plc

Open Terminal Source RNS
0H7D
0H7D Deutsche Bank AG NA O.N.
09:16
Market

Form 8.5 (EPT/RI)-Bluefield Solar Income Fund Ltd

Open Terminal Source RNS
0H7D
0H7D Deutsche Bank AG NA O.N.
09:14
Market

Form 8.5 (EPT/RI) - IQE plc

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:14
Market

Form 8.5 EPT/Non RI SCHRODERS PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:14
Market

Form 8.5 EPT/Non RI BRCK GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:13
Market

Form 8.5 EPT/Non RI BEAZLEY PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:13
Market

Form 8.5 EPT/Non RI CAB PAYMENTS HOLDINGS PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:13
Market

Form 8.5 EPT/Non RI SENIOR PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:13
Market

Form 8.5 EPT/Non RI PICTON PROPERTY INCOME LIMITED

Open Terminal Source RNS
GEN
GEN Genuit Group plc
09:12
Market

Notice of AGM

Open Terminal Source RNS
PIN
PIN Pantheon International PLC
09:11
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
CPIC
CPIC China Pacific Insurance (Gr…
09:08
Market

PDMR Shareholding

Open Terminal Source RNS
CNE
CNE Capricorn Energy PLC
09:03
Market

Form 8.3 - Capricorn Energy PLC

Open Terminal Source RNS
FORT
FORT Forterra PLC
09:01
Market

Transaction in Own Shares

Open Terminal Source RNS
KGF
KGF Kingfisher PLC
09:01
Market

Notice of AGM

Open Terminal Source RNS
DGE
DGE Diageo PLC
08:53
Market

Director/PDMR Shareholding

1. <mark style="background-color:yellow">purchase</mark> of partnership shares using deductions from salary; and

1. <mark style="background-coloryellow">purchase</mark> of partnership shares using deductions from salary
and
Open Terminal Source RNS
INVP
INVP Investec PLC
08:46
Market

Form 8.5 (EPT/RI)- Gamma Communications Plc

Open Terminal Source RNS
CRH
CRH CRH PLC
08:46
Market

Transaction in Own Shares

Open Terminal Source RNS
CAPD
CAPD Capital Drilling Ltd
08:45
Market

Issue of Equity and Director / PDMR Shareholding

Open Terminal Source RNS
GFM
GFM Griffin Mining
08:44
Market

Standard form for notification of major holdings

TR1 Buy

TR1 Buy
Open Terminal Source RNS
ASL
ASL Aberforth Smaller Companies…
08:43
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Evelyn Partners Limited', '4.852125', '5.081000']
Open Terminal Source RNS
SEIT
SEIT Sdcl Energy Efficiency Inco…
08:41
Market

TR-1 Notification of Major Holdings

TR1 Buy

TR1 Buy
Open Terminal Source RNS
GLE
GLE MJ Gleeson plc
08:35
Market

Director/PDMR Shareholding

Open Terminal Source RNS
GLE
GLE MJ Gleeson plc
08:34
Market

Director/PDMR Shareholding

Open Terminal Source RNS
AMGO
AMGO Amigo Holdings PLC
08:31
Market

Director and PDMR dealing

Open Terminal Source RNS
BRSC
BRSC Blackrock Smaller Companies…
08:29
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Saba Capital Management, L.P.', '2.568941', '2.311881']
Open Terminal Source RNS
YNGA
YNGA Young & Co’S Brewery A
08:29
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['FitzWalter Capital Limited', '15.349468', '14.408009']
Open Terminal Source RNS
FOUR
FOUR 4Imprint Group Plc
08:28
Market

Annual Financial Report

Open Terminal Source RNS
IPO
IPO IP Group
08:26
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Saba Capital Management, L.P.', '0.149931', '0.064366']
Open Terminal Source RNS
JTC
JTC JTC PLC
08:18
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['JPMorgan Chase & Co.', '3.034819', '2.855338']
Open Terminal Source RNS
BARC
BARC Barclays PLC
08:09
Market

Form 8.3 SPIRE HEALTHCARE GROUP PLC Replacement

Open Terminal Source RNS
BARC
BARC Barclays PLC
08:08
Market

Form 8.5 EPT/Non RI SCHRODERS PLC Replacement

Open Terminal Source RNS
BARC
BARC Barclays PLC
08:08
Market

Form 8.3 NCC GROUP PLC Replacement

Open Terminal Source RNS
BARC
BARC Barclays PLC
08:07
Market

Form 8.3 JTC PLC Replacement

Open Terminal Source RNS
BARC
BARC Barclays PLC
08:07
Market

Form 8.3 BRITISH LAND COMPANY PLC, THE Replacement

Open Terminal Source RNS
BARC
BARC Barclays PLC
08:07
Market

Form 8.3 IQE PLC Replacement

Open Terminal Source RNS
BARC
BARC Barclays PLC
08:07
Market

Form8.3INTERNATIONALPERSONALFINANCEPLC Replacement

Open Terminal Source RNS
RG62
RG62 RG62
08:03
Market

Compre announces FY 2025 results

Open Terminal Source RNS
APTD
APTD Aptitude Software Group PLC
08:03
Market

Form 8.3

Open Terminal Source RNS
TGA
TGA Thungela Resources Limited
08:01
Market

Dealings in Securities

Open Terminal Source RNS
AMGO
AMGO Amigo Holdings PLC
08:01
Market

Admission of shares

Open Terminal Source RNS
NFM
NFM NFM
07:58
Market

Proposed issue of Securities

Open Terminal Source RNS
AFL
AFL Artemis UK Future Leaders p…
07:58
Market

Transaction in Own Shares

Open Terminal Source RNS
ORR
ORR Oriole Resources PLC
07:48
Market

Greenwood Research Report

Open Terminal Source RNS
FARN
FARN Faron Pharmaceuticals Oy
07:46
Market

Faron Pharmaceuticals Ltd: Registration of New Shares

Open Terminal Source RNS
MFAI
MFAI Mindflair Plc
07:45
Market

New investment in Agentic payments company

Open Terminal Source RNS
PZC
PZC PZ Cussons PLC
07:44
Market

Director/PDMR Shareholding

Dividend reinvestment and <mark style="background-color:yellow">purchase</mark> of Ordinary shares of 1p each in PZ Cussons plc

Dividend reinvestment and <mark style="background-color:yellow">purchase</mark> of Ordinary shares of 1p each in PZ Cussons plc
Open Terminal Source RNS
BARC
BARC Barclays PLC
07:42
Market

Form 8.5 EPT/Non RI SENIOR PLC Replacement

Open Terminal Source RNS
BARC
BARC Barclays PLC
07:42
Market

Form8.5EPT/NonRIPICTONPROPERTYINCOMELI Replacement

Open Terminal Source RNS
BARC
BARC Barclays PLC
07:42
Market

Form8.5EPT/NonRICABPAYMENTSHOLDINGSPLC Replacement

Open Terminal Source RNS
BARC
BARC Barclays PLC
07:42
Market

Form 8.5 EPT/Non RI SCHRODERS PLC Replacement

Open Terminal Source RNS
BARC
BARC Barclays PLC
07:42
Market

Form 8.5 EPT/Non RI BEAZLEY PLC Replacement

Open Terminal Source RNS
BARC
BARC Barclays PLC
07:42
Market

Form8.5EPT/NonRIACONSORTIUMCOMPRISINGL Replacement

Open Terminal Source RNS
EOT
EOT European Opportunities Trus…
07:41
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['1607 Capital Partners, LLC', '10.641627', '11.875311']
Open Terminal Source RNS
SDR
SDR Schroders PLC
07:35
Market

Form 8.3

Open Terminal Source RNS
50AS
50AS 50AS
07:17
Market

ITEMS IMPACTING HALF YEAR 2026 RESULTS

Open Terminal Source RNS
BYG
BYG Big Yellow Group PLC
07:01
Market

Notification of Full Year Results

Open Terminal Source RNS
GSC
GSC GS Chain PLC
07:01
Market

Allotment and Admission of New Shares

Open Terminal Source RNS
GRI
GRI Grainger PLC
06:52
Market

Non-Executive Board Director Appointment

Open Terminal Source RNS
FCH
FCH Funding Circle Holdings PLC
06:42
Market

Funding Circle renews funding agreement

Open Terminal Source RNS
KEFI
KEFI KEFI Gold and Copper Plc
06:32
Market

Results of General Meeting

Open Terminal Source RNS
UFO
UFO Alien Metals Ltd
06:31
Market

Diamond Drilling Below the Elizabeth Hill Mine

Open Terminal Source RNS
AMOI
AMOI Anemoi International Ltd
06:30
Market

Anemoi enters into amended and updated binding Sale and Purchase Agreement to acquire Trasna, Share Consolidation and Warrantholder Surrender and Subscription Offer

Anemoi International Ltd has entered into an amended and updated binding Sale and Purchase Agreement to acquire Trasna Solutions FZ LLC via a reverse takeover (RTO), valuing Trasna at $150 million. The transaction includes a share consolid…

Anemoi International Ltd has entered into an amended and updated binding Sale and Purchase Agreement to acquire Trasna Solutions FZ LLC via a reverse takeover (RTO), valuing Trasna at $150 million. The transaction includes a share consolidation (1 for 100 reverse stock split), a voluntary warrant surrender and subscription offer for existing warrantholders at £0.02 per share, and a proposed name change to Trasna Ltd upon completion. The deal is subject to conditions, including due diligence and a fundraise, with readmission to the London Stock Exchanges Main Market planned post-RTO. Shareholders are cautioned that the transaction may not proceed or terms may change.
Offers
Open Terminal Source RNS
FUTR
FUTR Future PLC
06:22
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['FIL Limited', '9.652700', '9.728200']
Open Terminal Source RNS
KOD
KOD Kodal Minerals PLC
06:14
Market

Bougouni Lithium Project Quarterly Update

Open Terminal Source RNS
0A3F
0A3F 0A3F
06:11
Market

Net Asset Value(s)

Open Terminal Source RNS
0A3G
0A3G 0A3G
06:11
Market

Net Asset Value(s)

Open Terminal Source RNS
0A3D
0A3D iShares VII Public Limited …
06:11
Market

Net Asset Value(s)

Open Terminal Source RNS
0A3E
0A3E 0A3E
06:11
Market

Net Asset Value(s)

Open Terminal Source RNS
CMB1
CMB1 iShares FTSE MIB UCITS
06:11
Market

Net Asset Value(s)

Open Terminal Source RNS
PAT
PAT Panthera Resources PLC
06:10
Market

Conversion of Options

Open Terminal Source RNS
FIN
FIN Finseta Plc
06:06
Market

Launch of Retail Offer

Finseta PLC, a foreign exchange and payments solutions company, announced a retail offer to raise up to £0.1 million by issuing new ordinary shares at 8.5 pence each. The offer is open to existing UK-based shareholders, with a minimum subs…

Finseta PLC, a foreign exchange and payments solutions company, announced a retail offer to raise up to £0.1 million by issuing new ordinary shares at 8.5 pence each. The offer is open to existing UK-based shareholders, with a minimum subscription of £100. The proceeds will be used alongside funds from a placing and subscription to support the companys operations. The retail offer is conditional on the completion of the placing and subscription, with shares expected to be admitted to trading on AIM around 20 April 2026.
Launch
Open Terminal Source RNS
BEZ
BEZ Beazley plc
06:06
Market

Directorate Update

Open Terminal Source RNS
FIN
FIN Finseta Plc
06:03
Market

Director and PDMR Subscriptions

Open Terminal Source RNS
ITRK
ITRK Intertek Group PLC
06:02
Market

Strategic Review Initiation & Trading Statement

Intertek Group PLC initiates a strategic review to evaluate the potential separation of Intertek Energy & Infrastructure from Intertek Testing & Assurance, aiming to accelerate growth and create two specialist, global ATIC businesses. The …

Intertek Group PLC initiates a strategic review to evaluate the potential separation of Intertek Energy & Infrastructure from Intertek Testing & Assurance, aiming to accelerate growth and create two specialist, global ATIC businesses. The review, concluding by mid-2027, assesses whether a sale or demerger would unlock full potential, enhance focus, and improve capital allocation. Intertek reports strong Q1 2026 performance with 5.4% LFL revenue growth, reiterates full-year guidance, and highlights robust demand across divisions, except for stable performance in World of Energy. The company emphasizes its AAA strategy, strong cash flow, and commitment to delivering value for shareholders through disciplined execution and strategic focus.
Metric2026 (Q1)2025 (FY)2024 (FY)Year-on-Year Change (2026 vs 2025)Year-on-Year Change (2025 vs 2024)
Group Revenue£838.5m£3,431.6m£3,393.2m3.7% (actual), 6.7% (constant currency)1.1% (actual), 4.3% (constant currency)
LFL Revenue£828.3m£3,416.3m£3,391.8m2.4% (actual), 5.4% (constant currency)0.7% (actual), 3.9% (constant currency)
Consumer Products Revenue£232.6m£902.5m (2025)£884.3m (2024)2.5% (actual), 6.5% (constant currency)2.1% (actual), 5.8% (constant currency)
Corporate Assurance Revenue£126.5m£485.6m (2025)£468.9m (2024)8.2% (actual), 10.8% (constant currency)3.6% (actual), 7.2% (constant currency)
Health and Safety Revenue£92.2m£350.9m (2025)£337.2m (2024)16.3% (actual), 15.8% (constant currency)4.1% (actual), 6.8% (constant currency)
Industry and Infrastructure Revenue£209.9m£788.0m (2025)£786.3m (2024)2.8% (actual), 6.7% (constant currency)0.2% (actual), 3.5% (constant currency)
World of Energy Revenue£177.3m£904.6m (2025)£916.5m (2024)(2.4%) (actual), 0.2% (constant currency)(1.3%) (actual), 1.8% (constant currency)
Net Financial Debt (FY)N/A£930-980m (FY26 Guidance)£880m (2025)~5.7% - 11.4% increase (estimated)N/A
Open Terminal Source RNS
HVO
HVO hVIVO plc
06:02
Market

hVIVO launches unified brand identity

hVIVO plc announces a unified brand identity, marking its strategic transformation into a fully integrated clinical development partner. The rebrand follows the successful integration of Venn Life Sciences, CRS, and Cryostore, simplifying …

hVIVO plc announces a unified brand identity, marking its strategic transformation into a fully integrated clinical development partner. The rebrand follows the successful integration of Venn Life Sciences, CRS, and Cryostore, simplifying the groups structure under the hVIVO brand. The company now operates through four integrated service lines: Consulting, Clinical Trials, Human Challenge Trials, and Laboratories, offering a seamless pathway from pre-clinical strategy to clinical proof-of-concept. This transformation aims to accelerate drug development, reduce complexity, and provide high-quality human data for clients. CEO Yamin Mo Khan emphasizes the unified brands ability to help pharmaceutical and biotech companies bring medicines to patients faster.
Launch
Open Terminal Source RNS
HVPE
HVPE HarbourVest Global Private …
06:02
Market

Transaction in Own Shares

Open Terminal Source RNS
FSTA
FSTA Fuller Smith & Turner
06:01
Market

Fuller, Smith & Turner PLC: Appointment of Joint Corporate Broker

Open Terminal Source RNS
WCAT
WCAT Wildcat Petroleum Plc
06:01
Market

Change of Name

Open Terminal Source RNS
ITH
ITH Ithaca Energy PLC
06:01
Market

2025 Annual Report Publication & 2026 AGM Notice

Open Terminal Source RNS
ZIN
ZIN Zinc Media Group
06:01
Market

Appointment of Chief Content Officer

Open Terminal Source RNS
PEY
PEY Princess Private Equity Hol…
06:01
Market

PGPE Ltd publishes February NAV

Open Terminal Source RNS
ANIC
ANIC Agronomics Ltd
06:01
Market

Tropic’s product receives regulatory approval

Tropic Biosciences, a portfolio company of Agronomics Limited, has received regulatory approval in Japan and Brazil for its non-browning banana variety. This approval allows the banana to be imported, sold, and consumed in both countries, …

Tropic Biosciences, a portfolio company of Agronomics Limited, has received regulatory approval in Japan and Brazil for its non-browning banana variety. This approval allows the banana to be imported, sold, and consumed in both countries, with Brazil also permitting its cultivation. The development supports sustainability, reduces food waste, and expands market opportunities. Tropics innovation, launched in 2025, marks the first new commercial banana variety in over 75 years and was named one of TIME Magazines Best Inventions of 2025. The approvals in Japan and Brazil, two critical markets, enhance Tropics global regulatory footprint, reinforcing its leadership in agricultural biotechnology. Agronomics, with a 1.6% stake in Tropic, highlights the significance of these approvals in validating Tropics platform and unlocking commercial potential.
Approvals
Open Terminal Source RNS
PCIP
PCIP PCI-PAL PLC
06:01
Market

HIPAA, HITRUST & SOC 2 Type II certification

Open Terminal Source RNS
ZEN
ZEN Zenith Energy Ltd
06:01
Market

Tunisia recognises ownership of crude oil

Open Terminal Source RNS
HEMO
HEMO Hemogenyx Pharmaceuticals P…
06:01
Market

Annual IND Report with FDA

Open Terminal Source RNS
RICA
RICA Ruffer Investment Company L…
06:01
Market

Monthly Investment Report - March 2026

Open Terminal Source RNS
OBI
OBI Ondine Biomedical Inc
06:01
Market

Steriwave ICU Study Shows 39.5% Pneumonia Drop

Open Terminal Source RNS
IHC
IHC Inspiration Healthcare Grou…
06:01
Market

Change of Adviser

Open Terminal Source RNS
MKA
MKA Mkango Resources Ltd
06:01
Market

HYPROMAG AND MKANGO RARE EARTHS UK TO COLLABORATE

HyProMag and Mkango Rare Earths UK have been awarded a £6.5 million grant under the UKs DRIVE35 R&D competition to develop recycled neodymium-iron-boron (NdFeB) magnets for high-grade automotive applications. The project, named REACT UK, a…

HyProMag and Mkango Rare Earths UK have been awarded a £6.5 million grant under the UKs DRIVE35 R&D competition to develop recycled neodymium-iron-boron (NdFeB) magnets for high-grade automotive applications. The project, named REACT UK, aims to establish a full circular supply chain for these magnets in the UK, combining advanced recycling methods and hydrogen-based processing to enhance sustainability and supply security. Led by HyProMag, the consortium includes Mkango UK, EMR Group, Jaguar Land Rover, Less Common Metals, and the University of Birmingham. The project will run for three years, with £3.2 million (49%) funded by the UK government. This initiative supports the UKs transition to zero-emission mobility and strengthens domestic manufacturing capabilities.
Collaborate
Open Terminal Source RNS
SWC
SWC Summerway Capital Plc
06:01
Market

Bitcoin Purchase

Open Terminal Source RNS
STAF
STAF Staffline Group Plc
06:01
Market

Posting of Annual Report & Notice of AGM

Open Terminal Source RNS
HVPE
HVPE HarbourVest Global Private …
06:01
Market

Further initiatives to enhance shareholder value

Open Terminal Source RNS
TM1
TM1 Technology Minerals PLC
06:01
Market

Recyclus awarded TFS licence and ISO Accreditation

Open Terminal Source RNS
SNDA
SNDA Sunda Energy Plc
06:01
Market

Acquisition Deposit and Change of Control

Open Terminal Source RNS
EVOK
EVOK EVOKE PLC
06:01
Market

Block Listing Six Monthly Return

Open Terminal Source RNS
HWG
HWG Harworth Group PLC
06:01
Market

Publication of ARA, Notice of AGM and NZC Report

Open Terminal Source RNS
CARD
CARD Card Factory PLC
06:01
Market

Notice of Results

Open Terminal Source RNS
ELCO
ELCO Eleco PLC
06:01
Market

Notice of Results and Company Presentations

Open Terminal Source RNS
AUTO
AUTO Auto Trader Group plc
06:01
Market

Notice of Full Year Results

Open Terminal Source RNS
SEED
SEED Seed Innovations Ltd
06:01
Market

Investment in Clean Food Group Funding Round

Seed Innovations Ltd (AIM: SEED) has invested £260,000 in a £4.5 million funding round for its portfolio company, Clean Food Group (CFG), a UK biotech manufacturer of sustainable oils and fats. The funding, led by Clean Growth Fund and New…

Seed Innovations Ltd (AIMSEED) has invested £260,000 in a £4.5 million funding round for its portfolio company, Clean Food Group (CFG), a UK biotech manufacturer of sustainable oils and fats. The funding, led by Clean Growth Fund and New Agrarian Company Limited, is structured as a convertible loan note (CLN) with a 12% annual coupon, maturing in August 2027. This investment supports CFGs scale-up of its Knowsley fermentation facility, positioning it as the worlds largest manufacturer of yeast-derived oils and fats. SEEDs total exposure to CFG, including equity and CLN, reaches £1.98 million, with CFG valued at £1.7 million in SEEDs 2025 Interim Report. CFG, pre-revenue with £13 million raised to date, aims to address supply chain fragility and sustainability in the global food system, targeting a sustainable food market projected to reach US$524 billion by 2032.
Premium Placing
Open Terminal Source RNS
SERE
SERE Schroder European Reit Plc
06:01
Market

Property Portfolio Valuation

Open Terminal Source RNS
ABDX
ABDX Abingdon Health Plc
06:01
Market

Trading to commence on the OTCQB in the US

Open Terminal Source RNS
AVON
AVON Avon Protection PLC
06:01
Market

Notice of Results and Investor Presentation

Open Terminal Source RNS
GEMD
GEMD Gem Diamonds Ltd
06:01
Market

Block listing application

Open Terminal Source RNS
VTU
VTU Vertu Motors Plc
06:01
Market

EBT Share Purchase

Open Terminal Source RNS
HEAD
HEAD Headlam Group
06:01
Market

Appointment of two Non-Executive Directors

Open Terminal Source RNS
CER
CER Cerillion PLC
06:01
Market

CFO Joining Date and Date of Trading Update

Open Terminal Source RNS
PRU
PRU Prudential plc
06:01
Market

Director/PDMR Shareholding

Acquisition of shares through the Prudential All Employee Share <mark style="background-color:yellow">Purchase</mark> Plan

Acquisition of shares through the Prudential All Employee Share <mark style="background-color:yellow">Purchase</mark> Plan
Open Terminal Source RNS
FLTR
FLTR Flutter Entertainment PLC
06:01
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Bank of America Corporation', '2.873447', '0.309604']
Open Terminal Source RNS
BAG
BAG A.G.Barr PLC
06:01
Market

Director/PDMR Shareholding

Open Terminal Source RNS
FDEV
FDEV Frontier Developments Plc
06:01
Market

Director/PDMR Shareholding

Open Terminal Source RNS
HAS
HAS Hays plc
06:01
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of shares at a price of 27p per share under the Hays plc US Employee Stock Purchase Plan on 13 April 2026. In accordance with the Plan rules, the shares will be held in a Holding Perio…

<mark style="background-coloryellow">Purchase</mark> of shares at a price of 27p per share under the Hays plc US Employee Stock Purchase Plan on 13 April 2026. In accordance with the Plan rules, the shares will be held in a Holding Period of one year.
Open Terminal Source RNS
JPEL
JPEL JPEL Private Equity Ltd
06:01
Market

Appointment of Directors

Open Terminal Source RNS
ESO
ESO EPE Special Opportunities L…
06:01
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of ordinary shares

<mark style="background-coloryellow">Purchase</mark> of ordinary shares
Open Terminal Source RNS
AAU
AAU Ariana Resources plc
06:01
Market

Appointment of New Non-Executive Chairman

Open Terminal Source RNS
GMS
GMS Gulf Marine Services PLC
06:01
Market

2025 Financial Results

**Summary:** Gulf Marine Services PLC (GMS) reported its 2025 financial results, highlighting a 12% increase in revenue to US$188.1 million and adjusted EBITDA to US$112.9 million, driven by an additional leased vessel and higher day rate…

**Summary**
Gulf Marine Services PLC (GMS) reported its 2025 financial results, highlighting a 12% increase in revenue to US$188.1 million and adjusted EBITDA to US$112.9 million, driven by an additional leased vessel and higher day rates. Adjusted net profit rose 30% to US$41.8 million, while net profit decreased 49% to US$19.5 million due to impairment charges and tax expenses. Fleet utilization dropped to 87% due to maintenance and geopolitical disruptions. Net leverage improved to 1.39x, and net bank debt reduced to US$156.6 million. The company secured new contracts totaling 15.4 years, increasing its backlog to US$606 million. Despite geopolitical challenges, GMS maintained operational reliability and safety standards, achieving zero Lost Time Injury Rate (LTIR) and Total Recordable Injury Rate (TRIR). The company acquired a new mid-class vessel and aims to double its 2024 adjusted EBITDA by 2030. However, the ongoing geopolitical situation in the Gulf region poses risks, leading to a cautious outlook for 2026 and the suspension of dividend declarations. Management is closely monitoring the impact on operations and financial performance.
Financial Metric2023 (US$m)2024 (US$m)2025 (US$m)2025 vs 2024 Change
Revenue151.6167.5188.1+12%
Adjusted EBITDA87.5100.4112.9+12%
Adjusted Net Profit9.832.241.8+30%
Net Profit42.138.319.5-49%
Net Bank Debt267.3201.2156.6-22%
Open Terminal Source RNS
FORT
FORT Forterra PLC
06:01
Market

Appointment of new Independent NED

Open Terminal Source RNS
EAH
EAH Eco Animal Health Group Plc
06:01
Market

Appointment of Head of Business Development

Open Terminal Source RNS
MAB1
MAB1 Mortgage Advice
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
ACG
ACG ACG Acquisition Co. Ltd.
06:01
Market

Full Year 2025 Results

Open Terminal Source RNS
DCTA
DCTA Directa Plus PLC
06:01
Market

Update on Funding

Open Terminal Source RNS
STAN
STAN Standard Chartered PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
FPO
FPO First Property Group plc
06:01
Market

Trading Update

Open Terminal Source RNS
FIN
FIN Finseta Plc
06:01
Market

Placing, Subscription and Proposed Retail Offer

Open Terminal Source RNS
BLOE
BLOE Block Energy PLC
06:01
Market

Binding Framework Agreement - Project III Farm Out

Block Energy plc has signed a binding Framework Agreement with Zhijiang Sanning Energy Co. Ltd for the farm-out of Project III in Georgia. Sanning will acquire 51% of Project III, carrying up to USD 75 million in costs for appraisal drilli…

Block Energy plc has signed a binding Framework Agreement with Zhijiang Sanning Energy Co. Ltd for the farm-out of Project III in Georgia. Sanning will acquire 51% of Project III, carrying up to USD 75 million in costs for appraisal drilling and early facilities construction. Block retains 49% and operatorship, while keeping 100% ownership of other projects and existing production. The deal focuses on appraising the Patardzueli-Samgori field, with potential expansion to Rustavi and Teleti fields, targeting 2.77 TCF 2C Contingent Resources and a gross success case NPV10 of USD 2.2 billion. Final agreements are expected in H2 2026, with operations starting in 1H 2027, pending approvals. The partnership leverages Blocks upstream expertise and Sannings downstream capabilities, enhancing Georgias energy security and investment appeal.
Agreement
Open Terminal Source RNS
BCE
BCE Beacon Energy PLC
06:01
Market

Update regarding LNEnergy

Open Terminal Source RNS
PRV
PRV Porvair plc
06:01
Market

AGM Trading Update

Porvair plcs AGM trading update highlights that the groups performance in the first four months of 2026 is in line with expectations, with 5% constant currency revenue growth. Key points include: - Strong aerospace order books, continued …

Porvair plcs AGM trading update highlights that the groups performance in the first four months of 2026 is in line with expectations, with 5% constant currency revenue growth. Key points include
Strong aerospace order bookscontinued robust nuclear demandand subdued petrochemical sales.
Steady life sciences consumables orders and stable environmental instrument demand in the Laboratory division.
Firm aluminium and superalloys demand in Metal Melt Quality, with progress on the new US manufacturing line and successful Drache acquisition integration.
Unchanged full-year performance expectations, supported by a diversified portfolio, recurring revenue, and disciplined management.
Increased focus on M&A opportunities, with no change to long-term strategic outlook.
Upcoming Capital Markets Event in October 2026 and interim results announcement in June 2026.
Since the provided text does not contain specific financial or debt figures for comparison, I cannot generate an HTML table with year-on-year comparisons. However, I can provide a generic HTML table structure that you can use to input the relevant data if it becomes available:
Metric20252026Change
Revenue Growth5%
Debt
If you provide the actual financial and debt figures, I can populate this table accordingly.
Open Terminal Source RNS
AV.
AV. AV.
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
SRT
SRT SRT Marine Systems plc
06:01
Market

Result of Oversubscribed Placing

Open Terminal Source RNS
AMCO
AMCO Amcomri Group plc
06:01
Market

Final Results, Analyst Briefing & Investor Pres

Amcomri Group PLC reported strong financial results for the year ending December 31, 2025, with a 22% increase in revenue to £70.9 million, a 19.3% rise in adjusted EBITDA to £9.2 million, and a 145% surge in profit before tax to £4.1 mill…

Amcomri Group PLC reported strong financial results for the year ending December 31, 2025, with a 22% increase in revenue to £70.9 million, a 19.3% rise in adjusted EBITDA to £9.2 million, and a 145% surge in profit before tax to £4.1 million. The companys Buy, Improve, Build strategy drove organic and acquisitive growth, with acquisitions like EMC Elite Engineering and Radnor Technologies expanding its service offerings. Operational highlights included growth across both divisions, improved gross margins, and a strengthened team. Post-year-end, Amcomri acquired the National Compliance and Testing division of Enerveo Limited, further enhancing its market position. The company remains well-positioned for future growth with a strong acquisition pipeline and positive trading conditions in key markets.
Financial Metric2024 (£'000)2025 (£'000)Change (£'000)Change (%)
Revenue58,06670,93812,87222%
Adjusted EBITDA7,7009,2001,50019.3%
Profit Before Tax1,6754,1062,431145%
Net Debt6,10011,2005,10083.6%
Cash Balances12,1008,600(3,500)(28.9%)
### Explanation: 1. **Revenue**: Increased by £12,872,000 (22%) from £58,066,000 in 2024 to £70,938,000 in 2025. 2. **Adjusted EBITDA**: Increased by £1,500,000 (19.3%) from £7,700,000 in 2024 to £9,200,000 in 2025. 3. **Profit Before Tax**: Increased by £2,431,000 (145%) from £1,675,000 in 2024 to £4,106,000 in 2025. 4. **Net Debt**: Increased by £5,100,000 (83.6%) from £6,100,000 in 2024 to £11,200,000 in 2025. 5. **Cash Balances**: Decreased by £3,500,000 (28.9%) from £12,100,000 in 2024 to £8,600,000 in 2025.
Open Terminal Source RNS
ESYS
ESYS Essensys PLC
06:01
Market

Day 35 acceptance level update

Open Terminal Source RNS
FORG
FORG Forgent plc
06:01
Market

Proposed Peak Hills Acquisition & £1.3m Placing

Open Terminal Source RNS
PALM
PALM Panther Metals PLC
06:01
Market

Winston Tailings Project: Batch 3 Assay Results

Open Terminal Source RNS
HVO
HVO hVIVO plc
06:01
Market

Influenza HCT contract signed with Traws Pharma

hVIVO plc, a leading clinical development partner, has signed a contract with Traws Pharma to conduct a Phase 2a human challenge trial for their influenza antiviral candidate, tivoxavir marboxil (TXM). The trial, utilizing hVIVOs Influenza…

hVIVO plc, a leading clinical development partner, has signed a contract with Traws Pharma to conduct a Phase 2a human challenge trial for their influenza antiviral candidate, tivoxavir marboxil (TXM). The trial, utilizing hVIVOs Influenza Human Challenge Study Model, will assess TXMs safety, tolerability, and efficacy in reducing influenza-induced illness in 150 healthy participants. The study, expected to commence in H1 2026, highlights hVIVOs integrated clinical development services and Traws Pharmas strategy to accelerate TXMs development.
NewContract
Open Terminal Source RNS
PEBB
PEBB The Pebble Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
REE
REE Altona Rare Earths PLC
06:01
Market

Heavy Rare Earths Identified at Monte Muambe

Open Terminal Source RNS
BMV
BMV Bluebird Merchant Ventures …
06:01
Market

Business Update

Open Terminal Source RNS
PTAL
PTAL Petrotal Corp
06:01
Market

Q1 2026 Operations and Financial Updates

Open Terminal Source RNS
ATYM
ATYM Atalaya Mining Ltd
06:01
Market

Q1 2026 Operations Update

Open Terminal Source RNS
JET2
JET2 Jet2 PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
MAB1
MAB1 Mortgage Advice
06:01
Market

Acquisition of HomeOwners Alliance Ltd

Open Terminal Source RNS
IMB
IMB Imperial Brands PLC
06:01
Market

Trading Update

Imperial Brands PLCs trading update for 14 April 2026 highlights a positive start to its 2030 transformation strategy, with the company reiterating its full-year guidance. Key points include: 1. **Revenue Growth**: Low-single-digit percen…

Imperial Brands PLCs trading update for 14 April 2026 highlights a positive start to its 2030 transformation strategy, with the company reiterating its full-year guidance. Key points include
1. **Revenue Growth**Low-single-digit percent growth expected in tobacco & NGP (Next Generation Products) net revenue for H1 2026, driven by robust tobacco pricing and NGP innovation.
2. **Profitability**Group adjusted operating profit slightly higher in H1 compared to 2025, with growth accelerating in H2, in line with previous guidance.
3. **Earnings and Cash Flow**On track for at least high-single-digit earnings per share growth and at least £2.2 billion in free cash flow for the full year.
4. **Share Repurchase**Completed £0.7 billion of the £1.45 billion FY26 share buyback as part of an "evergreen" program.
5. **Strategic Initiatives**Progress in becoming more consumer-centric, data-led, and efficient through partnerships (e.g., Capgemini), supply chain optimization, and IT application rollouts.
6. **Geopolitical Risks**Monitoring potential impacts from the Middle East conflict, though no material business impact to date.
7. **Regional Performance**Strong NGP growth in Europe and AAACE regions, offset by challenges in the US, Australia, and Logista.
8. **Forex Impact**Translation foreign exchange expected to be a 2.0-2.5% headwind on H1 earnings per share and 0-1% on full-year earnings.
Interim results for H1 FY26 will be announced on 12 May 2026.
Financial MetricFY2025FY2026 (Expected)Change
Tobacco & NGP Net Revenue GrowthN/ALow-single-digit%N/A
Group Adjusted Operating Profit GrowthN/ASlightly higher than H1 2025N/A
Earnings Per Share GrowthN/AHigh-single-digit%N/A
Free Cash FlowN/A£2.2 billionN/A
Share Repurchase (Completed)£0.1 billion (Oct 2024)£0.7 billion (of £1.45 billion)+£0.6 billion
Net Debt to EBITDA LeverageN/A2.0-2.5 range (lower end)N/A
NGP Adjusted Operating LossesN/AModerately higherN/A
**Notes:** * The table compares expected financials for FY2026 with available data from FY2025. Since specific FY2025 figures are not provided in the text, the "FY2025" column mostly contains "N/A". * "Change" column indicates the difference between FY2026 and FY2025 where applicable. * This table focuses on key financial metrics mentioned in the text, including revenue growth, profit growth, cash flow, share repurchases, leverage, and operating losses.
Open Terminal Source RNS
CRTA
CRTA Cirata plc
06:01
Market

Trading Statement

Cirata PLC reports a strong Q1 FY26 with its first-ever positive cash flow quarter, a 40% pipeline growth, and improved visibility through new KPIs (ACV, Billings, RCB). The company reaffirms its FY26 cash flow break-even target, highlight…

Cirata PLC reports a strong Q1 FY26 with its first-ever positive cash flow quarter, a 40% pipeline growth, and improved visibility through new KPIs (ACV, Billings, RCB). The company reaffirms its FY26 cash flow break-even target, highlighting momentum in enterprise sales, particularly with Cirata Symphony, and continued focus on new logo acquisition and existing customer expansion.
MetricQ1 FY26Q4 FY25 (31 Dec 2025)Year-on-Year Change
Cash Flow$0.7m (Positive)Not specified (Negative)First positive cash flow quarter in history
Closing ACV$4.9m$4.8m+2.08%
Billings$2.3mNot specifiedN/A
RCB$5.8mNot specifiedN/A
Cash Balance$4.7mNot specifiedN/A
Trade Receivables$0.7mNot specifiedN/A
Cash Overheads$3.1mNot specifiedN/A
Pipeline Growth+40% (since Jan 2026)Not specifiedN/A
Open Terminal Source RNS
BP.
BP. BP.
06:01
Market

1Q26 BP plc Trading Statement Part 1 of 1

Open Terminal Source RNS
CRPR
CRPR James Cropper PLC
06:01
Market

Full Year Trading Update

James Cropper plc announces a strong FY26 performance, with adjusted EBITDA of £8.8m (up 30% YoY) and revenue of £103m (up 4% YoY). Advanced Materials saw high single-digit EBITDA growth, while Paper & Packaging significantly reduced losse…

James Cropper plc announces a strong FY26 performance, with adjusted EBITDA of £8.8m (up 30% YoY) and revenue of £103m (up 4% YoY). Advanced Materials saw high single-digit EBITDA growth, while Paper & Packaging significantly reduced losses. Net debt decreased to £8.3m, with a net debt/EBITDA ratio below 1x. Positive trading momentum continues into FY27, with confidence in medium-term growth for both divisions. The company expects to announce audited FY26 results in July 2026.
MetricFY25FY26Change
Adjusted EBITDA (£m)6.678.8+31.9%
Group Revenue (£m)99.0103.0+4.0%
Net Debt (£m)12.98.3-35.7%
Net Debt to EBITDA Ratio1.9x<1.0xImproved
Open Terminal Source RNS
GLB
GLB Glanbia plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
DPP
DPP DP Poland Plc
06:01
Market

Q1 2026 Trading Update

DP Poland PLC reports strong Q1 2026 performance with 18.9% system sales growth and 13.7% order increase, driven by operational efficiency, promotions, and timely deliveries. Franchise ownership rose to 35%, with four more Pizzeria 105 sto…

DP Poland PLC reports strong Q1 2026 performance with 18.9% system sales growth and 13.7% order increase, driven by operational efficiency, promotions, and timely deliveries. Franchise ownership rose to 35%, with four more Pizzeria 105 stores converted. Supply chain optimization and network expansion (141 Dominos stores, 71 Pizzeria 105) supported growth. Poland and Croatia saw robust sales and order increases. The company targets 50% franchise ownership by 2027, 200+ stores, and margin improvement through disposals, automation, and scaling. Outlook remains positive with double-digit growth expected in 2026.
DP Poland PLC - Financials and Debt Comparison (Q1 2026 vs Q1 2025)
MetricQ1 2026Q1 2025YoY Change
Group System Sales (£m)17.214.518.9%
Group System Orders (m)1.31.113.7%
Poland
Total System Sales (PLNm)78.466.318.2%
LFL System Sales (PLNm)67.962.48.9%
Total System Orders (m)1.31.113.3%
LFL System Orders (m)1.11.13.9%
Croatia
Total System Sales (EURm)1.20.928.8%
LFL System Sales (EURm)1.11.09.5%
Total System Orders (m)0.10.120.0%
LFL System Orders (m)0.10.12.0%
Network Expansion
Domino's Stores (YoY Change)141 (+17%)120—
Franchise-Owned Stores (% of Estate)35%12%—
Pizzeria 105 Stores Converted (Cumulative)1713—
Open Terminal Source RNS
CTL
CTL CleanTech Lithium plc
06:01
Market

Replacement: Positive PFS Results RNS

Open Terminal Source RNS
LSL
LSL LSL Property Services Plc
06:01
Market

Transaction in own Shares and Total Voting Rights

Open Terminal Source RNS
GLV
GLV Glenveagh Properties PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
VOD
VOD Vodafone Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PLUS
PLUS Plus500 Ltd
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
IHG
IHG InterContinental Hotels Gro…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
ABDP
ABDP Ab Dynamics
06:01
Market

Half-year Report

**Summary:** AB Dynamics PLC, a designer and manufacturer of advanced testing and simulation products for the global transport market, reported its unaudited interim results for the six months ended 28 February 2026. Key highlights includ…

**Summary**
AB Dynamics PLC, a designer and manufacturer of advanced testing and simulation products for the global transport market, reported its unaudited interim results for the six months ended 28 February 2026. Key highlights include
**Financial Performance** Revenue decreased by 16% to £48.8 million due to delays in order intake and customer delivery requirements, as well as weaker volumes in the VadoTech Testing Services business in China. Adjusted EBITDA and operating profit also declined, but the operating margin was maintained at 18.6%. Net cash increased to £39.3 million.
**Strategic Review of VadoTech** Due to lower-than-anticipated customer activity in the VadoTech Testing Services business, the Group will undertake a strategic review of this business in the second half of the year. Exceptional items totaling £16.8 million, primarily a non-cash impairment charge, were recorded in relation to VadoTech.
**Innovation and Product Development** The Group continues to focus on innovation, with a technology roadmap aligned to regulatory and consumer ratings changes. The newly launched Delta S3 Spin simulator received its first order late in FY 2025 and further orders in FY 2026.
**Medium-Term Growth Ambitions** AB Dynamics remains committed to its medium-term growth targets, including average organic growth of 10% per year, margin expansion to greater than 20%, and strong cash generation.
**Current Trading and Outlook** The Group expects adjusted operating profit for FY 2026 to be in line with current market expectations, with a 55-60% revenue bias towards the second half of the year. The order book at the period end was £47 million, providing good visibility for the rest of FY 2026.
**Dividend** An interim dividend of 3.08p per share was declared, a 10% increase from the previous year, reflecting the Boards confidence in the Groups financial position and prospects.
Despite short-term challenges, AB Dynamics remains optimistic about its long-term growth prospects, supported by structural and regulatory drivers in the automotive sector.
Financial MetricH1 2026 (£m)H1 2025 (£m)Change (%)
Revenue48.858.0-16%
Gross Margin63.7%60.2%+350bps
Adjusted EBITDA11.312.9-12%
Adjusted Operating Profit9.110.8-16%
Adjusted Operating Margin18.6%18.6%0%
Net Cash39.327.2+44%
Debt (Lease Liabilities)(3.6)(3.4)-6%
### Key Observations: 1. **Revenue Decline**: Revenue decreased by 16% year-on-year, primarily due to delays in order intake and weaker volumes in the VadoTech Testing Services business in China. 2. **Margin Improvement**: Gross margin improved by 350 basis points to 63.7%, driven by operational improvements and positive revenue mix. 3. **Profitability**: Adjusted operating profit declined by 16%, but the adjusted operating margin was maintained at 18.6% due to cost mitigation actions. 4. **Cash Position**: Net cash increased significantly by 44% to £39.3m, reflecting strong working capital discipline. 5. **Debt**: Lease liabilities increased slightly by 6%, but overall debt remains minimal compared to cash reserves.
Open Terminal Source RNS
PSON
PSON Pearson PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
EXPN
EXPN Experian PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
TCF
TCF Theracryf Plc
06:01
Market

Non-Binding Proposal to Acquire TheraCryf’s Assets

TheraCryf plc received and rejected a non-binding, indicative proposal to acquire its lead neuropsychiatry assets, the Orexin-1 (Ox-1) and dopamine transporter (DAT) programs. The Board deemed the offer undervaluing the assets current and …

TheraCryf plc received and rejected a non-binding, indicative proposal to acquire its lead neuropsychiatry assets, the Orexin-1 (Ox-1) and dopamine transporter (DAT) programs. The Board deemed the offer undervaluing the assets current and future potential, particularly the Ox-1 program, which targets addiction in a $42 billion market. Fully funded to reach Phase 1 clinical study by Q4 2026, the Ox-1 program is seen as a significant value driver. CEO Dr. Huw Jones emphasized the assets strategic importance and potential, citing recent industry transactions valuing similar assets at up to $7.8 billion. TheraCryf remains committed to advancing its programs to enhance shareholder value.
Proposals
Open Terminal Source RNS
BATS
BATS British American Tobacco PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BAB
BAB Babcock International Group…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
AEP
AEP Anglo-Eastern Plantations P…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
RKT
RKT Reckitt Benckiser Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
COBR
COBR Cobra Resources PLC
06:01
Market

Further High-Grade Copper Results Support Scale

Open Terminal Source RNS
PRU
PRU Prudential plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PTEC
PTEC Playtech Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BPM
BPM B P Marsh and Partners PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
FAIR
FAIR Fair Oaks Income Limited
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PROC
PROC Procook Group PLC
06:01
Market

Fourth quarter trading update

ProCook Group PLC reports strong Q4 and full-year FY26 results, significantly outperforming the UK kitchenware market. Revenue grew 19.2% in Q4 to £18.5m and 23.0% for the full year to £85.5m, driven by both retail and ecommerce channels. …

ProCook Group PLC reports strong Q4 and full-year FY26 results, significantly outperforming the UK kitchenware market. Revenue grew 19.2% in Q4 to £18.5m and 23.0% for the full year to £85.5m, driven by both retail and ecommerce channels. Like-for-like revenue increased 9.9% in Q4 and 11.8% for the year. The company opened 13 new stores, expanded its digital content library, and increased its Revolving Credit Facility to £15m. EBITDA is expected to be slightly ahead of market expectations, while operating profit and PBT are in line. ProCook ended the year with a net cash position of £4.4m and £20.4m in available liquidity. The company remains focused on growth, aiming for 100 stores, £100m revenue, and a 10% operating profit margin.
MetricFY25FY26YoY Change
Revenue (£m)69.585.5+23.0%
Ecommerce Revenue (£m)25.531.3+22.9%
Retail Revenue (£m)44.054.2+23.1%
LFL Revenue (£m)62.971.1+11.8%
Ecommerce LFL Revenue (£m)25.030.4+21.2%
Retail LFL Revenue (£m)37.940.7+5.7%
Net Cash Position (£m)1.04.4+340.0%
Available Liquidity (£m)10.020.4+104.0%
Open Terminal Source RNS
SAA
SAA M&C Saatchi
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
OXIG
OXIG Oxford Instruments PLC
06:01
Market

Trading Update

Oxford Instruments PLC reports a resilient full-year performance for FY26, in line with market expectations. Key highlights include: - **Order intake** up ~8% on an organic constant currency (OCC) basis, with a book-to-bill ratio of ~1.0…

Oxford Instruments PLC reports a resilient full-year performance for FY26, in line with market expectations. Key highlights include
**Order intake** up ~8% on an organic constant currency (OCC) basis, with a book-to-bill ratio of ~1.07.
**Advanced Technologies (AT) division** saw ~30% OCC order growth, driven by compound semiconductor market tailwinds and volume manufacturing customers.
**Imaging & Analysis (I&A) division** returned to growth in H2, with full-year orders marginally up on an OCC basis.
**Revenue** significantly improved in H2, slightly positive on an OCC basis.
**Operating profit margin** benefited from cost restructuring and H2 revenue growth.
**Share buyback program** progressed, with £11.7m of the second £50m tranche completed by March 2026.
Strong momentum and order book position the Group well for growth in FY27 and beyond. Preliminary results will be presented on June 9, 2026.
MetricFY25FY26Change
Order Intake (OCC)N/A+8%+8% (YoY)
Book-to-Bill RatioN/A1.07N/A
Imaging & Analysis Order Intake (OCC)N/AMarginally UpMarginally Up (YoY)
Advanced Technologies Order Intake (OCC)N/A+30%+30% (YoY)
H2 Revenue (OCC)N/ASlightly PositiveSlightly Positive (YoY)
Operating Profit MarginN/AImprovedImproved (YoY)
Share Buyback (Completed)N/A£61.7m (out of £100m)N/A
**Note:** Since the provided text does not contain specific financial figures for FY25, the table compares the changes and expectations for FY26 based on the available information. The "Change" column indicates the year-on-year comparison where possible.
Open Terminal Source RNS
CLBS
CLBS Celebrus Technologies plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
GSK
GSK GSK plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
TRIG
TRIG Renewables Infrastructure G…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
SPMU
SPMU Spiritus Mundi PLC
06:01
Market

Update on Proposed Acquisition

Open Terminal Source RNS
SOS
SOS Sosandar Plc
06:01
Market

Full Year Trading Update

Sosandar PLC reports strong FY26 performance with 14% revenue growth to £42.3m, driven by 24% increase in own site sales. Profit before tax (PBT) reached £0.4m, in line with market expectations, and gross margin improved to 63.9%. Net cash…

Sosandar PLC reports strong FY26 performance with 14% revenue growth to £42.3m, driven by 24% increase in own site sales. Profit before tax (PBT) reached £0.4m, in line with market expectations, and gross margin improved to 63.9%. Net cash increased to £8.4m, supported by cash generation and share buybacks. The company maintained strong performance across all categories and third-party partnerships, with stores showing positive uplifts, though still impacting overall profitability. The Board remains confident in sustainable, profitable growth.
MetricFY26FY25Year-on-Year Change
Total Revenue (£m)42.337.1+14%
Own Site Revenue (£m)N/AN/A+24%
Profit Before Tax (£m)0.4-0.1+500%
Gross Margin (%)63.962.1+1.8%
Net Cash (£m)8.47.3+15%
Open Terminal Source RNS
GRP
GRP Greencoat Renewables PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PPET
PPET Patria Private Equity Trust
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
ENW
ENW Enwell Energy plc
06:01
Market

Q1 2026 Operations Update

Open Terminal Source RNS
PIN
PIN Pantheon International PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
IWG
IWG IWG PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
IMI
IMI IMI PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
FDEV
FDEV Frontier Developments Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
STJ
STJ St. Jamess Place plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PAGE
PAGE Pagegroup PLC
06:01
Market

FIRST QUARTER 2026 TRADING UPDATE

Open Terminal Source RNS
HILS
HILS Hill & Smith Holdings PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
RMMC
RMMC River and Mercantile UK Mic…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PYC
PYC Physiomics Plc
06:01
Market

Physiomics Awarded New Contract by Numab

Physiomics PLC has been awarded a new contract by Numab Therapeutics AG to develop a mechanistic pharmacokinetic-pharmacodynamic (PK/PD) modelling framework for a new oncology program. The project, starting in April 2026 and completing in …

Physiomics PLC has been awarded a new contract by Numab Therapeutics AG to develop a mechanistic pharmacokinetic-pharmacodynamic (PK/PD) modelling framework for a new oncology program. The project, starting in April 2026 and completing in Q3 2026, will support proof-of-concept activities and strategic decision-making. This collaboration strengthens Physiomics relationship with Numab Therapeutics, highlighting the integration of model-informed approaches in drug development.
NewContract
Open Terminal Source RNS
N91
N91 Ninety One PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
OMI
OMI Orosur Mining Inc
06:01
Market

New mineralised zone discovered near Pepas

Open Terminal Source RNS
GFTU
GFTU Grafton Group plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CLDN
CLDN Caledonia Investments
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
SEQI
SEQI Sequoia Econ Infrastructure
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CHRY
CHRY Chrysalis Investments Ltd
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
GMR
GMR Gaming Realms plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
SNX
SNX Synectics plc
06:01
Market

Posting of Annual Report & Accounts, Notice of AGM

Open Terminal Source RNS
EDIN
EDIN Edinburgh Investment Trust
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
UTG
UTG Unite Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
NCC
NCC NCC Group plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
THS
THS Tharisa plc
06:01
Market

Production Report Q2 FY2026

Open Terminal Source RNS
INPP
INPP International Public Partne…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
FEVR
FEVR Fevertree Drinks Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
KEFI
KEFI KEFI Gold and Copper Plc
06:01
Market

General Meeting Statement

Open Terminal Source RNS
KLR
KLR Keller Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
RHR
RHR Responsible Housing REIT PLC
06:01
Market

Martello update

Open Terminal Source RNS
SUNB
SUNB SUNBELT RENTALS HOLDINGS CDI
06:01
Market

Share Repurchase Program - Weekly Report

Open Terminal Source RNS
BRGE
BRGE BlackRock Greater Europe In…
06:01
Market

Total Voting Rights

Open Terminal Source RNS
SRB
SRB Serabi Gold PLC
06:01
Market

Reports Q1-2026 Production & Operational Highlights

Open Terminal Source RNS
NBPE
NBPE NB Private Equity Partners …
06:01
Market

NBPE Announces Transaction in Own Shares

Open Terminal Source RNS
EDV
EDV Endeavour Mining Corp
06:01
Market

Holding(s) in Company

<mark style="background-color:yellow">TR1</mark> Buy

<mark style="background-coloryellow">TR1</mark> Buy
['City and country of registered office (if applicable) New York, NY USA', 'applicable) 8.0133 8.0133 19,323,642', 0]
Open Terminal Source RNS
TTE
TTE TotalEnergies SE
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
POLN
POLN Pollen Street PLC
06:01
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['BlackRock, Inc.', '5.350000', '4.990000']
Open Terminal Source RNS
KGF
KGF Kingfisher PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
QQ.
QQ. QQ.
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
RCN
RCN Redcentric
06:01
Market

Exercise of Options

Open Terminal Source RNS
13AA
13AA 13AA
06:01
Market

XS1579297638 Partial Buyback 15 April 2026

Open Terminal Source RNS
KNOS
KNOS Kainos Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
AVAP
AVAP Avation PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
VEIL
VEIL Vietnam Enterprise Investme…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CYPC
CYPC China Yangtze Power Co. Ltd…
06:01
Market

1st Quarter Results

Open Terminal Source RNS
93TH
93TH 93TH
06:01
Market

Issue of Debt

Open Terminal Source RNS

Digested News

The ticker catalyst tape is rendered as native mobile cards. Articles and ticker links stay clickable.

IGET logo
Latest RNS 15:59
IGET

Issue of Equity

Invesco Perpetual Select Trust plc - Global Equity Income Share Portfolio

SBO logo
Latest RNS 15:45
SBO

Holding(s) in Company

Schroder British Opportunities Trus

TR1 Buy
['Philip J Milton & Company Plc', '3.010000', 0]
FGP logo
Latest RNS 15:25
FGP

Director/PDMR Shareholding

FirstGroup PLC

<mark style="background-coloryellow">Purchase</mark> of Partnership Shares under the FirstGroup SIP
BGS logo
Latest RNS 15:06
BGS

Holding(s) in Company

Baillie Gifford Shin Nippon PLC

TR1 Buy
['City of London Investment Management Company Limited', '10.920000', '11.410000']
ONT logo
Latest RNS 15:01
ONT

Share Incentive Plan - Director/PDMR Shareholding

Oxford Nanopore Technologies Ltd

Under the SIP, the SIP Trustee will award each participating employee one Matching Share (as defined in the SIP) for each Ordinary Share <mark style="background-color:yellow">purchase</mark>d by the employee under the SIP. On 14 April 2026, the Company issued 136 Ordinary Shares to the SIP Trustee to hold on behalf of Francis Van Parys to satisfy the Matching Shares awarded under the SIP to him on that date, and 136 Ordinary Shares to the SIP Trustee to hold on behalf of Nick Keher to satisfy the Matching Shares awarded under the SIP to him on that date.
BGCG logo
Latest RNS 14:54
BGCG

Holding(s) in Company

Baillie Gifford China Growth Trust PLC

TR1 Buy
['City of London Investment Management Company Limited', '22.170000', '21.010000']
ALT logo
Latest RNS 14:26
ALT

Director/PDMR Dealing

Altitude Group Plc

Bob Wigley, Non-Executive Director, <mark style="background-color:yellow">purchase</mark>d 200,000 Ordinary Shares at an average price of 24.75 pence per share. Following the purchase of Ordinary Shares, Bob Wigleys beneficial holding is 400,000 Ordinary Shares, representing approximately 0.55% of the Companys issued share capital.
IPF logo
Latest RNS 14:26
IPF

Form 8.3

International Personal Finance PLC

IPF logo
Latest RNS 14:26
IPF

Form 8.3

International Personal Finance PLC

FTV logo
Latest RNS 14:16
FTV

Final Results

Foresight VCT PLC

**Summary**
Foresight VCT plc, managed by Foresight Group LLP, released its final results for the year ended 31 December 2025, approved by the Board of Directors on 13 April 2026. The company reported a Net Asset Value (NAV) Total Return per share of 0.1%, with dividends of 10.5p leading to a 10.4p fall in NAV from 82.0p to 71.6p. Key financial highlights include a special interim dividend of 6.4p and a final dividend of 4.1p, distributing £19.3 million and £12.4 million respectively. The company made six new investments totaling £7.8 million and twelve follow-on investments costing £7.7 million. The value of the investment portfolio decreased by £8.4 million, driven by the sale of an investment for £24.3 million and a loan repayment of £0.1 million, offset by new and follow-on investments. The company raised £38.6 million through a share offer in January 2026 and recommends a final dividend of 3.6p per share for 2025. The Chair’s statement highlights a 16.0% dividend yield, including a special dividend, and emphasizes the company’s diversified portfolio resilience in a challenging economic environment. The company maintains its strategic objectives, including paying annual dividends of at least 5% of NAV, achieving a NAV Total Return <mark style="background-color:yellow">above</mark> 5%, and implementing regular share buybacks. The Board and Manager remain committed to these goals, despite the flat performance in 2025, and are focused on long-term value creation for shareholders.
Year-on-Year Financial and Debt Comparison (2024 vs 2025)
Metric20242025Change
Net Asset Value (NAV) (£ million)222.9214.0-8.9 (-4.0%)
NAV per share (pence)82.071.6-10.4 (-12.7%)
Total Dividends Paid (£ million)31.731.70 (0.0%)
Dividend per share (pence)10.510.50 (0.0%)
Investment Portfolio Value (£ million)166.6158.2-8.4 (-5.0%)
New Investments (£ million)14.315.5+1.2 (+8.4%)
Follow-on Investments (£ million)7.77.70 (0.0%)
Proceeds from Disposals (£ million)36.524.4-12.1 (-33.1%)
Debt (Amounts falling due within one year) (£ million)3.32.2-1.1 (-33.3%)
Cash and Cash Equivalents (£ million)55.955.2-0.7 (-1.3%)
### Key Observations: 1. **Net Asset Value (NAV):** Decreased by 4.0% from £222.9 million in 2024 to £214.0 million in 2025, primarily due to dividend payments and investment losses. 2. **NAV per Share:** Fell by 12.7% from 82.0p to 71.6p, reflecting the decrease in NAV and the impact of dividends. 3. **Dividends:** Remained consistent at £31.7 million, with no change in dividend per share. 4. **Investment Portfolio:** Decreased by 5.0% from £166.6 million to £158.2 million, driven by a successful realisation and loan repayment, offset by new and follow-on investments. 5. **Debt:** Reduced by 33.3% from £3.3 million to £2.2 million, indicating improved liquidity. 6. **Cash and Cash Equivalents:** Slightly decreased by 1.3% from £55.9 million to £55.2 million, reflecting operational and investment activities.
AA4 logo
Latest RNS 14:01
AA4

Form 8.3

Amedeo Air Four Plus Limited

SCT logo
Latest RNS 14:00
SCT

Holding(s) in Company

Softcat plc

TR1 Buy
['JPMorgan Asset Management Holdings Inc.', '4.612059', '4.559041']
NFG logo
Latest RNS 13:21
NFG

Holding(s) in Company

Next 15 Group PLC

TR1 Buy
['Liontrust Investment Partners LLP', '11.142000', '10.419000']
BGEU logo
Latest RNS 12:46
BGEU

Holding(s) in Company

Baillie Gifford European Growth Trust PLC

TR1 Buy
['1607 Capital Partners, LLC', '9.532047', '10.088416']
LST logo
Latest RNS 12:27
LST

Holding(s) in Company

Light Science Technologies Holdings PLC

TR1 Buy
['Simon Deacon', '9.69', '28.89']
IPF logo
Latest RNS 11:10
IPF

Form 8.3

International Personal Finance PLC

LST logo
Latest RNS 11:05
LST

Holding(s) in Company

Light Science Technologies Holdings PLC

TR1 Buy
['Dr Graham Cooley', '4.18', '8.71']
AA4 logo
Latest RNS 10:41
AA4

Form 8.3

Amedeo Air Four Plus Limited

IPF logo
Latest RNS 10:38
IPF

Form 8.3

International Personal Finance PLC

CURY logo
Latest RNS 09:57
CURY

Holding(s) in Company

Currys PLC

TR1 Buy
['JPMorgan Asset Management Holdings Inc.', '4.999805', '5.007933']
DGE logo
Latest RNS 08:53
DGE

Director/PDMR Shareholding

Diageo PLC

1. <mark style="background-coloryellow">purchase</mark> of partnership shares using deductions from salary
and
ASL logo
Latest RNS 08:43
ASL

Holding(s) in Company

Aberforth Smaller Companies Trust PLC

TR1 Buy
['Evelyn Partners Limited', '4.852125', '5.081000']
BRSC logo
Latest RNS 08:29
BRSC

Holding(s) in Company

Blackrock Smaller Companies Trust PLC

TR1 Buy
['Saba Capital Management, L.P.', '2.568941', '2.311881']
YNGA logo
Latest RNS 08:29
YNGA

Holding(s) in Company

Young & Co’S Brewery A

TR1 Buy
['FitzWalter Capital Limited', '15.349468', '14.408009']
PZC logo
Latest RNS 07:44
PZC

Director/PDMR Shareholding

PZ Cussons PLC

Dividend reinvestment and <mark style="background-color:yellow">purchase</mark> of Ordinary shares of 1p each in PZ Cussons plc
EOT logo
Latest RNS 07:41
EOT

Holding(s) in Company

European Opportunities Trust plc

TR1 Buy
['1607 Capital Partners, LLC', '10.641627', '11.875311']
AMOI logo
Latest RNS 06:30
AMOI

Anemoi enters into amended and updated binding Sale and Purchase Agreement to acquire Trasna, Share Consolidation and Warrantholder Surrender and Subscription Offer

Anemoi International Ltd

Anemoi International Ltd has entered into an amended and updated binding Sale and Purchase Agreement to acquire Trasna Solutions FZ LLC via a reverse takeover (RTO), valuing Trasna at $150 million. The transaction includes a share consolidation (1 for 100 reverse stock split), a voluntary warrant surrender and subscription offer for existing warrantholders at £0.02 per share, and a proposed name change to Trasna Ltd upon completion. The deal is subject to conditions, including due diligence and a fundraise, with readmission to the London Stock Exchanges Main Market planned post-RTO. Shareholders are cautioned that the transaction may not proceed or terms may change.
Offers
FIN logo
Latest RNS 06:06
FIN

Launch of Retail Offer

Finseta Plc

Finseta PLC, a foreign exchange and payments solutions company, announced a retail offer to raise up to £0.1 million by issuing new ordinary shares at 8.5 pence each. The offer is open to existing UK-based shareholders, with a minimum subscription of £100. The proceeds will be used alongside funds from a placing and subscription to support the companys operations. The retail offer is conditional on the completion of the placing and subscription, with shares expected to be admitted to trading on AIM around 20 April 2026.
Launch
ITRK logo
Latest RNS 06:02
ITRK

Strategic Review Initiation & Trading Statement

Intertek Group PLC

Intertek Group PLC initiates a strategic review to evaluate the potential separation of Intertek Energy & Infrastructure from Intertek Testing & Assurance, aiming to accelerate growth and create two specialist, global ATIC businesses. The review, concluding by mid-2027, assesses whether a sale or demerger would unlock full potential, enhance focus, and improve capital allocation. Intertek reports strong Q1 2026 performance with 5.4% LFL revenue growth, reiterates full-year guidance, and highlights robust demand across divisions, except for stable performance in World of Energy. The company emphasizes its AAA strategy, strong cash flow, and commitment to delivering value for shareholders through disciplined execution and strategic focus.
Metric2026 (Q1)2025 (FY)2024 (FY)Year-on-Year Change (2026 vs 2025)Year-on-Year Change (2025 vs 2024)
Group Revenue£838.5m£3,431.6m£3,393.2m3.7% (actual), 6.7% (constant currency)1.1% (actual), 4.3% (constant currency)
LFL Revenue£828.3m£3,416.3m£3,391.8m2.4% (actual), 5.4% (constant currency)0.7% (actual), 3.9% (constant currency)
Consumer Products Revenue£232.6m£902.5m (2025)£884.3m (2024)2.5% (actual), 6.5% (constant currency)2.1% (actual), 5.8% (constant currency)
Corporate Assurance Revenue£126.5m£485.6m (2025)£468.9m (2024)8.2% (actual), 10.8% (constant currency)3.6% (actual), 7.2% (constant currency)
Health and Safety Revenue£92.2m£350.9m (2025)£337.2m (2024)16.3% (actual), 15.8% (constant currency)4.1% (actual), 6.8% (constant currency)
Industry and Infrastructure Revenue£209.9m£788.0m (2025)£786.3m (2024)2.8% (actual), 6.7% (constant currency)0.2% (actual), 3.5% (constant currency)
World of Energy Revenue£177.3m£904.6m (2025)£916.5m (2024)(2.4%) (actual), 0.2% (constant currency)(1.3%) (actual), 1.8% (constant currency)
Net Financial Debt (FY)N/A£930-980m (FY26 Guidance)£880m (2025)~5.7% - 11.4% increase (estimated)N/A
HVO logo
Latest RNS 06:02
HVO

hVIVO launches unified brand identity

hVIVO plc

hVIVO plc announces a unified brand identity, marking its strategic transformation into a fully integrated clinical development partner. The rebrand follows the successful integration of Venn Life Sciences, CRS, and Cryostore, simplifying the groups structure under the hVIVO brand. The company now operates through four integrated service lines: Consulting, Clinical Trials, Human Challenge Trials, and Laboratories, offering a seamless pathway from pre-clinical strategy to clinical proof-of-concept. This transformation aims to accelerate drug development, reduce complexity, and provide high-quality human data for clients. CEO Yamin Mo Khan emphasizes the unified brands ability to help pharmaceutical and biotech companies bring medicines to patients faster.
Launch
ANIC logo
Latest RNS 06:01
ANIC

Tropic’s product receives regulatory approval

Agronomics Ltd

Tropic Biosciences, a portfolio company of Agronomics Limited, has received regulatory approval in Japan and Brazil for its non-browning banana variety. This approval allows the banana to be imported, sold, and consumed in both countries, with Brazil also permitting its cultivation. The development supports sustainability, reduces food waste, and expands market opportunities. Tropics innovation, launched in 2025, marks the first new commercial banana variety in over 75 years and was named one of TIME Magazines Best Inventions of 2025. The approvals in Japan and Brazil, two critical markets, enhance Tropics global regulatory footprint, reinforcing its leadership in agricultural biotechnology. Agronomics, with a 1.6% stake in Tropic, highlights the significance of these approvals in validating Tropics platform and unlocking commercial potential.
Approvals
MKA logo
Latest RNS 06:01
MKA

HYPROMAG AND MKANGO RARE EARTHS UK TO COLLABORATE

Mkango Resources Ltd

HyProMag and Mkango Rare Earths UK have been awarded a £6.5 million grant under the UKs DRIVE35 R&D competition to develop recycled neodymium-iron-boron (NdFeB) magnets for high-grade automotive applications. The project, named REACT UK, aims to establish a full circular supply chain for these magnets in the UK, combining advanced recycling methods and hydrogen-based processing to enhance sustainability and supply security. Led by HyProMag, the consortium includes Mkango UK, EMR Group, Jaguar Land Rover, Less Common Metals, and the University of Birmingham. The project will run for three years, with £3.2 million (49%) funded by the UK government. This initiative supports the UKs transition to zero-emission mobility and strengthens domestic manufacturing capabilities.
Collaborate
SEED logo
Latest RNS 06:01
SEED

Investment in Clean Food Group Funding Round

Seed Innovations Ltd

Seed Innovations Ltd (AIMSEED) has invested £260,000 in a £4.5 million funding round for its portfolio company, Clean Food Group (CFG), a UK biotech manufacturer of sustainable oils and fats. The funding, led by Clean Growth Fund and New Agrarian Company Limited, is structured as a convertible loan note (CLN) with a 12% annual coupon, maturing in August 2027. This investment supports CFGs scale-up of its Knowsley fermentation facility, positioning it as the worlds largest manufacturer of yeast-derived oils and fats. SEEDs total exposure to CFG, including equity and CLN, reaches £1.98 million, with CFG valued at £1.7 million in SEEDs 2025 Interim Report. CFG, pre-revenue with £13 million raised to date, aims to address supply chain fragility and sustainability in the global food system, targeting a sustainable food market projected to reach US$524 billion by 2032.
Premium Placing
PRU logo
Latest RNS 06:01
PRU

Director/PDMR Shareholding

Prudential plc

Acquisition of shares through the Prudential All Employee Share <mark style="background-color:yellow">Purchase</mark> Plan
FLTR logo
Latest RNS 06:01
FLTR

Holding(s) in Company

Flutter Entertainment PLC

TR1 Buy
['Bank of America Corporation', '2.873447', '0.309604']
HAS logo
Latest RNS 06:01
HAS

Director/PDMR Shareholding

Hays plc

<mark style="background-coloryellow">Purchase</mark> of shares at a price of 27p per share under the Hays plc US Employee Stock Purchase Plan on 13 April 2026. In accordance with the Plan rules, the shares will be held in a Holding Period of one year.
ESO logo
Latest RNS 06:01
ESO

Director/PDMR Shareholding

EPE Special Opportunities Limited

<mark style="background-coloryellow">Purchase</mark> of ordinary shares
GMS logo
Latest RNS 06:01
GMS

2025 Financial Results

Gulf Marine Services PLC

**Summary**
Gulf Marine Services PLC (GMS) reported its 2025 financial results, highlighting a 12% increase in revenue to US$188.1 million and adjusted EBITDA to US$112.9 million, driven by an additional leased vessel and higher day rates. Adjusted net profit rose 30% to US$41.8 million, while net profit decreased 49% to US$19.5 million due to impairment charges and tax expenses. Fleet utilization dropped to 87% due to maintenance and geopolitical disruptions. Net leverage improved to 1.39x, and net bank debt reduced to US$156.6 million. The company secured new contracts totaling 15.4 years, increasing its backlog to US$606 million. Despite geopolitical challenges, GMS maintained operational reliability and safety standards, achieving zero Lost Time Injury Rate (LTIR) and Total Recordable Injury Rate (TRIR). The company acquired a new mid-class vessel and aims to double its 2024 adjusted EBITDA by 2030. However, the ongoing geopolitical situation in the Gulf region poses risks, leading to a cautious outlook for 2026 and the suspension of dividend declarations. Management is closely monitoring the impact on operations and financial performance.
Financial Metric2023 (US$m)2024 (US$m)2025 (US$m)2025 vs 2024 Change
Revenue151.6167.5188.1+12%
Adjusted EBITDA87.5100.4112.9+12%
Adjusted Net Profit9.832.241.8+30%
Net Profit42.138.319.5-49%
Net Bank Debt267.3201.2156.6-22%
BLOE logo
Latest RNS 06:01
BLOE

Binding Framework Agreement - Project III Farm Out

Block Energy PLC

Block Energy plc has signed a binding Framework Agreement with Zhijiang Sanning Energy Co. Ltd for the farm-out of Project III in Georgia. Sanning will acquire 51% of Project III, carrying up to USD 75 million in costs for appraisal drilling and early facilities construction. Block retains 49% and operatorship, while keeping 100% ownership of other projects and existing production. The deal focuses on appraising the Patardzueli-Samgori field, with potential expansion to Rustavi and Teleti fields, targeting 2.77 TCF 2C Contingent Resources and a gross success case NPV10 of USD 2.2 billion. Final agreements are expected in H2 2026, with operations starting in 1H 2027, pending approvals. The partnership leverages Blocks upstream expertise and Sannings downstream capabilities, enhancing Georgias energy security and investment appeal.
Agreement
PRV logo
Latest RNS 06:01
PRV

AGM Trading Update

Porvair plc

Porvair plcs AGM trading update highlights that the groups performance in the first four months of 2026 is in line with expectations, with 5% constant currency revenue growth. Key points include
Strong aerospace order bookscontinued robust nuclear demandand subdued petrochemical sales.
Steady life sciences consumables orders and stable environmental instrument demand in the Laboratory division.
Firm aluminium and superalloys demand in Metal Melt Quality, with progress on the new US manufacturing line and successful Drache acquisition integration.
Unchanged full-year performance expectations, supported by a diversified portfolio, recurring revenue, and disciplined management.
Increased focus on M&A opportunities, with no change to long-term strategic outlook.
Upcoming Capital Markets Event in October 2026 and interim results announcement in June 2026.
Since the provided text does not contain specific financial or debt figures for comparison, I cannot generate an HTML table with year-on-year comparisons. However, I can provide a generic HTML table structure that you can use to input the relevant data if it becomes available:
Metric20252026Change
Revenue Growth5%
Debt
If you provide the actual financial and debt figures, I can populate this table accordingly.
AMCO logo
Latest RNS 06:01
AMCO

Final Results, Analyst Briefing & Investor Pres

Amcomri Group plc

Amcomri Group PLC reported strong financial results for the year ending December 31, 2025, with a 22% increase in revenue to £70.9 million, a 19.3% rise in adjusted EBITDA to £9.2 million, and a 145% surge in profit before tax to £4.1 million. The companys Buy, Improve, Build strategy drove organic and acquisitive growth, with acquisitions like EMC Elite Engineering and Radnor Technologies expanding its service offerings. Operational highlights included growth across both divisions, improved gross margins, and a strengthened team. Post-year-end, Amcomri acquired the National Compliance and Testing division of Enerveo Limited, further enhancing its market position. The company remains well-positioned for future growth with a strong acquisition pipeline and positive trading conditions in key markets.
Financial Metric2024 (£'000)2025 (£'000)Change (£'000)Change (%)
Revenue58,06670,93812,87222%
Adjusted EBITDA7,7009,2001,50019.3%
Profit Before Tax1,6754,1062,431145%
Net Debt6,10011,2005,10083.6%
Cash Balances12,1008,600(3,500)(28.9%)
### Explanation: 1. **Revenue**: Increased by £12,872,000 (22%) from £58,066,000 in 2024 to £70,938,000 in 2025. 2. **Adjusted EBITDA**: Increased by £1,500,000 (19.3%) from £7,700,000 in 2024 to £9,200,000 in 2025. 3. **Profit Before Tax**: Increased by £2,431,000 (145%) from £1,675,000 in 2024 to £4,106,000 in 2025. 4. **Net Debt**: Increased by £5,100,000 (83.6%) from £6,100,000 in 2024 to £11,200,000 in 2025. 5. **Cash Balances**: Decreased by £3,500,000 (28.9%) from £12,100,000 in 2024 to £8,600,000 in 2025.
HVO logo
Latest RNS 06:01
HVO

Influenza HCT contract signed with Traws Pharma

hVIVO plc

hVIVO plc, a leading clinical development partner, has signed a contract with Traws Pharma to conduct a Phase 2a human challenge trial for their influenza antiviral candidate, tivoxavir marboxil (TXM). The trial, utilizing hVIVOs Influenza Human Challenge Study Model, will assess TXMs safety, tolerability, and efficacy in reducing influenza-induced illness in 150 healthy participants. The study, expected to commence in H1 2026, highlights hVIVOs integrated clinical development services and Traws Pharmas strategy to accelerate TXMs development.
NewContract
IMB logo
Latest RNS 06:01
IMB

Trading Update

Imperial Brands PLC

Imperial Brands PLCs trading update for 14 April 2026 highlights a positive start to its 2030 transformation strategy, with the company reiterating its full-year guidance. Key points include
1. **Revenue Growth**Low-single-digit percent growth expected in tobacco & NGP (Next Generation Products) net revenue for H1 2026, driven by robust tobacco pricing and NGP innovation.
2. **Profitability**Group adjusted operating profit slightly higher in H1 compared to 2025, with growth accelerating in H2, in line with previous guidance.
3. **Earnings and Cash Flow**On track for at least high-single-digit earnings per share growth and at least £2.2 billion in free cash flow for the full year.
4. **Share Repurchase**Completed £0.7 billion of the £1.45 billion FY26 share buyback as part of an "evergreen" program.
5. **Strategic Initiatives**Progress in becoming more consumer-centric, data-led, and efficient through partnerships (e.g., Capgemini), supply chain optimization, and IT application rollouts.
6. **Geopolitical Risks**Monitoring potential impacts from the Middle East conflict, though no material business impact to date.
7. **Regional Performance**Strong NGP growth in Europe and AAACE regions, offset by challenges in the US, Australia, and Logista.
8. **Forex Impact**Translation foreign exchange expected to be a 2.0-2.5% headwind on H1 earnings per share and 0-1% on full-year earnings.
Interim results for H1 FY26 will be announced on 12 May 2026.
Financial MetricFY2025FY2026 (Expected)Change
Tobacco & NGP Net Revenue GrowthN/ALow-single-digit%N/A
Group Adjusted Operating Profit GrowthN/ASlightly higher than H1 2025N/A
Earnings Per Share GrowthN/AHigh-single-digit%N/A
Free Cash FlowN/A£2.2 billionN/A
Share Repurchase (Completed)£0.1 billion (Oct 2024)£0.7 billion (of £1.45 billion)+£0.6 billion
Net Debt to EBITDA LeverageN/A2.0-2.5 range (lower end)N/A
NGP Adjusted Operating LossesN/AModerately higherN/A
**Notes:** * The table compares expected financials for FY2026 with available data from FY2025. Since specific FY2025 figures are not provided in the text, the "FY2025" column mostly contains "N/A". * "Change" column indicates the difference between FY2026 and FY2025 where applicable. * This table focuses on key financial metrics mentioned in the text, including revenue growth, profit growth, cash flow, share repurchases, leverage, and operating losses.
CRTA logo
Latest RNS 06:01
CRTA

Trading Statement

Cirata plc

Cirata PLC reports a strong Q1 FY26 with its first-ever positive cash flow quarter, a 40% pipeline growth, and improved visibility through new KPIs (ACV, Billings, RCB). The company reaffirms its FY26 cash flow break-even target, highlighting momentum in enterprise sales, particularly with Cirata Symphony, and continued focus on new logo acquisition and existing customer expansion.
MetricQ1 FY26Q4 FY25 (31 Dec 2025)Year-on-Year Change
Cash Flow$0.7m (Positive)Not specified (Negative)First positive cash flow quarter in history
Closing ACV$4.9m$4.8m+2.08%
Billings$2.3mNot specifiedN/A
RCB$5.8mNot specifiedN/A
Cash Balance$4.7mNot specifiedN/A
Trade Receivables$0.7mNot specifiedN/A
Cash Overheads$3.1mNot specifiedN/A
Pipeline Growth+40% (since Jan 2026)Not specifiedN/A
CRPR logo
Latest RNS 06:01
CRPR

Full Year Trading Update

James Cropper PLC

James Cropper plc announces a strong FY26 performance, with adjusted EBITDA of £8.8m (up 30% YoY) and revenue of £103m (up 4% YoY). Advanced Materials saw high single-digit EBITDA growth, while Paper & Packaging significantly reduced losses. Net debt decreased to £8.3m, with a net debt/EBITDA ratio below 1x. Positive trading momentum continues into FY27, with confidence in medium-term growth for both divisions. The company expects to announce audited FY26 results in July 2026.
MetricFY25FY26Change
Adjusted EBITDA (£m)6.678.8+31.9%
Group Revenue (£m)99.0103.0+4.0%
Net Debt (£m)12.98.3-35.7%
Net Debt to EBITDA Ratio1.9x<1.0xImproved
DPP logo
Latest RNS 06:01
DPP

Q1 2026 Trading Update

DP Poland Plc

DP Poland PLC reports strong Q1 2026 performance with 18.9% system sales growth and 13.7% order increase, driven by operational efficiency, promotions, and timely deliveries. Franchise ownership rose to 35%, with four more Pizzeria 105 stores converted. Supply chain optimization and network expansion (141 Dominos stores, 71 Pizzeria 105) supported growth. Poland and Croatia saw robust sales and order increases. The company targets 50% franchise ownership by 2027, 200+ stores, and margin improvement through disposals, automation, and scaling. Outlook remains positive with double-digit growth expected in 2026.
DP Poland PLC - Financials and Debt Comparison (Q1 2026 vs Q1 2025)
MetricQ1 2026Q1 2025YoY Change
Group System Sales (£m)17.214.518.9%
Group System Orders (m)1.31.113.7%
Poland
Total System Sales (PLNm)78.466.318.2%
LFL System Sales (PLNm)67.962.48.9%
Total System Orders (m)1.31.113.3%
LFL System Orders (m)1.11.13.9%
Croatia
Total System Sales (EURm)1.20.928.8%
LFL System Sales (EURm)1.11.09.5%
Total System Orders (m)0.10.120.0%
LFL System Orders (m)0.10.12.0%
Network Expansion
Domino's Stores (YoY Change)141 (+17%)120—
Franchise-Owned Stores (% of Estate)35%12%—
Pizzeria 105 Stores Converted (Cumulative)1713—
ABDP logo
Latest RNS 06:01
ABDP

Half-year Report

Ab Dynamics

**Summary**
AB Dynamics PLC, a designer and manufacturer of advanced testing and simulation products for the global transport market, reported its unaudited interim results for the six months ended 28 February 2026. Key highlights include
**Financial Performance** Revenue decreased by 16% to £48.8 million due to delays in order intake and customer delivery requirements, as well as weaker volumes in the VadoTech Testing Services business in China. Adjusted EBITDA and operating profit also declined, but the operating margin was maintained at 18.6%. Net cash increased to £39.3 million.
**Strategic Review of VadoTech** Due to lower-than-anticipated customer activity in the VadoTech Testing Services business, the Group will undertake a strategic review of this business in the second half of the year. Exceptional items totaling £16.8 million, primarily a non-cash impairment charge, were recorded in relation to VadoTech.
**Innovation and Product Development** The Group continues to focus on innovation, with a technology roadmap aligned to regulatory and consumer ratings changes. The newly launched Delta S3 Spin simulator received its first order late in FY 2025 and further orders in FY 2026.
**Medium-Term Growth Ambitions** AB Dynamics remains committed to its medium-term growth targets, including average organic growth of 10% per year, margin expansion to greater than 20%, and strong cash generation.
**Current Trading and Outlook** The Group expects adjusted operating profit for FY 2026 to be in line with current market expectations, with a 55-60% revenue bias towards the second half of the year. The order book at the period end was £47 million, providing good visibility for the rest of FY 2026.
**Dividend** An interim dividend of 3.08p per share was declared, a 10% increase from the previous year, reflecting the Boards confidence in the Groups financial position and prospects.
Despite short-term challenges, AB Dynamics remains optimistic about its long-term growth prospects, supported by structural and regulatory drivers in the automotive sector.
Financial MetricH1 2026 (£m)H1 2025 (£m)Change (%)
Revenue48.858.0-16%
Gross Margin63.7%60.2%+350bps
Adjusted EBITDA11.312.9-12%
Adjusted Operating Profit9.110.8-16%
Adjusted Operating Margin18.6%18.6%0%
Net Cash39.327.2+44%
Debt (Lease Liabilities)(3.6)(3.4)-6%
### Key Observations: 1. **Revenue Decline**: Revenue decreased by 16% year-on-year, primarily due to delays in order intake and weaker volumes in the VadoTech Testing Services business in China. 2. **Margin Improvement**: Gross margin improved by 350 basis points to 63.7%, driven by operational improvements and positive revenue mix. 3. **Profitability**: Adjusted operating profit declined by 16%, but the adjusted operating margin was maintained at 18.6% due to cost mitigation actions. 4. **Cash Position**: Net cash increased significantly by 44% to £39.3m, reflecting strong working capital discipline. 5. **Debt**: Lease liabilities increased slightly by 6%, but overall debt remains minimal compared to cash reserves.
TCF logo
Latest RNS 06:01
TCF

Non-Binding Proposal to Acquire TheraCryf’s Assets

Theracryf Plc

TheraCryf plc received and rejected a non-binding, indicative proposal to acquire its lead neuropsychiatry assets, the Orexin-1 (Ox-1) and dopamine transporter (DAT) programs. The Board deemed the offer undervaluing the assets current and future potential, particularly the Ox-1 program, which targets addiction in a $42 billion market. Fully funded to reach Phase 1 clinical study by Q4 2026, the Ox-1 program is seen as a significant value driver. CEO Dr. Huw Jones emphasized the assets strategic importance and potential, citing recent industry transactions valuing similar assets at up to $7.8 billion. TheraCryf remains committed to advancing its programs to enhance shareholder value.
Proposals
PROC logo
Latest RNS 06:01
PROC

Fourth quarter trading update

Procook Group PLC

ProCook Group PLC reports strong Q4 and full-year FY26 results, significantly outperforming the UK kitchenware market. Revenue grew 19.2% in Q4 to £18.5m and 23.0% for the full year to £85.5m, driven by both retail and ecommerce channels. Like-for-like revenue increased 9.9% in Q4 and 11.8% for the year. The company opened 13 new stores, expanded its digital content library, and increased its Revolving Credit Facility to £15m. EBITDA is expected to be slightly ahead of market expectations, while operating profit and PBT are in line. ProCook ended the year with a net cash position of £4.4m and £20.4m in available liquidity. The company remains focused on growth, aiming for 100 stores, £100m revenue, and a 10% operating profit margin.
MetricFY25FY26YoY Change
Revenue (£m)69.585.5+23.0%
Ecommerce Revenue (£m)25.531.3+22.9%
Retail Revenue (£m)44.054.2+23.1%
LFL Revenue (£m)62.971.1+11.8%
Ecommerce LFL Revenue (£m)25.030.4+21.2%
Retail LFL Revenue (£m)37.940.7+5.7%
Net Cash Position (£m)1.04.4+340.0%
Available Liquidity (£m)10.020.4+104.0%
OXIG logo
Latest RNS 06:01
OXIG

Trading Update

Oxford Instruments PLC

Oxford Instruments PLC reports a resilient full-year performance for FY26, in line with market expectations. Key highlights include
**Order intake** up ~8% on an organic constant currency (OCC) basis, with a book-to-bill ratio of ~1.07.
**Advanced Technologies (AT) division** saw ~30% OCC order growth, driven by compound semiconductor market tailwinds and volume manufacturing customers.
**Imaging & Analysis (I&A) division** returned to growth in H2, with full-year orders marginally up on an OCC basis.
**Revenue** significantly improved in H2, slightly positive on an OCC basis.
**Operating profit margin** benefited from cost restructuring and H2 revenue growth.
**Share buyback program** progressed, with £11.7m of the second £50m tranche completed by March 2026.
Strong momentum and order book position the Group well for growth in FY27 and beyond. Preliminary results will be presented on June 9, 2026.
MetricFY25FY26Change
Order Intake (OCC)N/A+8%+8% (YoY)
Book-to-Bill RatioN/A1.07N/A
Imaging & Analysis Order Intake (OCC)N/AMarginally UpMarginally Up (YoY)
Advanced Technologies Order Intake (OCC)N/A+30%+30% (YoY)
H2 Revenue (OCC)N/ASlightly PositiveSlightly Positive (YoY)
Operating Profit MarginN/AImprovedImproved (YoY)
Share Buyback (Completed)N/A£61.7m (out of £100m)N/A
**Note:** Since the provided text does not contain specific financial figures for FY25, the table compares the changes and expectations for FY26 based on the available information. The "Change" column indicates the year-on-year comparison where possible.
SOS logo
Latest RNS 06:01
SOS

Full Year Trading Update

Sosandar Plc

Sosandar PLC reports strong FY26 performance with 14% revenue growth to £42.3m, driven by 24% increase in own site sales. Profit before tax (PBT) reached £0.4m, in line with market expectations, and gross margin improved to 63.9%. Net cash increased to £8.4m, supported by cash generation and share buybacks. The company maintained strong performance across all categories and third-party partnerships, with stores showing positive uplifts, though still impacting overall profitability. The Board remains confident in sustainable, profitable growth.
MetricFY26FY25Year-on-Year Change
Total Revenue (£m)42.337.1+14%
Own Site Revenue (£m)N/AN/A+24%
Profit Before Tax (£m)0.4-0.1+500%
Gross Margin (%)63.962.1+1.8%
Net Cash (£m)8.47.3+15%
PYC logo
Latest RNS 06:01
PYC

Physiomics Awarded New Contract by Numab

Physiomics Plc

Physiomics PLC has been awarded a new contract by Numab Therapeutics AG to develop a mechanistic pharmacokinetic-pharmacodynamic (PK/PD) modelling framework for a new oncology program. The project, starting in April 2026 and completing in Q3 2026, will support proof-of-concept activities and strategic decision-making. This collaboration strengthens Physiomics relationship with Numab Therapeutics, highlighting the integration of model-informed approaches in drug development.
NewContract
EDV logo
Latest RNS 06:01
EDV

Holding(s) in Company

Endeavour Mining Corp

<mark style="background-coloryellow">TR1</mark> Buy
['City and country of registered office (if applicable) New York, NY USA', 'applicable) 8.0133 8.0133 19,323,642', 0]
IRSH logo
AI Chartist

IRSH

Today News501
Pulse--
AI Net0
Ticker AI

IRSH

AI sentiment, signals and catalyst scoring — loaded fresh from the site engine for the selected ticker.

Market AI · 2026-04-14

LONDON MARKET CLOSE: Stocks rise, oil falls, on fresh Middle East hope

European stocks advanced, and oil prices slid amid cautious optimism for de-escalation in the Middle East. FTSE 100 closed up 0.3%, FTSE 250 up 2.0%, and AIM All-Share up 1.1%. CAC 40 in Paris and DAX 40 in Frank…

Market AI · 2026-04-14

LONDON MARKET MIDDAY: FTSE 100 flat as oil slips below USD100

London stock prices mixed at midday: FTSE 100 little changed, FTSE 250 up 1.1%, AIM all-share up 0.9%. European equities: CAC 40 up 0.5%, DAX 40 up 1.0%. Markets monitoring Middle East developments, including US …

Market AI · 2026-04-14

LONDON BROKER RATINGS: Morgan Stanley cuts Berkeley and Barratt Redrow

UBS raises Halma price target to 4,775 (4,200) pence - 'buy' Barclays raises Halma price target to 4,550 (4,100) pence - 'overweight' Morgan Stanley raises Convatec price target to 280 (270) pence - 'overweight' …

Market AI · 2026-04-14

LONDON MARKET OPEN: Intertek jumps as oil eases below USD100

London stock prices opened higher on Tuesday, buoyed by a slight oil price pullback and strong corporate updates, despite Middle East tensions. FTSE 100 opened up 0.3% at 10,615.52, FTSE 250 up 0.8% at 22,452.15, a…

Market AI · 2026-04-14

LONDON MARKET EARLY CALL: FTSE 100 seen up as Brent slips below USD100

London stocks set to open slightly higher on Tuesday, with FTSE 100 futures up 0.1% at 10,590.86. Brent crude oil eases below USD100 per barrel despite US blockade on Iranian ports and Strait of Hormuz. Tensions …

🤖
AI Intel
Sentiment scoring · good/bad/net · catalyst intensity · AI groups
Select a ticker above
Nexus Signal

Market Pulse

--pulse
Up
0
Down
0
News501
AI Net0
Movers2
📡
Nexus Signal
Price geometry · AI sentiment · short pressure · catalyst density fused into one read
Select a ticker above
Fundamentals

IRSH

MarketALL-MARKETS
RNS Today501
AI Score—
Business readCatalyst first, then balance-sheet — revenue quality, recurring income and debt maturity are the key filters after a major RNS.
Risk readWatch dilution risk, covenant headroom and customer concentration. Ask whether today's RNS changes the re-rating case.
🔭
Fundamentals
Market cap · broker target · float · valuation ratios · sector context
Select a ticker above
Financials

IRSH

Earnings lensCheck if today's RNS changes revenue timing, cash conversion or funding pressure — then confirm against historical trend.
Balance-sheet lensPrioritise net cash position, debt covenants, working capital and capex direction before acting on price momentum.
Forecast lensRevenue quarterly table, EPS, PE ratios, enterprise value multiples and analyst revisions load with the selected ticker.
📊
P&L / Financials
Revenue · income · cash flow · leverage · EPS · PE ratios
Select a ticker above
Structure DNA

IRSH

MarketALL-MARKETS
Up Count0
RNS Today501
Float structure Ownership pattern TR1 flow Re-rating potential
🧬
Structure DNA
Float · shares out · long/short interest · ownership concentration
Select a ticker above
RNS Today501
Up0
Down0
💎
Capital Radar
Broker targets · director dealing · TR1 flow · institution holders · market position
Select a ticker above
Short Data

IRSH

RNS Today501
MarketALL-MARKETS
AI Net0
Short pressure lensShort data matters most when it conflicts with fresh catalysts — high short interest plus a positive RNS is a squeeze candidate. Low short interest plus bad news has less bounce risk.
🎯
Short Data
Holder positions · % float shorted · borrow cost · squeeze candidates
Select a ticker above
Volatility Lab

IRSH

Movers2
News501
Up0
Execution lensATR defines stop width. Use it to judge whether today's RNS triggered a clean breakout or noise within the daily range.
Volume confirmsVolume expansion on catalyst day is the key signal — high volume on break through resistance confirms the move; low volume warns of fade.
⚡
Volatility Lab
ATR · realized range · volume profile · reaction zones · breakout confirmation
Select a ticker above
🧠
Ask AI
Chart context · RNS news · support/resistance · MACD · catalyst risk — all live
Target path News risk Invalidation Capital flow